Western University

Scholarship@Western
Canadian Journal of Surgery

Digitized Special Collections

7-1-1985

Volume 28, issue 4
Canadian Medical Association

Follow this and additional works at: https://ir.lib.uwo.ca/cjs
Part of the Surgery Commons

Recommended Citation
Canadian Medical Association, "Volume 28, issue 4" (1985). Canadian Journal of Surgery. 167.
https://ir.lib.uwo.ca/cjs/167

This Book is brought to you for free and open access by the Digitized Special Collections at Scholarship@Western.
It has been accepted for inclusion in Canadian Journal of Surgery by an authorized administrator of
Scholarship@Western. For more information, please contact wlswadmin@uwo.ca.

This section provides a medium through which Canadian
surgeons can declare themselves, briefly and informally, on
the day-to-day affairs of surgery.

Occult Breast Cancer and Changing Patterns
of Surgical Practice
Until Egan’s landmark paper in I960,1
breast cancer was diagnosed mainly by
physical examination. Egan demonstrated
that “ occult” breast cancer could be
detected by mammography in patients
who had no clinically palpable lesion.
This observation was greeted with great
skepticism by many surgeons and even
some radiologists. The troubling fact is
that even today there are many physicians
who think that if they cannot feel a lesion,
it’s not there. No one claims that
breast examination can be done by mam
mography alone. It remains complemen
tary to a competent clinical examination.
A clinically suspicious lesion should never
be ignored because the mammogram
appears normal. However, to deny the
value of mammography in picking up
nonpalpable lesions is simply to ignore
established findings. Clinicians who hold
this view must be obtaining less than
optimal films and inexpert radiologic
interpretation.
The concept of minimal breast cancer,
advanced by Gallager and M artin,2
offered the promise that earlier recogni
tion would result in better survival, gener
ally with less surgery. Many minimal
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breast cancers are occult and therefore accept a deviation of 1 cm in either plane.
found only on mammography. Mam This can easily be corrected at surgery.
mography may be considered as part of Needles are held in place with Steristrips,
the work-up in women with symptomatic and no needle has ever become dislodged
breast disease or may be done routinely in moving the patient from the radiol
in selected asymptomatic women (screen ogy department to the operating room.
ing). The commonest occult abnormality Under anesthesia, toluidine blue is
is a cluster of microcalcifications, with or injected through the needle as it is with
without a nodular density. Sometimes drawn. The dye has effectively replaced
architectural distortion without calcifica the needle. Toluidine blue does not
tions may be the clue to a malignant diffuse into the tissues and in several
lesion.
hundred procedures has not caused a sin
In this issue (pages 329 and 330) Maho gle reaction. Incisions are made in the
ney describes his technique of intraope areola whenever possible. Some surgeons
advocate a blind resection of the quad
rative localization of these tumours.
To localize these lesions, we, at the rant harbouring the suspicious area. This
Mount Sinai Hospital in Toronto, favour results in an unacceptable and unneces
a technique of simple needle-guided sary deformity, and the suspicious area
localization which has been developed to may still be missed. We see no merit in
a fine art within our Department of Radi placing a needle into the area of suspicion
ology. Credit must go to Dr. Imre Simor without then taking a two-view mam m o
for his diagnostic acumen and enthusiasm gram to define the relation of the needle
in instituting the technique and teaching to the suspect lesion. Clearly, close and
it to others. Basically, it is the method harmonious teamwork must exist between
described by Libshitz and colleagues.3 It surgeon and radiologist. Roentgenogra
is simple, efficient and satisfactory. Fol phy of the excised tissue is m andatory to
lowing localization, two-view mammo confirm that the microcalcifications seen
graphy is done to correlate the position in the mammogram are present in the
of the needle to the suspect lesion. We specimen. The pathologist is able to cut
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blocks more accurately if he examines the
specimen roentgenogram and has tissue
calcifications marked. We obtain a mam
mogram of the breast 3 months after the
biopsy to prove that the appropriate tis
sue has been excised.
Between January 1977 and December
1983, we performed 595 such needleguided surgical biopsies and found 84 car
cinomas (14%). Of these, 60 (71%) were
infiltrating and 24 (29%) were noninvasive. Carcinoma was found in 24% of the
biopsies done for lesions with microcal
cifications. The incidence of diseased
nodes in the patients with invasive carci
noma was almost 25%, half that usually
found in patients with lesions detected
clinically. Although this is still a high inci
dence, better survival can presumably be

expected in such patients. Occult cancers
must not be considered as less than real
cancers. Women harbouring suspicious
m am m ographic lesions should be
managed aggressively. A cancer detection
rate of one in five is quite acceptable for
clinically diagnosed lesions and should
not present a philosophical problem in the
management of lesions detected by mam
mography. Concern expressed by some
clinicians that this aggressive stance will
induce undue patient apprehension and
morbidity is unfounded. In our ex
perience, practically all patients wish to
have a biopsy if it is recommended, and
feel greatly relieved when the lesion is
found to be benign. Those patients who
are found to have a malignant lesion are
happy that it was detected and treated at

an earlier stage than would have been pos
sible if its discovery had awaited the
development of a palpable mass.
A.A. Bassett, md , frcsc , facs
Director, Breast Treatment Unit,
Mount Sinai Hospital,
600 University Ave.,
Toronto, Ont.
M5G 1X5
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Morbidity Audit, Canadian Society for Vascular Surgery

One of the primary objectives of the
Canadian Society for Vascular Surgery is
to monitor standards of care for patients
with vascular disease by the development
of a national vascular registry. As a step
towards this objective, we established a
30-day hospital morbidity audit in 1982,
the concept being to monitor selected,
commonly performed vascular opera
tions.
The audit form (Fig. 1) records the
number of procedures performed, any
reoperations (revision, hemorrhage,
amputation) and the major complications
(wound infections, graft failure and
death) that occur in hospital or within 30
days of the operation. Since the audit is
keyed to procedures that are billed, the
information can be filled out from the
ward complication book, office surgery
book or from billing cards. Surgeons who
do not have a complication book are
advised to note complications with their
billing cards at least every 3 months. Our
aim is to direct orderly documentation of
complications to identify problem areas.
The form can be completed in about an
hour if the information is organized.
The present audit does not collect
information on symptoms (claudication
versus salvage), outflow or patient selec
tion, which obviously can skew the case
load, complications and results. It does
give a score-card whereby each surgeon
can quickly assess the year’s work and
compare it with the national experience.
As the years go by, he can look back on
his personal profile. As members of the
society develop more experience with the
298

audit, it will be possible to introduce addi
tional important variables to the data col
lected, but this will require more docu
mentation at the time the case is processed
initially and needs enthusiastic partici
pation.
The individual data collected by the
audit are completely confidential. About
half of the active members of the society

reported in 1982 (63) and 1983 (59). An
audit report (Fig. 2) is generated from the
form on an IBM PC (International Busi
ness Machines, Inc.) using Lotus 1-2-3
(Lotus Development Corp., Cambridge,
Mass.) software. This report is circulated
to the membership annually with the
names of the members who participated.
The reported results are good and speak
30 day/hospital morbidity is "early morbidity" and usually
includes the first office visit.
operations and complications.

This is an audit of selected

(We know you do more surgery!).

DIRECTIONS:
Canadian Society for Vascular Surgery
3Q Day / Hospital M orbidity Audit

1)

Chart only the most important procedure at each operation.

2)

If the patient returned to surgery for a

operation (not revision), count it as another "ca

RUPTURED
A .A .A .

3)

Please note cause of each death.

4)

To allow correlation of complications, amputation and

death on individual patients please:

x
x

a) Use a single line for each complicated patient,
charting all his/her complications on that line. 1- once, 2-

b) Use a second form if there are more than 5 patients
who had a complication in any section.

tx

c) If there was an amputation despite a patent
reconstruction, chart ”0 " under occluded.

If not charted 0 the

reconstruction is considered occluded "1" (please chart).

IX

All

other blanks are considered 0 and need not be charted.

•Complicated cases : monitored complications only.

The

r in this box will equal the number of lines you used in eac
section if the form is completed correctly.

•Occluded : this reconstruction was occluded at discharge c
30 days.

•T.N.D. : Transient Neurological Deficit.

FIG. 1—Audit form is completed each year by members of Canadian Society for Vascular
Surgery. It tabulates common procedures performed and major complications.
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tion and provides an opportunity for self Maxwell, J. McGoey, N. McKenzie, G.
Meads, R. Moffat, V. Moonje, J.E.
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Rx Summary
Indications
The follo w in g in fections w hen caused by susceptible
pathogens:
■ upper and low er respiratory tra c t (partic u la rly c h ro n ic
bron c h itis and including acute and c h ro n ic o titis
media)
■ urina ry tract: acute, recurren t and ch ro n ic
■ genital tract: unco m plicated gon o c o c c a l urethritis
■ gastrointestinal tract
■ skin and soft tissue
■ P neum ocystis c a rin ii pneum onitis in infants and
children.
Not in dicated in in fectio ns due to Pseudom onas,
M ycoplasm a or viruses.

Contraindications
Evidence of m arked liver dam age or renal im pairm ent
where repeated serum assays ca n n o t be carried out;
blood dyscrasias; know n hypersensitivity to trim ethop rim
or sulfonam ides.
During pregnancy, and in new born o r prem ature infants
during first few weeks of life.

Precautions
Benefit should be c ritic a lly appraised against risk in
patients w ith liver damage, renal dam age, urina ry
obstruction, blood dyscrasias, allergies, or bronchial
asthma. Reduce dosage in patients w ith renal im pair
ment. Do not adm inister if serum creatinine level is above
2 mg%. C onsider possible supe rinfe ction w ith a non
sensitive organism .

Adverse reactions
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Cases COMPLICATED Rev/T Hg Inf

Operation
Aortic Aneurysm
Ruptured AA
Aortofemoral
Femorofemoral
Axillofemoral
Fem-pop vein
Fem-pop synth
Fem-tibial
Profundaplasty
Totals

721
231
926
258
128
664
476
190
259

50
90
60
17
38
71
66
60
21

3853

473

545

32

Carotid end'y

MORBIDITY

(%)
(6.9)
(39.0)
(6.5)
(6.6)
(29.7)
(10.7)
(13.9)
(31.6)
(8.1)

(7=)
(5.9)

OF

during

Operation
Aortic Aneurysm
Ruptured AA
Aortofemoral
Femorofemoral
Axillofemoral
Fem-pop vein
Fem-pop synth
Fem-tibial
Profundaplasty
Carotid end'y

Rev/T Hg

Amputated
MORTALITY
BK
AK

10
6
23
9
13
18
18
24
6

5
6
3
0
2
6
1
3
1

10
2
11
3
5
19
3
2
5

3
1
11
9
15
37
40
43
6

0
0
7
2
1
8
8
15
4

2
2
9
3
4
6
11
14
6

127

27

60

165

45

57

5

9

2

1

(%)
31
(4.3)
83 (35.9)
21
(2.3)
5 (1.9)
14 (10.9)
7 (1.1)
13
(2.7)
5
(2.6)
2 (0.8)
181

TND Stroke
8
12
5
2.2%

(%)
(0.9)

T H R O M B E C T O M Y / R E V 1S I O N
hospital

v ascular

after

Occl

Occl

10
6
23
9
13
18
18
24
6

0
0
0
0
1
2
1
0
0

0
0
1
1
1
3
1
0
0

1
0
4
2
4
9
7
16
0

(%)
(10.0)
(0.0)
(17.4)
(22.2)
(30.8)
(50.0)
(38.9)
(66.7)
(0.0)

5

1

0

0

(0.0)

Amputated
AK
BK

MORTALITY

2
1
0
3
0
0
2
1
1
1
0
0
0
1
1
2
0
0
4
2
3
6
2
5
2
0
0
TNI Stroke
1
2
0

Dosage
Children: 6 mg trim e th o p rim /k g body weight per day,
plus 30 mg sulfam e th o x a z o le /k g body w eight per day,
divided into tw o equal doses.
Adults an d c hildren over 12 years o f age:
Standard dosage:
1 'B a ctrim ' DS 'R o che' table t or 2 adult tablets, tw ice
daily.
M inimum dosage and dosage fo r long-term treatm ent:
V2 B a ctrim ' DS R oche’ table t or 1 adult tablet, tw ice
daily.
M axim um dosage (overw helm ing infections):
1V2 ‘B a c trim ’ DS 'R o che' table ts or 3 adult tablets, tw ice
daily.
In acute in fectio ns trea t for at least 5 days o r until patient
is asym ptom atic for 48 hours; in urina ry tract infections,
until urine sterile.
U n com plicated gonorrhea: 2 adult table ts or
1 ‘B a ctrim ’ DS ‘R o che’ tab le t fo u r tim es daily fo r 2 days.
P neum ocystis c a rin ii pneum onitis: 20 mg /k g /d a y tri
m ethoprim and 100 m g /k g /d a y sulfam ethoxazole in fo u r
divided doses fo r 14 days.

Supply

stay

reconstruction

Inf

Most frequent: nausea, vom iting, gastric intolerance,
and rash.
Less freq uent: diarrhea, constip ation, flatulence, ano re
xia, pyrosis, gastritis, gastroenteritis, urticaria, head
ache, and liver changes (abnorm al elevations in alkaline
phosphatase and serum transam inase).
O ccasionally reported: glossitis, oliguria, hem aturia,
trem or, vertigo, alopecia, and elevated BUN, NPN, and
serum creatinine.
Hem atological changes: prim arily, neutropenia and
throm bocytopenia, and less frequently, le ukopenia,
aplastic or hem olytic anemia, purpura, agranulocytosis,
and bone m arrow depression; o c c u r particularly in the
elderly and m ostly prove reversible on w ithdraw al.

m

(20.0)
(50.0)
(8.7)
(11.1)
(7.7)
(0.0)
(16.7)
(8.3)
(0.0)
(0.0)

A dult tablets: W hite, capsule-shaped, biconvex table t
w ith ROCHE C engraved on one face and BACTRIM and
indented score on the other, each c o ntaining 80 mg tri
m ethoprim and 400 mg sulfam ethoxazole.
Bottles of 100 and 500. U nit dose, boxes of 100.
DS tablets: W hite, capsule-shaped, biconvex tab le t with
ROCHE engraved on one face and BACTRIM DS and
indented score on the other, each c o ntaining 160 mg
trim ethop rim and 800 mg sulfam ethoxazole.
Bottles of 100 and 250.
Suspension: C herry flavoured, 40 mg trim ethop rim and
200 mg sulfam ethoxazole per 5 ml.
Bottles of 100 and 400 ml.
Pediatric tablets:
x
W hite, cylin d ric a l biplane table t w i t h x Z V
engraved on one face, sin gle scored on the other
with C above and below score line, each containing 20 mg
trim ethoprim and 100 mg sulfam ethoxazole.
Bottles of 100.
Solution for Infusion: 5 ml amber-coloured ampoules,
containing 80 mg trimethoprim (16 m g/m l) and 400 mg
sulfamethoxazole (80 m g/m l) for infusion with D5W,
Ringer’s solution or NaCl 0.9% solution. Packs of
25 ampoules.
Product m onograph available on request.
TM: Trade Mark of H offm ann-La R oche Lim ited
®Reg. Trade Mark

(59 surgeons reported)

FIG. 2—This audit report is generated from audit form on personal computer and circu
lated to membership annually. COMPLICATED = one or more of following complications:
Rev/T = revision and/or thrombectomy, Hg = hemorrhage (requiring operation), Inf = infec
tion (wound, graft), Occl = occluded, BK = below knee, AK = above knee; MORTALITY
= died within 30 days or during hospital stay; TND = transient neurologic deficit.
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Contributions to the Correspondence section are welcomed.
They should be typewritten and double spaced.

Occult Breast Cancer
To the editors.—In response to Bassett’s
editorial in this issue (pages 297 and 298),
any woman who has an occult breast
lesion discovered by mammography has
a 10% to 15% chance of harbouring a
small, invasive breast cancer. Most of
these lesions are now detected through
screening programs of asymptomatic
volunteers, but there is no conclusive evi
dence that this leads to better survival.
There is good evidence, however, that
survival following lumpectomy and axil
lary dissection is the same as that follow
ing total mastectomy and axillary dissec
tion.1 It seems only fair, then, that these
women should receive the benefits of
“ conservative surgery” if at all possible.
It is the only reward we can offer them
for their participation in such programs.
The surgical technique of lumpectomy
has been well documented. An incision is
made directly over the lesion; the lesion
is removed with 1 cm of surrounding nor
mal breast tissue; the resection margins
are carefully identified; the defect in the
breast tissue is not repaired; the skin is
closed with subcuticular suture and Steristrips. Drains must not be used if a per
fect cosmetic result is to be achieved.
Since these lesions are usually not pal
pable during the operative procedure,
frozen sections are inappropriate and the
actual diagnosis must await the findings
of paraffin sections. If the option of a
lumpectomy is to be preserved for those
who turn out to have an invasive cancer,
all lesions should be removed by the
appropriate technique. This can be done
if the localizing needle is sutured into
position in the breast tissue and remains
palpable throughout the procedure but is
usually impossible if Bassett’s technique
is followed. A circumareolar incision will
not necessarily be directly over the lesion;
if the dye is visualized in the breast tis
sue, the area of normal tissue around the
suspect cancer has probably been vio
lated. Thus, it may be very difficult to
define the margins of the excision for the
300

pathologist who cannot then assess if the
lumpectomy is adequate.
Whether a radiologist and the radiol
ogy department are involved in the nee
dle localization procedure will depend on
the resources available to the operating
surgeon. As long as the needle is inserted
into the breast tissue through the skin
immediately overlying the calculated loca
tion of the lesion, it can be secured by a
suture and a proper lumpectomy per
formed.
L. Mahoney , md , ms(tor ), frcsc, facs
Ste. 403,
55 Queen St. E,
Toronto, Ont.
M5C 1R6
Reference
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Head Injuries
To the editors.—I wish to thank Dr.
Schwartz (Can JSurg 1985; 28: 197-8) for
his thoughtful comments on our article
on head injuries (Can J Surg 1985; 28:
79-83). His two questions deal with
quotes from other papers. In the first
instance, Jennett and colleagues'
reported th at intracranial pressure
monitoring had no effect on mortality
and that, as a whole, patients treated
more intensively did less well as a group
than might have been expected. On page
82, in the last paragraph under “ Treat
ment” , we noted that Becker and his
associates2 did not agree. With so many
variables, conclusions are difficult, but
our impressions resulting from the out
come in these two groups would confirm
Jennett’s observation. It is interesting that
since our article appeared, Becker’s
group3 have reported that “ while the use
of barbiturates in high doses can lower
ICP [intracranial pressure] and may be
required when all other methods fail,

based on our data, we cannot recommend
the prophylactic use of pentobarbital
coma in the treatment of patients with
severe head injury. In addition, we believe
that its use is accompanied by significant
side effects that can potentially worsen
the condition of a patient with severe head
injury.”
Regarding Dr. Schwartz’s second ques
tion, again we are quoting somebody else,
namely Marshall and associates4 who
stated that mortality and morbidity are
probably not significantly modified by
efforts to reduce transportation time in
patients with head injuries alone. Prob
ably, the key word here is “ significantly” .
We tried to find out how many patients
with head injuries alone died before
reaching the Health Sciences Centre in
Winnipeg and could get statistics only on
the total number of deaths associated with
head injuries for the province of
Manitoba. There was no way of deter
mining which of these were cases of head
injury alone or of knowing which of these
patients would have been taken to the
Health Sciences Centre; hence, we had to
let it go at that. We certainly agree with
Dr. Schwartz that many patients with
acute subdural hematoma can be saved
with very early admission and, even more
importantly, with very early recognition
and transport to the operating room.
During the period of our study, there was
no recorded instance of a patient with a
head injury alone and a lucid interval
dying in transport. With only this infor
mation we did not feel justified in trying
to make further assumptions in this area.
D wight P arkinson, md , facs, frcsc
Professor,
Section of Neurosurgery,
University of Manitoba,
750 Bannatyne Ave.,
Winnipeg, Man.
R3E 0W3
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Mediastinal Packing
for Refractory Bleeding
After Open-Heart Surgery
To the editors.—I read with interest Dr.
Del Campo’s article on mediastinal pack
ing for refractory nonsurgical bleeding
after open-heart surgery (Can J Surg
1985; 28: 55-6).
I used this technique 7 years ago on a
child who underwent insertion of a right
ventricular pulmonary artery valved con-

duit. At the end of the operation, bleed
ing from the pulmonary artery suture line
could not be controlled by conventional
means, but tight packing with several
pieces of 4 X 4-inch gauze successfully
stopped the bleeding. The postoperative
chest film (Fig. 1) shows the radiopaque
markers in the gauze pack. The gauze
pack was removed under direct vision the
following day by reopening the ster
notomy (Fig. 2). There was no more
bleeding and the child was discharged
from the hospital without further com
plications.
Del Campo’s technique of bringing the
end of the mediastinal pack through a
skin incision for later removal without
sternotomy is certainly an attractive alter
native technique.
R icardo J. M oreno-Cabral, md, frcsc
Ste. 710,
1380 Lusitana St.,
Honolulu, HI 96813
USA

Military Surgery and the Medical
Profession’s Responsibilities

FIG. 1—Postoperative roentgenogram
showing radiopaque markers in mediastinal
pack used to control bleeding.

FIG. 2—Appearance following removal of
mediastinal pack.

To the editors.— Ox. A.C. Derby’s paper
on military surgery (Can J Surg 1985; 28:
183-6) and Professor Cruse’s editorial
comment (Can J Surg 1985; 28: 102) say
two things: first, that for centuries the
medical profession has tried to treat
lesions resulting from war and, second,
some new procedures developed in war
time are useful in peacetime, if they are
not forgotten. Neither writer points out
that the medical profession has not, so
far, seriously addressed the etiology and
pathology of war itself.
Down the centuries, military strategy
has evolved from combat between profes
sional soldiers to the involvement of large
numbers of conscripts to the mass killing
of civilians. Machines of increasing com
plexity from the longbow to the ther
monuclear bomb have been invented for
killing and maiming people. Still, the
basic sequence has changed little: rulers
and politicians initiate wars, militarists
direct them, and populations suffer and
die. While it is encouraging to know that
medicine has salvaged a higher propor
tion of the wounded in successive wars,
this must not obscure the fact that in each
successive war there have been larger
numbers of deaths and injuries.
It is now accepted that a nuclear war
would destroy most living things on earth.
This knowledge should make war obso
lete. But politicians and m ilitary
strategists keep on making the same old
mistakes; the rhetoric of distrust and hate
goes unchecked; new and deadlier
w eapons are being invented and

deployed. War should be unthinkable,
but never in human history has it been
more imminent.
This is why the medical profession
world-wide must put all its effort towards
preventing catastrophe, both by insisting
on the abolition of weapons of mass des
truction and by encouraging more ra
tional ways of preventing or resolving
conflicts.
D .B .

Stewart , mbe, frcsc

PO Box 805,
Killarney, Man.
R0K 1G0

To the editors.—I concur with Dr. D.B.
Stewart that the medical profession
should make every effort to prevent war.
The question is, should this effort be
made through strength or weakness?
Many needless lives were lost in two world
wars as the result of unsuccessful attempts
at prevention by appeasement and disar
mament.
To deal with the causes and prevention
of wars was not appropriate to or within
the scope of my paper “ The military sur
geon — not least in the crusade” (Can J
Surg 1985; 28: 183-6). I certainly did not
intend to obscure the horrors of war or
glorify the participants, but, rather, I
wished to remind Canadian surgeons of
the importance of a working knowledge
of the principles of military surgery and
to review our military surgical heritage to
which we owe so much.
I saw the first casualty who came
from Korea, while on posting at an
army hospital in the United States. In less
than 6 years the military surgeons had
forgotten (or never knew), for example,
that wounds of the colon should be exteri
orized or that all wounds should be
debrided. The results were often disas
trous.
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It is 40 years since the last atomic bomb
was dropped. Since then, there have been
numerous conventional wars, incidents
and terrorists attacks and it is likely that
this type of conflict will continue in spite
of all efforts and that Canada may well
be involved.

5.

A. Campbell Derby, md , frcsc

To the editors.—In response to Dr.
Derodra, it was not our intent to publish
a treatise on the diagnosis and treatment
of common-duct stones but to report
what we perceived as an unusual and
interesting case. I do not know the opin
ions of patient’s attending physicians on
operative cholangiography or endoscopic
sphincterotomy before August 1983,
when we first saw this patient. Neverthe
less, the indications and value of opera
tive cholangiography are well recognized
by most medical students and the tech
nique has routinely been practised at our
hospital for at least 10 years.
As to the use of endoscopic papil
lotomy before the development of the

RR l,
Iroquois, Out.

KOE 1K0

Choledochoduodenal Fistula
and Gallstone Ileus
in the Absence of the Gallbladder
To the editors.—I read with interest the
case reported by Masters and Wellington
(Can JSurg 1985; 28: 65-6) and I believe
it merits further comment.
The authors did not mention whether
cholangiograms were performed at the
time of the initial cholecystectomy. Rou
tine use of operative cholangiograms is
useful in detecting unsuspected stones in
the common bile duct,1-3 decreasing the
number of negative duct explorations2’4’5
and thus the incidence of retained
stones.1’2,6 The old-fashioned method of
palpating the duct for stones is unreliable
and unnecessary.
During the 6 years after the cho
lecystectomy the patient had recurrent
bouts of cholangitis. Ultrasonography
confirmed the presence of a stone within
the common bile duct. In these circum
stances, endoscopic papillotomy and
extraction of the stone should have been
carried out.7 This procedure is relatively
safe and is least hazardous to the patient.
Finally, I was not quite sure about the
indication for performing barium studies
when the correct clinical diagnosis of gall
stone ileus had already been made. It did
not provide any further information and
probably delayed the operation.
J. Derodra , frcs
Rm. 4W8,
Department of Gastroenterology,
McMaster University,
1200 Main St. W,
Hamilton, Ont.

6.
7.

DOYLE P J, WARD-McQUAID JN , SMITH AM: The
value of routine peroperative cholangiography—a report
of 4000 cholecystectomies. Br J Surg 1982; 69: 617-9
STUBBS RS: Peroperative cholangiography: routine or
selective? Ausl N Z J Surg 1982; 52: 488-91
C lassen M, Leuschner U, Sch reiber hw : Stenosis
of papilla vateri and common duct calculi. Clin Gastroen
terol 1983; 12: 203-29

choledochoduodenal fistula, a stone
measuring 3.0 X 2.5 cm would not be
expected to pass through an endoscopically incised sphincter nor would a stone
of this size and consistency be likely to
yield to attempts at crushing.
Finally, a barium study was done in this
woman because we had not before seen
gallstone ileus in the absence of the gall
bladder. Perhaps this is excusable since
only one reported case could be found in
the surgical literature. As to the opera
tive delay resulting from performance of
the barium study, the patient was in fact
in better condition after the development
of her choledochoduodenal fistula, be
cause the long-standing common-duct
obstruction was relieved.
J.L. Wellington , md , frcsc
Department of Surgery,
Ottawa General Hospital,
501 Smyth Rd.,
Ottawa, Ont.
K1H 8L6

SESAP IV Question

12.

Which of the following statements about Barrett’s esophagus is NOT true?
(A)

A stricture is usually present above the arch of the aorta

(B)

A stricture usually forms at the junction of squamous and
columnar epithelium

(C)

Barrett’s ulcer is in columnar-lined esophagus

(D)

Sliding esophageal hiatus hernia is usually present

(E)

The risk of esophageal carcinoma is significant

For the question above select one of the five answers given.

L8N 3Z5
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What's new in surgery is the subject of this column. The short items are designed to let readers know
who's doing what and why. Surgeons are interested in what other surgeons are doing in
research, education, practice and administration. Surgery is a vibrant specialty, and. as
its practitioners, you must be the source as well as the readers of this column.

Ethics in Research on Surgical Techniques:
a Conversation

Without a word, Baby Fae reminded
everyone that surgeons, in consultation
with their patients (parents or guardians),
can carry out research on human beings
using techniques that haven’t necessarily
been thoroughly tested in animal models
and laboratories.
However, according to Jean G. Cou
ture, President of the Royal College of
Physicians and Surgeons of Canada, the
operation to introduce a baboon’s heart
into a baby who was fatally ill produced
concerns among the public more because
of the unconventionality of the transplant
than because of the ethical questions
involved. Among scientists, the work was
criticized because the backcloth of
research was thin at best. Said Couture
in a conversation with CJS about ethics
in surgery and surgical research, “ The
procedure was strongly criticized because
the research was insufficient to show a
human could tolerate a baboon’s heart.”
The operation was experimental, not a
logical link in systematic research.
Despite the criticisms, the Baby Fae
operation was seen by many as a last
resort, said Couture. The child was going
to die, so the ethical consideration was
“ whether you should apply preliminary
experimental surgery to human beings” .
Other ethical questions that were asked
last month at a meeting on transplanta
tion at the University of Kentucky, said
Couture, were: What happens to a per
son’s “ soul” or behaviour when he or she
receives a transplant from a baboon?
Would the hormones intrinsic in the heart
produce anomalous characteristics?
Contributions to this column are welcome.
Please send your material to: Mrs. Amy
Chouinard, Canadian Journal o f Surgery, PO
Box 8650, Ottawa, Ont. K1G 0G8.

Quite different are the ethical questions
in research on a technique that works but
could be improved — for example, ask
ing a patient to test a cement to repair a
fracture of the femur when one knows
that screws will do the trick and that in
10 years the cement may give way.
Different again are the questions in
randomized clinical trials. Said Couture,
“ If a clinical trial is properly put together
and supervised, you have two good treat
ments, and you want to find out which
treatment is better. The ethical problem
comes in the middle of the trial when you
find that one treatment is better than the
other. Even then, you’re not sure until the
trial is complete. You have to have a cer
tain number of cases or the answer is not
scientifically sound. You should stop the
trial if you find that one treatment is
b ad.”
In 1978, the Medical Research Coun
cil of Canada drew up guidelines for ethi
cal research on human subjects and has
since maintained a standing committee on
ethics and experimentation as well as a
working group that meets regularly. At
the urging of the MRC, medical schools
that did not have their own ethics review
committees established them. The com
mittees carefully examine the protocols
and methods for human experiments pro
posed by investigators. They ensure that
there are provisions for obtaining
informed consent from the subjects; that
the proposed question and research pro
tocol are scientifically valid; that the use
of human subjects is necessary; that the
risks and benefits to the subjects and to
society are identified; and that the group
of proposed subjects has the ability to
give informed consent.
In effect, the committees provide pro
tection for those involved in formal

Couture: Clinical trials protect the public.

research projects. Said Couture, “ Ethics
review committees are strictly organized
so the protection of the subjects is
ensured. Problems would be in research
funded outside recognized agencies where
the guidelines for ethics review might not
be as strict.” How much research falls
into this category is uncertain but, accord
ing to the MRC, patients in hospital are
an at-risk group. To safeguard this group,
or at least ensure that the ethical questions
are asked for any treatment given, some
hospital are hiring experts in ethics — the
Montreal Children’s Hospital recently
became the second in Canada to employ
an “ ethicist” , Dawson Schultz.
“ Chemical trials protect the public” ,
and the ideal, according to Couture, is a
clinical trial of two good treatments —
well-organized, randomized trials that
show one o f the treatments is better. The
best recent example is part of an ongo
ing study by the National Surgical A dju
vant Breast Project. “ It proved without
any doubt that conservative surgery is as
good as more radical surgery for women
who have tumours smaller than 4 cm and
disease confined to the breast and
regional lymph nodes.”
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Couture, who is involved in surgical
research at Laval University, said, essen
tially, that all surgery is experimental until
supported by properly controlled trials.
The focus of the work that Couture is
doing is biomaterial prostheses: “ 50% of
what we are doing is for vascular
prostheses, but in the last couple of years
we have been working on cardiac valves
and mammary prostheses.” The work is
being funded by the MRC and the minis
try of health; thus, the protocols for any
human experiments would be carefully
screened.
The information obtained from their
trials is passed to the Bureau of Medical
Devices within the Health Protection
Branch and provides an objective meas
ure of clinical trials by manufacturers.
Couture noted that the seller’s vested
interest makes many clinicians suspicious
about the quality of the manufacturers’
tests despite the efforts of the bureau. He
would like to see the bureau take on an
advisory role as well as its current func
tions as a controlling agency. “ I think the
bureau should be able to advise surgeons
on what is a good graft and what is not,
by drawing on objective research. We
need to have as much assistance as is
available for drugs; for example, we
should have a com pendium of
prostheses.”

Devices Approved for Clinical
Trials Mainly Surgical
The annual list of devices approved by
the Bureau of Medical Devices for clini
cal trials was published recently, and all
but 1 of the 50 items were designed for
use by a surgical specialty.
Dr. A.K. DasGupta, Director of the
Bureau of Medical Devices, spoke to CJS
about the process: “ From our point ot
view, the prime responsibility for testing
belongs to the guy who sells the device.
A regulation agency like ours has to check
that the man has done the testing needed
and that the results assure that the device
does what it claims to do .” The level of
testing depends on the claims for the
device. “ Laboratory testing is enough for a
device that measures blood sugar whereas
some implants need years of testing in
humans. The tests are done at the
manufacturer’s expense by appropriate
specialists.” If the results of the trials are
satisfactory, then the bureau relies on
reports from clinicians to monitor the
quality of the products on the market.

Medical Devices Adverse
Experiences Registry Under Way
but Under Used
Since February this year, the Canadian
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Medical Association, with a grant from
the Department of National Health and
Welfare, has been housing the Medical
Devices Adverse Experiences Registry. To
date, the registry has had only two credible
calls. Lynn Cohen, who is the CMA staff
member taking the calls, told CJS that the
response is expected to pick up now that
information kits have gone out to 38 000
physicians, 1500 hospitals and 250 medi
cal writers.

Proposed Data Collection Registry
for Surgery of Morbid Obesity
Losing Impetus

The Canadian Consensus Group for the
Surgery of Morbid Obesity has been
stymied in its attempts to obtain funds for
a central registry to collect information
on the operations currently being used to
treat morbid obesity. According to Dr.
Joel Freeman, the secretary for the group,
there are at least two dozen varieties of
operations and currently no long-term
data showing what works. The operations
are being modified continuously, and vir
tually no data span more than 24 months.
The consensus group, which was
formed just a year ago, drew up a form
for follow-up of patients who are mor
bidly obese, whether or not they undergo
surgical treatment, and submitted a
proposal for funding from the National
Health Research Development Program.
The group was hoping for enough money
to cover the costs of collecting and analys
ing the information. The proposal was
refused, so the group began urging
interested surgeons to contribute $1000 to
$1500 towards a registry and recom
mended that only two operations be used:
vertical-banded gastroplasty and gastric
bypass.
Currently, the proposal is in limbo, but
the group is still committed to informa
tion-gathering. The experience with hori
zontal gastroplasty as treatment for mor
bid obesity clearly indicates why. Initially
the procedure was promising. Although
associated with many complications,
including stenosis of the stoma, leakage
with or without subphrenic abscess, and
pneumonia, it seemed to work: most
patients who underwent this form of gas
tric partitioning lost weight. Unfor
tunately, after about 12 months, they
either regained it or reached a plateau. A
few surgeons, however, still perform the
procedure.
All provincial health plans currently
cover the costs of surgical intervention for
morbid obesity and more than 5000 oper
ations are performed annually in Ontario

alone, according to data Freeman ob
tained from Statistics Canada. Patients
who are referred for surgery have virtu
ally no alternatives, although jaw wiring
has been proposed as an intermediate
measure for people who are too obese to
undergo an operation safely.
Surgical intervention is a last resort,
reserved for patients who have tried
repeatedly to diet under medical supervi
sion, have had subclinical hypothyroidism
ruled out, and have been suffering clini
cally recognizable disease because of their
obesity.
The goup is committed to finding
which treatment is best for their patients;
ironically, the health insurance system is
willing to pay regardless of the efficacy
of the treatment, yet no one is anxious to
invest in finding out what works.

New Head of Neurosurgery
at Toronto Western

Charles H. Tator, Professor of Neu
rosurgery at the University of Toronto,
recently accepted positions at Toronto
Western Hospital as head of neurosurgery
and codirector of the Playfair Neuros
cience Unit.
A scientist of international standing in
both the clinical and basic scientific
aspects of neurosurgery, Tator’s current
work is being supported by the MRC as
well as various other agencies. He is
exploring the use of hormones and elec
trical currents to stimulate regeneration
of nervous tissue.
A my C houinard

Charles H. Tator, MD, FACS, FRCSC
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Endoscopic Control of Upper G astrointestinal Bleeding
One important objective in managing
patients with upper gastrointestinal
hemorrhage is to control the bleeding
until the patient's condition is stable and
definitive therapy can be carried out.
Endoscopic techniques are now available
to attain this goal. Endoscopic sclerosis
has become an accepted treatment for
bleeding esophageal varices, especially in
patients with Child's class B or C cirrho
sis. Control of nonvariceal bleeding by
endoscopic techniques is now feasible
and involves laser photocoagulation and
electrocoagulation. Clinical experience
with endoscopic laser photocoagulation
has demonstrated that it can success
fully arrest bleeding in gastric and duo
denal ulcers. Endoscopic electrocoagula
tion has been successful in stopping
bleeding from Mallory-Weiss tears, acute
gastric erosions, and gastric, duodenal
and stomal ulcers. Use of an endoscopic
heater probe, now in the development
stage, to control bleeding gastric and
duodenal ulcers will be an important
addition.
Chez les patients souffrant d'hemorragie
des voies gastro-intestinales superieures,
un des objectifs importants du traitement
consiste a maitriser les saignements
jusqu'a ce que I'etat du patient soit
stabilise et qu'on puisse appliquer un
traitement definitif. Des techniques
endoscopiques existent maintenant qui
permettent d'atteindre ce but. La
sclerose endoscopique est maintenant
acceptee comme traitement des varices
oesophagiennes, specialement chez les
cirrhotiques de classe B ou C dans la
classification de Child. L'arret des hemorragies non variqueuses par methodes

From the Department o f Surgery, Toronto
Western Hospital and University o f
Toronto, Toronto, Ont.
Accepted for publication Dec. 27, 1984
Reprint requests to: Dr. H.S. Himal, Ste.
103, Toronto Western Medical Building, 25
Leonard Ave., Toronto, Ont. M5T 2R2

endoscopiques est maintenant possible
grace d la photocoagulation au laser et
I'electrocoagulation. L'experimentation
clinique de la photocoagulation endosco
pique au laser revelle que celle-ci peut
venir a bout des saignements dans les
cas d'ulcdres gastriques et duodenaux.
L'electrocoagulation endoscopique permet d'arreter I'hemorragie dans les cas
de dechirures de Mallory-Weiss, d'erosions gastriques aigues et d'ulceres gast
riques, duodenaux ou du stoma.
Pr6sentement en developpement, les
sondes endoscopiques chauffantes constitueront une addition importante aux
moyens deja connus de juguler les
saignements des ulceres gastriques et
duodenaux.

gastrointestinal bleeding should be to con
trol the bleeding until the patient’s con
dition has stabilized, when definitive
therapy can be performed. Endoscopic
techniques (Table II) are available to stop
upper gastrointestinal hemorrhage and
will be discussed in this report.
Sclerosis of Esophageal Varices

Crafoord and Frenckner11 in 1939
were the first to report the use of
sclerotherapy for bleeding esophageal
varices. A 19-year-old patient presented
with hematemesis and melena. Esophagoscopy demonstrated large esophageal
varices. Repeated injection of the varices
was carried out until they had all disap
peared. There was no further bleeding in
Upper gastrointestinal hemorrhage is one the 3-year follow-up period. This report
of the most common causes of emergency did not create much enthusiasm because
hospital admission in North America. at that time portasystemic shunting was
Mortality varies between 5% and 30%, considered the most effective method of
depending on the cause and severity of the managing esophageal varices. In spite of
bleeding.1'3 In spite of greater emphasis the widespread use of portasystemic
on early diagnosis and improvements in shunts, the occasional report appeared,
medical, surgical and critical care, mor describing variceal sclerotherapy.12'13 In
tality is still around 10% and has not
changed significantly in the last 25
years.4'6
Table II—Endoscopic Techniques Available to
Various reports710 have documented a
Control Upper Gastrointestinal Hemorrhage
substantial decrease in operative mortal
Sclerosis of esophageal varices
ity when conservative therapy controlled
Laser photocoagulation
Electrocoagulation
the hemorrhage so that surgery could be
Thermal probe
carried out on a semielective basis (Table
Tissue adhesives
I). Thus, one of the main objectives in
managing patients with profuse upper
Table l-Surgical Mortality in Patients With Upper Gastrointestinal Hemorrhage:
Emergency Versus Semielective Surgery
Semielective surgery
Emergency surgery
Operative
Operative
No. of
No. of
mortality, %
patients
mortality, %
Authors, yr
patients
3
19
99
Kelley and associates, 19637
151
7
20
168
Schiller and associates, 19708
412
84
7
21
Halmagyi, 19709
34
102
11
Crook and associates, 197210
111
31
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the 1960s, because of dissatisfaction with
shunt surgery, many surgeons began to
look for alternative methods of controll
ing bleeding esophageal varices. In 1973,
Johnston and Rodgers14 reported their
15-year experience with injection
sclerotherapy. They did 217 endoscopic
injections in 116 patients; hemorrhage
was controlled in 93 % of the bleeding epi
sodes.
This report was the first of many from
around the world, describing the effec
tiveness o f endoscopic injection
sclerotherapy in controlling variceal
bleeding. In 1979, Terblanche and
associates15 reported a controlled trial of
24 patients; 13 control patients and 11
who had endoscopic injection sclerother
apy. Recurrent variceal hemorrhage
occurred in 9 (69%) patients in the con
trol group, while variceal bleeding
occurred in only 4 (36%) patients in the
injection sclerotherapy group. The total
follow-up was 25 months. MacDougall
and associates16 reported a controlled
trial of 107 patients with bleeding
esophageal varices. Twenty-two (43%) of
the 51 patients in their sclerotherapy
group had further bleeding compared
with 42 (75%) of the 56 control patients.
Recent studies17’18 have also confirmed
that endoscopic sclerotherapy effectively
controls acute variceal bleeding and, also,
compares favourably to portacaval shunt
ing. Larson and colleagues17 reported a
controlled trial of 82 patients who were
randomized to either medical therapy (39
patients) or injection sclerotherapy (43
patients) within 48 hours after an acute
variceal hemorrhage. The incidence of
rebleeding and the number of units of
blood transfused was significantly
(p < 0.01) lower in the sclerotherapy
group. Cello and associates18 carried out
a randomized trial, comparing endoscopic
sclerotherapy with portacaval shunting in
Child’s class C patients with alcoholic cir
rhosis and profuse variceal bleeding. The
number of units of blood received was
significantly (p < 0.01) less but the num
ber of rebleeding episodes was signifi
cantly (p < 0.05) higher in the sclerother
apy group. The overall survival was
similar in both groups. The authors con
cluded that the effectiveness of portacaval
shunting was similar to that of sclerother
apy in managing variceal bleeding in these
patients and suggested that endoscopic
sclerotherapy should be the procedure of
choice.
Many different techniques of endo
scopic sclerosis of esophageal varices have
been described in the literature. Some
advocate rigid endoscopy under general
anesthesia,19'20 fiberoptic endoscopy with
premedication alone,21’22 intravariceal or
paravariceal injection,19’20 the addition
of a flexible esophageal sheath23 or the
incorporation of a balloon at the end of
306

the fiberoptic endoscope to compress the
varix after injection.24 Various sclerosing
solutions have been used: ethanolamine
oleate, sodium m orrhuate, sodium
tetradecyl sulfate and ethanol. In an
animal model, Jensen and associates25
found that ethanol 95%, tetradecyl 1.5%
and ethanolamine 5% each gave greater
than 60% sclerosis of esophageal varices.
The complications reported have
included hemorrhage, esophageal ulcers,
esophageal strictures and p erfo ra
tions.15'21 The use of flexible endoscopy
has decreased the incidence of perfora
tions and with increased experience the
incidence of esophageal ulcers and stric
tures has also been lowered.
Sclerotherapy Protocol

the bleeding is not controlled, then oper
ative procedures such as the Sugiura
procedure26 should be considered.
Endoscopic Control of Nonvariceal
Bleeding

Endoscopic control of nonvariceal
bleeding of the upper gastrointestinal
tract has become an important therapeu
tic modality. The first report in 197027
involved the use, in two patients, of a cystoscope passed through a gastrostomy.
One patient had a gastrostomy for an
inoperable squamous cell carcinoma of
the esophagus. After radiotherapy, pro
fuse gastrointestinal bleeding occurred
due to a large gastric ulcer. Conservative
therapy did not stop the hemorrhage. A
cystoscope was passed through the gas
trostomy into the stomach and a panen
doscope was then used to identify and
successfully cauterize a bleeding vessel at
the edge of the ulcer. The second patient
was a 47-year-old woman who had under
gone cholecystectomy and choledochotomy for cholelithiasis and choledocholithiasis. Postoperatively, serious upper
gastrointestinal bleeding occurred. Con
servative therapy was unsuccessful in con
trolling the bleeding, so vagotomy, sub
total gastrectomy and gastrostomy for
multiple bleeding gastric erosions were
carried out. Four days later, bleeding
recurred. Through a cystoscope passed
through the gastrostomy opening, a
panendoscope visualized multiple bleed
ing gastric ulcers in the gastric remnant.
These were successfully cauterized.
Since 1970 many groups have inves
tigated and applied various endoscopic
methods to control nonvariceal upper
gastrointestinal bleeding. These have
involved laser coagulation, electrocoagu
lation, thermal probes and tissue adhe
sives.

The following protocol has proven
effective in managing patients with bleed
ing esophageal varices. The patient is
admitted to hospital, preferably to an
intensive care unit. Endoscopy should be
carried out immediately to ensure that the
bleeding is not from a lesion other than
varices. Endoscopy will also indicate
whether the varices are actively bleeding
or whether variceal bleeding has stopped.
If there is active bleeding, a SengstakenBlakemore tube is passed down the
esophagus and balloon tam ponade
applied for 24 hours. In most patients this
controls the bleeding. Endoscopic sclero
sis is then carried out. The patient is
sedated with meperidine (50 mg intra
venously) and diazepam (10 to 20 mg
intravenously). The varices are visualized
with the flexible endoscope and sclerosis
is carried out. An injection needle is
passed down the biopsy channel and 2 to
3 mL of ethanolamine oleate 5% is
injected intraluminally into the varix. A
maximum of three varices, beginning at
the esophagogastric ju n ctio n , are
sclerosed at one time. The procedure is
repeated weekly until most or all the Laser Photocoagulation
varices are sclerosed. If the sclerosis is
successful, the patient is readmitted to
Laser photocoagulation has been used
hospital in 3 months for repeat endoscopy
for a long time to manage retinal detach
and if esophageal varices are still present ment and skin lesions. In 1967, Ketcham
or have recurred, endoscopic sclerosis is and associates28 reported on the effec
carried out again.
tiveness of this technique in producing
small-vessel thrombosis. In 1970, GoodConclusions
ale and colleagues29 successfully used a
carbon dioxide continuous-wave laser
It seems clear that endoscopic injection
applied to a gastroscope to control bleed
sclerotherapy is now playing an important
ing gastric ulcers in dogs. Nath and
role in the treatm ent of bleeding
colleagues30 in 1973 reported an
esophageal varices. Accumulating evi experimental study with a fiberoptic laser
dence suggests that this should be the ini endoscopy system. Two years later,
tial approach and there is a strong possi Dwyer and associates31 successfully con
bility that sclerotherapy will replace
trolled arterial bleeding from gastric
shunting procedures in the management
ulcers in dogs using an argon laser cou
of most patients with bleeding esophageal
pled to a fiberoptic endoscope. Other
varices. However, it must be emphasized
reports appeared describing endoscopic
that endoscopic sclerosis will not always
laser photocoagulation of bleeding gas
stop bleeding from esophageal varices. If tric lesions in animals.32'34
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Initial clinical experience with this tech
nique was described by Kiefhaber and his
group.35 Of 140 bleeding episodes in 110
patients, 131 were effectively controlled
by endoscopic laser photocoagulation.
The lesions included esophageal varices,
Mallory-Weiss tears, gastric and duo
denal ulcers and acute gastric erosions.
Dwyer and associates36 documented two
cases of upper gastrointestinal bleeding:
one was a 50-year-old woman with bleed
ing gastric erosions, successfully con
trolled by argon laser photocoagulation.
In the other case, a 42-year-old man with
a malignant bleeding gastric carcinoma,
laser photocoagulation was unsuccessful
and operation was needed to control the
hem orrhage. Friihmorgen and col
leagues37 reported a success rate of over
90% when they used laser photocoagu
lation to control bleeding gastric lesions.
In 1981, Ihre and associates38 reported
a controlled trial comparing endoscopic
laser treatment (66 patients) with conser
vative management (69 patients) for
upper gastrointestinal bleeding. They did
not find any difference between the two
groups with respect to the number of
units of blood received, mortality and
rebleeding rate. There were several
problems with this trial: the power level
of the laser was too low to obtain effec
tive hematemesis. Technical difficulty
with the equipment prevented laser pho
tocoagulation in 8 of 66 patients. Ten
patients in the laser group had bleeding
esophageal varices, and experience has
shown that laser photocoagulation is fre
quently unsuccessful in controlling bleed
ing esophageal varices.
In a controlled trial, Vallon and
associates39 investigated the role of argon
laser photocoagulation in bleeding pep
tic ulcers. Sixty-eight patients were in each
of the laser and control groups. Laser
photocoagulation was no more effective
than standard therapy in stopping bleed
ing and preventing rebleeding from pep
tic ulcers. Swain and colleagues40 also
studied the efficacy of argon laser pho
tocoagulation in controlling hemorrhage
from peptic ulcers. Thirty-six patients
were in the laser group and 40 patients
were in the control group in which
endoscopy was carried out, aiming the
laser beam on the bleeding point but not
applying full power. There was significant
(p < 0.05) reduction in the rebleeding rate
and in mortality (p < 0.02) in the laser
photocoagulation group.
To analyse the role of laser photo
coagulation in arresting bleeding lesions
of the upper gastrointestinal tract, Rutgeerts and associates41 carried out a con
trolled trial. All 23 patients with spurt
ing arterial bleeding (13 gastric and 10
duodenal ulcers) underwent laser therapy.
Bleeding stopped in 20 patients but
recurred in 11. Fourteen of the 23 patients

required surgery. The overall mortality
was 30% (7 of 23). Eighty-six patients
with active, nonspurting bleeding and 43
patients with inactive bleeding lesions
were randomized to YAG (yttriumaluminum-garnet) laser phototherapy or
conservative therapy. In the patients with
active, nonspurting bleeding, there was an
increase in the number of bleeding lesions
controlled by laser treatment and a reduc
tion in the rebleeding rate. The overall
mortality was similar in the laser and con
servative groups. In patients with inactive
bleeding, laser therapy reduced the
rebleeding rate and overall mortality. The
authors concluded that laser therapy was
successful in all groups except those with
arterial spurting lesions.
Swain and colleagues,42 in an update
report in 1984, analysed the role of
neodymium-YAG laser photocoagulation
in 123 patients with bleeding peptic ulcers
(visible vessel or blood clot). In the
visible-vessel group, laser therapy reduced
the rebleeding rate and need for emer
gency surgery.
The results of the above studies are
encouraging but further trials are
required, especially those involving cer
tain subgroups such as patients with gas
tric or duodenal ulcers with either acute
bleeding or visible vessels. Further infor
mation is urgently required before we can
conclude that laser photocoagulation has
an important role in the management of
patients with upper gastrointestinal
hemorrhage. Laser equipment is costly,
special requirements are necessary for
installation and service and it can’t be
moved around the hospital. There are
also hazards to endoscopists using laser
phototherapy. Therefore, although its
potential is evident, widespread use of this
technique is unwarranted at present.
Electrocoagulation
Endoscopic electrocoagulation has
been widely accepted in the treatment of
colonoscopic polypectomy; morbidity is
minimal and mortality almost nil. In
1971, Blackwood and Silvis43 reported
on the use of endoscopic electrocoagula
tion in upper gastrointestinal hemor
rhage. Papp44 described seven patients
with upper gastrointestinal hemorrhage
who underwent endoscopic electrocoagu
lation; three had gastric ulcers, one a duo
denal ulcer, one patient had acute gastric
erosions, one a stomal ulcer and one a
bleeding gastric varix. Electrocoagulation
successfully stopped the bleeding gastric
ulcers, duodenal ulcer, gastric erosions
and stomal ulcer. Electrocoagulation of
the gastric varix temporarily controlled
the bleeding, but several hours later the
patient died of exsanguination from
esophageal varices. In 1975, Sugawa and
colleagues45 carried out electrocoagula

tion in six seriously ill patients. Three had
acute gastric erosions, one a gastric ulcer,
one a Mallory-Weiss tear and another a
bleeding gastric polyp. Electrocoagulation
controlled the bleeding in all patients
except the one with a bleeding gastric
ulcer and one patient with bleeding acute
gastric erosions. Papp46 updated his
experience and analysed the efficacy of
electrocoagulation in 38 patients with
upper gastrointestinal bleeding. Bleeding
was controlled in 15 patients with gastric
ulcers, 14 with duodenal ulcers, 6 with
Mallory-Weiss tears, 1 patient with acute
gastric erosions, 1 with a gastric varix and
1 with an esophageal ulcer. Electrocoagu
lation was unsuccessful in one patient
with a Mallory-Weiss tear and one with
a bleeding duodenal ulcer. Three gastric
and three duodenal ulcers rebled. One
gastric and one duodenal ulcer were suc
cessfully controlled by repeat elec
trocoagulation. In total, bleeding was
controlled in 95% of the cases.
Gaisford47 reported his experience
w ith 71 patients who underw ent
endoscopic electrohemostasis. Twentynine had gastric ulcers, 16 pyloroduodenal ulcers, 8 jejunal ulcers and 6
M allory-W eiss tears. O ther lesions
included esophageal ulcers, gastric
varices, acute gastric erosions, gastric
polyps and leiomyomas. Initial hemosta
sis was obtained in all patients and per
manent cessation of bleeding in 65.
Volpicelli and colleagues48 carried out
endoscopic electrocoagulation in 12
patients with bleeding upper gastrointes
tinal lesions; 6 with duodenal ulcers, 5
with gastric ulcers and 1 with an
esophageal ulcer. Hemostasis was initially
obtained in all 12 patients. One patient
rebled and then underwent surgery.
The results of endoscopic electrocoagu
lation to date are very promising. Bleed
ing can be controlled permanently. This
technique can also temporarily control the
bleeding lesion so that the patient can be
prepared for semielective surgery. Any
hospital that manages patients with upper
gastrointestinal bleeding should assign
one endoscopist to become experienced in
the use of endoscopic electrocoagulation.
Thermal Probes
Based on the principle of enhanced
coagulation of a bleeding area by thermal
coagulation in association with direct
pressure, Protell and associates49 deve
loped a heater probe that could be passed
through an endoscope. Prelim inary
experiments demonstrated that it was very
effective in stopping bleeding gastric
ulcers. In a clinical study, Johnson and
associates50 reported that the heater
probe was superior to YAG laser therapy
in controlling bleeding from gastric and
duodenal ulcers. The heater probe

VOLUME 28, NO. 4, JU L Y 1985 / THE CANADIAN JOURNAL OF SURGERY

307

stopped the bleeding in 19 o f 20 patients
while laser therapy was successful in only
24 o f 35 bleeding peptic ulcers.
The thermal probe shows excellent
promise. It is inexpensive, does not
require complex instrumentation and is
portable.

Tissue Adhesives
Several authors have reported on the
use o f tissue adhesives or sprays applied
through the endoscope. Keller and
Logan51 reported satisfactory results
with acrylic polymer sprayed on acute
ulcers in a patient with hemorrhagic gas
tritis. Linscheer and Fazio52 endoscopically sprayed thrombin and fibrinogen
directly onto a bleeding gastric ulcer in
an experimental dog model. Bleeding time
was greatly decreased both in nonheparinized and heparinized dogs. On the
other hand, Protell and associates53 did
not find that tissue adhesives stopped
bleeding from experimental gastric ulcers.
In a canine model, endoscopic spray
application of trifluoroisopropyl 2-cyano
acrylate did not completely stop bleeding
although there was a reduction in the rate
o f bleeding. It appears that endoscopic
spraying or application of tissue adhesives
or clotting factors to control bleeding
lesions o f the upper gastrointestinal tract
is not yet ready for clinical use.

Summary
Endoscopic control o f upper gastroin
testinal hemorrhage has progressed from
experimental studies to widespread clini
cal use. As instrumentation improves, it
will be possible to control bleeding lesions
o f the upper gastrointestinal tract, at least
temporarily, so that surgery can be per
formed under ideal conditions. This will
reduce overall mortality in patients
presenting with upper gastrointestinal
hemorrhage.
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BEFORE CLOSURE GIVES UP TO 15 HOURS OF
POST-OPERATIVE PAIN RELIEF1
PO ST-O PERATIVE S T R E S S can be
substantially reduced by preventing
post-operative pain in those critical
first hours after surgery2

Marcaine blocks this pain, giving an
easier, quicker recovery; often w ithout
the need for narcotic analgesics.3
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Marcaine*

(bupivacaine hydrochloride injection U.S.P.).
Indications:
Peripheral nerve block including retrobulbar block, infiltration, sympa
thetic blockade, caudal, epidural, and pudendal blocks.
Contraindications:
Bupivacaine is contraindicated in persons with known sensitivity to
local anesthetics of the amide type.
The use of bupivacaine is contraindicated in the presence of sepsis
near the site of proposed injection, in severe shock and in heart block.
Warnings:
Usage in Pregnancy: There are no adequate and well-controlled studies
in pregnant women of the effect of bupivacaine on the developing
fetus. Decreased pup survival in rats and an embryocidal effect in rab
bits have been observed when bupivacaine hydrochloride was adminis
tered to these species in doses comparable to nine and five times
respectively the maximum recommended daily human dose (400 mg).
Bupivacaine hydrochloride should be used during pregnancy only if the
potential benefit justifies the potential risk to the fetus. This does not
exclude the use of Marcaine 0.25% or 0.50% at term for obstetrical
anesthesia or analgesia.
Obstetrics: The highest (0.75%) concentration is not recommended for
obstetrical anesthesia. There have been reports of cardiac arrest with
difficult resuscitation or death following its use for epidural anesthesia
in obstetrical patients.
Due to the high risk to the fetus, paracervical block is no longer recom
mended.
The obstetrician is warned that severe persistent hypertension may
occur after administration of certain oxytocic drugs, if vasopressors
have already been used during labor (e.g. in the local anesthetic solu
tion or to correct hypotension).
Until further experience is gained in children younger than 12 years,
administration of bupivacaine in this age group is not recommended
Precautions:
Marcaine (bupivacaine) should be used cautiously in persons with
known drug allergies or sensitivities, particularly to the amide-type local
anesthetics.
Caution is advised in administration of repeat doses of bupivacaine to
patients with severe liver disease.
The lowest dosage that gives effective anesthesia should be used, to
avoid high plasma levels and serious systemic side effects. Injection of
repeated doses of bupivacaine may cause a significant increase in
blood levels due to accumulation of the drug or its metabolites or slow
metabolic degradation.
Tolerance varies with the status of the patient. Debilitated, elderly and
acutely ill patients may require reduced doses commensurate with age
and physical condition.
It should be remembered that solutions containing a vasopressor
agent, e.g. epinephrine, should be used with caution, if at all, in patients
who are receiving monoamine oxidase inhibitors or anti depressants
of the triptyline or imipramine type, because severe, prolonged hyper
tension may result. Dose-related cardiac arrhythmias may occur if
preparations containing epinephrine are employed in patients during or
immediately following the administration of chloroform, halothane,
cyclopropane, trichloroethylene or other related agents. In deciding
whether to use these products concurrently in the same patient,
the combined action of both agents upon the myocardium, the concen
tration and volume of vasoconstrictor used, and the time since injec
tion, when applicable, should be taken into account.
The decision to use a local anesthetic containing a vasoconstrictor in
areas with a limited blood supply or in patients with peripheral vascular
disease, will depend on the physician’s appraisal of the relative advan
tages and risks.
Local anesthetics which contain preservatives, i.e. those supplied in mul
tiple dose vials, should not be used for caudal or epidural anesthesia.
Epidural Use: It is advised that a test dose, generally 2-3 mL of 0.5%
bupivacaine (or other amide anesthetic) containing 1:200,000 epine
phrine (10-15 micrograms) be administered to check that the spinal
canal or a blood vessel has not been entered while locating the epidural
needle or catheter.
In the event of spinal injection clinical signs of spinal block would
become evident in a few minutes.
In the event of intravascular injection a transient increase in pulse rate
and possibly momentary increase in systolic blood pressure are
usually detectable with a monitor. The other symptoms and signs of
“epinephrine response" are less dependable. The effects of other medi
cation the patient has received may modify this response.
When reinforcing doses are required the test dose should be used
again to check the catheter location.
Use in Ophthalmic Surgery: When Marcaine 0.75% is used for retrobulbar block, complete corneal anesthesia usually precedes onset of clini
cally acceptable external ocular muscle akinesia. Therefore, presence
of akinesia rather than anesthesia alone should determine readiness of
the patient for surgery.
Adverse Reactions:
Reactions to bupivacaine are characteristic of those associated with
amide-type local anesthetics. A major cause of adverse reactions to
this group of drugs is excessive plasma levels, which may be due to
over-dosage, inadvertent intravascular injection, or slow metabolic
degradation. Other causes of reactions to these local anesthetics may
be hypersensitivity, idiosyncrasy, or diminished tolerance.
Excessive plasma levels cause systemic reactions involving the central
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nervous system and the cardiovascular system. The central nervous
system effects are characterized by excitation or depression. The first
manifestation may be nervousness, dizziness, blurred vision, or tre
mors, followed by drowsiness, convulsions, unconsciousness, and pos
sibly respiratory arrest. Since excitement may be transient or absent,
the first manifestation may be drowsiness, sometimes merging into
unconsciousness and respiratory arrest.
Other central nervous system effects may be nausea, vomiting, chills,
constriction of the pupils, or tinnitus. The cardiovascular manifesta
tions of excessive plasma levels may include depression of the myocardium, blood pressure changes (usually hypotension), and cardiac
arrest. Recent clinical reports and animal studies suggest this may be
more likely to occur with the long acting amide local anesthetics such
as bupivacaine.
Allergic reactions are characterized by cutaneous lesions (e.g. urticaria,
edema) and other manifestations of allergy.
Reactions following epidural or caudal anesthesia may include: high or
total spinal block, urinary retention; fecal incontinence, loss of perineal
sensation and sexual function; persistent analgesia, paresthesia, and
paralysis of the lower extremities; headache and backache; and slow
ing of labor and increased incidence of forceps delivery.
It should be noted that reactions due to systemic absorption may be
slow or rapid in onset. Those of rapid onset include respiratory depres
sion, cardiovascular collapse and cardiac arrest. This type of reaction
necessitates a high degree of preparedness since it can occur with little
warning.
In co-ordinated studies of 3200 procedures carried out by 15 investiga
tors, there were 2 severe systemic reactions. Both patients experienced
convulsions as a result of inadvertent vascular injection.
Fetal bradycardia has been observed with the use of bupivacaine. Most
cases, including a few fatalities, occurred when the paracervical route
was used (see “Warnings").
In some subjects bupivacaine may produce marked peripheral vaso
constriction in unanesthetized areas which may last for several hours.
Treatment of Overdose and Severe Reactions:
Toxic effects of local anesthetics require symptomatic treatment; there
is no specific cure. The physician should be prepared to maintain an
airway and to support ventilation with oxygen and assisted or con
trolled respiration as required. Supportive treatment of the cardiovas
cular system includes intravenous fluids and, when appropriate, vaso
pressors (preferably those that stimulate the myocardium).
Convulsions may be controlled with oxygen and intravenous adminis
tration, in small increments, of a barbiturate or muscle relaxant, as
follows: preferably, an ultra short-acting barbiturate such as thiopental
or thiamylal; if this is not available, a short-acting barbiturate (e.g. seco
barbital or pentobarbital) or a short-acting muscle relaxant (succmylcholine). Intravenous muscle relaxants and barbiturates should only be
administered by those familiar with their use.
Dosage and Administration:
The duration of anesthesia with bupivacaine is such that, for most pro
cedures, a single dose is sufficient. Maximum dosage limit must be indi
vidualized in each case after evaluating the size and physical status of
the patient, as well as the usual rate of systemic absorption from a par
ticular injection site. Most experience to date is with single doses of
bupivacaine up to 225 mg with epinephrine 1:200,000, and 175 mg
without epinephrine; more or less drug may be used depending on indi
vidualization of each case.
At present there is insufficient clinical evidence with multiple dosage or
intermittent dose techniques to permit precise recommendations for
such procedures to be given. However, limited clinical experience in this
area of use indicates that bupivacaine may be repeated in 3 to 6 hours
up to a maximum dose of 400 mg in 24 hours. In most cases the dura
tion of anesthetic effect is prolonged by the addition of epinephrine.
The following doses have generally proved satisfactory for the average
adult. They may require adjustment in relation to age and the physical
condition of the patient.
Local infiltration: up to a maximum dosage of 0.25% solution.
Peripheral nerve block: 5 to 30 mL of 0.50% or 5 to 60 mL of 0.25%
solution.
Sympathetic: 20 to 50 mL of a 0.25% solution.
Epidural: 10 to 20 mL of a 0.25%, 0.50%, or 0.75%t solution.
Caudal: 15 to 30 mL of a 0.25% or 0.50% solution.
tO.75% not recommended for obstetric use.
Supplied:
Each 20 mL single dose vial contains: bupivacaine 0.25%, 0.50% or
0. 7 5 . with or without epinephrine 1:200,000. Boxes of 5 vials.
Each 50 mL multiple dose vial contains: bupivacaine 0.25% or 0.50%.
Boxes of 1 vial.
Note: Bupivacaine solutions without epinephrine may be autoclaved.
Product Monograph available on request.
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Cancer of the Colon and Rectum: 30-Year Follow-up Study
c o n s ta n t rate, fo r 3 0 years. The data
su g g est th a t th e cancer w a s eradicated
in one th ird o f all p a tie n ts, and in one
h a lf o f p a tie n ts in subgroups w ith no
lym p h a d e n o p a th y or w ith sh a llo w
prim ary lesions.

This stu d y review s the course o f all
patients registered at th e Saskatoon
Cancer Clinic b e tw e en 1 9 4 9 and 1951,
w ith h isto lo g ica lly proven cancer o f the
colon or rectum . The data were
abstracted, coded and analysed by lifetable m ethods. F ollow -u p w as com plete
to death or to 1 9 8 2 . There w ere 4 0 3
patients (5 8 .3 % w e re m en). Cancer of
the rectum acco u nte d fo r 5 1 % o f the
to ta l, the sigm oid colon 2 2 % and the
cecum 1 0% . The p rim a ry tu m o u r was
resected by abdom inoperineal resection,
h e m ico le cto m y or segm ental co lectom y
in 6 3 % o f the pa tie nts; co lo sto m y alone
w a s perform ed in 2 1 % .
The overall su rvival w a s 3 1 % a t 5
years, 2 4 % at 10 years, 1 5 % a t 20
years and 7 % a t 3 0 years fro m diagno
sis. M any o f th e deaths in th is relatively
elderly group o f p a tie n ts w ere due to
causes o th er th a n th e cancer. Consider
ing cancer-related causes o f death only
in pa tie nts w ith resectable lesions, the
cu m u la tive p ro b a b ility o f su rvival at 5,
10, 20 and 3 0 years w a s 6 3 % ± 4 % ,
5 4 % ± 4 % , 4 8 % ± 4 % and 4 7 % ±
6 % , respectively (p ro b a b ility ± 1 stand
ard error), fo r th o se w ith o u t lym phadenopathy, and 1 4 % ± 3 % , 1 2 % ±
2 % , 10% ± 2 % and 9 % ± 3 % , respec
tiv e ly , fo r th o se w ith in vo lve d nodes.
Death fro m th e cancer w a s rare after
10 years w h ile deaths fro m com peting
causes co n tin ue d to o ccu r, a t a near
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C ette e tu de passe en revue re v o lu tio n
de to u s les p a tie n ts qui o n t ete in scrits a
la S askatoon Cancer Clinic s o u ffra n t
d 'u n cancer h isto lo g iq u e m e n t dem ontre
du colon ou du rectu m . Les donnees ont
ete resum ees, co difiees e t analysees au
m oyen de m ethodes actuarielles. La sur
veillance des suites the ra p e u tiq ue s s'e st
arretee avec la m o rt du p a tie nt ou a I'annee 1 9 8 2 . On a co m p te 4 0 3 patients
(do n t 5 8 .3 % d 'h o m m e s). Les cancers du
rectu m rep r6 se n ta ie n t 5 1 % du to ta l,
ceux du sigmoTdes 2 2 % et ceux du
caecum 1 0 % . La tu m e u r prim aire avait
et6 soum ise a une resection
abdom inoperin£ale, £ une hem icolecto m ie ou d une co le cto m ie segm entaire
dans 6 3 % des cas; une co lo sto m ie sim 
ple a va it et6 pratiquee dans 2 1 % des
cas.
G lobalem ent, le ta u x de survie fu t de
3 1 % a 5 ans, de 2 4 % d 10 ans, de
1 5 % & 2 0 ans e t 7 % a 3 0 ans apres le
d ia g n o stic. Parmi ce groupe de patients
re la tive m e n t ages, plusieurs deces fu re n t
a ttrib u a b le s a des causes autres que le
cancer. Si Ton s'e n tie n t aux causes de
nature cancereuse chez les pa tie nts qui
o n t eu une lesion resecable, la probabilite
c u m u la tive de survie d 5, 10, 2 0 et 30
ans fu t de 6 3 % ± 4 % , 5 4 % ± 4 % ,
4 8 % ± 4 % e t 4 7 % ± 6 % respectivem en t (pro b a b ilite ± I'e rre u r type) pour
ceux qui n 'a v a ie n t pas de lym phad£nopathie, e t de 1 4 % ± 3 % , 1 2 % ± 2 % ,
1 0 % ± 2 % e t 9 % ± 3 % respectivem en t chez ceux qui ava ie n t une a tte inte
lym p ha tiq u e .
Apres 10 ans les d£ces dus au cancer
d e vin re n t rare alors que les d£c£s de
causes autres co n tin u d re n t de survenir a

un ta u x presque c o n s ta n t pen da n t 3 0
ans. Ces donnees in d iq u e n t que le
ca n ce r a pu e tre eradique chez un tie rs
de to u s les p a tie n ts ou chez la m o itie
d 'u n so u s-g ro u pe de p a tie n ts qui
n 'a v a ie n t pas de lym p ha d 6 n o p ath ie ou
qui a va ie n t une tu m e u r prim aire superficie lle .

Although numerous reports present
5-year survival figures for cancer o f the
colon and rectum,1-7 there is a dearth o f
inform ation on long-term results. H ow
many patients survive cancer o f the colon
or rectum to die o f other causes? In how
many patients is the cancer apparently
eradicated? W hat is the mortality o f the
disease at various times follow ing diag
nosis? W hat is the shape o f the life-table
curve over a prolonged period? The
records o f the Saskatchewan cancer
clinics provide a unique opportunity to
answer these questions. This study was
designed to analyse the results in a popu
lation o f patients with cancer o f the colon
or rectum follow ed up fo r 30 years.
The Saskatchewan cancer clinics have
records o f patients in that province from
1932 to the present with a diagnosis o f
any type o f cancer. The accuracy and
completeness o f follow-up data are quite
remarkable, due to the stability o f the
population, the prestige enjoyed by the
clinics and the policies o f the provincial
health department concerning patients
with cancer. In 1944, the government
decided to reimburse patients for all serv
ices related to a diagnosis o f cancer,
provided that they were registered with
one o f the cancer clinics, a decision that
ensured 100% registration.

Patients and Methods
A ll 403 patients registered with the
Saskatoon Cancer Clinic from 1949 to
1951, who had histologically proven

T H E C A N A D IA N J O U R N A L O F S U R G E R Y

311

adenocarcinoma of the colon or rectum,
were studied. Each patient’s chart was
reviewed and the information obtained
was coded onto a prepared “ OP-SCAN”
form which could be read directly by the
computer’s optical scanning input device.
The following information was ob
tained for each patient: sex, dates of birth
and diagnosis, presenting complaint,
location of primary tumour, histologic
features of the tumour, extent of bowelwall and lymph-node involvement, surgi
cal treatment, date of termination and
status at termination. Concerning the
extent of bowel-wall invasion, stage A
refers to involvement of the mucosa
including the muscularis mucosae, stage
B, includes cancer confined to the bowel
wall including the muscularis propria and
stage B2 extension to the serosa. It was
not possible in every case to correlate the
stage of bowel-wall invasion with the sta
tus of mesenteric nodes because lymph
nodes were not always found in the
specimen.
The data from the “ OP-SCAN” forms
were read into the computer and analysed
using the BMDP8 software for life tables
and survival functions.
Findings

Patient Data
Of the 403 patients, 235 (58.3%) were
men. The patients’ ages ranged from 18
to 88 years (mean 61.3 ± 12.1 years [±
1 SD]). The age distribution is shown in
Fig. 1. The distribution o f the primary
lesions in the various segments of the
bowel is shown in Table I.
Primary Surgical Treatment
The operations performed are listed in
Table II. In many cases it was not possi
ble to establish from the chart whether the
operation had been performed for cure.
This aspect of the procedure was, there
fore, not coded for analysis.
Extent o f Tumour at Diagnosis
In those patients who had resection of
the cancer, the extent of bowel-wall inva
sion was as follows: stage A, 5%; stage
B|, 22%; stage B2, 73%. Lymph nodes
were examined in 247 patients and 73
(30%) were found to contain tumour. The
presence of metastatic disease, most com
monly in the liver, was recorded in 34%
of patients at the time of primary diag
nosis or operation.
Follow-up
The follow-up information was com
plete. Every patient was followed up until
death or until 1982 to give a complete
30-year study. Twenty-two patients were
312

alive and well 30 years from the time of
diagnosis.
The patient’s status at the time of death
or termination was determined in all
except 14 cases. The cause of death was
recorded in 96.5% of those who died. Of
the 367 patients who died of known cause
during the follow-up period, 289 (79%)
died of bowel cancer, and 78 (21%) of
other causes. No patient was alive with
disease or alive with unknown status at
the conclusion of the study.
Operative Mortality
Death occurred within 1 month of
operation in 6.5% of patients with resec
table lesions. These deaths are included
in all the life tables.

colon (Fig. 5) but the difference was
neither significant nor important.
Including only those patients who had
a procedure to resect the primary tumour,
Fig. 6 depicts the life-table analysis for
cancer deaths only in patients with and
without positive mesenteric lymph nodes.
With no lymphadenopathy, the probabil
ity of survival at 5, 10, 20 and 30 years
was 63% ± 4%, 54% ± 4%, 48% ±
4% and 47% ± 6% respectively (proba
bility ± 1 standard error). The equiva
lent figures in patients with involved
nodes were 14% ± 3%, 12% ± 2%,
10% ± 2% and 9% ± 3% respectively.

iso-

L ife Tables and Survival Analysis
The cumulative proportion of patients
surviving at intervals up to 30 years is
depicted in Fig. 2, showing the different
curves for deaths due to cancer and to all
causes. Ninety-five percent of patients
who died of the cancer died within 8 years
of diagnosis. Death from cancer was rare
after 10 years. Deaths from all other
causes continued to occur in this relatively
elderly patient population. The overall
actual survival was 31% at 5 years, 24%
at 10 years, 15% at 20 years and 7% at
30 years from diagnosis.
In Fig. 3, the overall cumulative sur
vival is shown on a semilogarithmic scale.
This demonstrates that deaths from all
other causes occurred at a near-constant
rate from the 8th to the 30th year,
whereas the rate of cancer death at that
time fell close to zero.
There was no difference in the outcome
related to sex (Fig. 4). The results for
patients with rectal cancer were slightly
worse than for those with cancer of the
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FIG. I—Age distribution.

..
o* 0.9-

................ I I i i I i I I i |i i i t I
10
15
20
25
30

Table 1—Location of the Primary Tumour
Site
No.
%
Cecum
39
10
Ascending colon
17
4
Transverse colon
and flexures
35
9
Descending colon
17
4
Sigmoid colon
87
22
Rectum
206
51

Table II—Primary Operation Performed
No.
Procedure
%
Abdominoperineal resection
123
30
Anterior resection
36
9
Hemicolectomy or
segmental resection
79
20
Colostomy alone
84
21
Other procedures,
e.g., Hartmann, Mikulicz
16
4
No operation, biopsy only
65
16

TIM E (Years)

FIG. 2—Life-table analysis for 30 years,
comparing cancer deaths (broken line) with
deaths from all causes (solid line).

FIG. 3—Life-table analysis for 30 years on
semilogarithmic scale: cancer deaths (broken
line) and deaths from all causes (solid line).
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The life table for patients with varying
involvement of the bowel wall is shown
in Fig 7. Only deaths due to cancer were
included in this analysis and, again, death
was rare after 10 years. The probability
of survival at 30 years was 57% ± 14%
for stage A, 37% ± 6% for stage B, and
21% ± 3% for stage B2 (probability ±
1 standard error).
Discussion
FIG. 4—Life-table analysis for men (broken
line) and women (solid line). Deaths from
cancer only.

FIG. 5—Life-table analysis for patients with
cancer of rectum (broken line) and other sites
in colon (solid line). Deaths from cancer only.

FIG. 6—Life-table analysis for patients hav
ing resection of primary lesion, with (broken
line) and without (solid line) involved lymph
nodes. Deaths from cancer only.

FIG. 7—Life-table analysis for patients with
varying extent of involvement of bowel wall:
stage A (short dashes), stage B, (long dashes)
and stage B2 (solid line). Deaths from cancer
only.

The method of abstracting and coding
the information from patients’ charts
used in this study was chosen because it
involves only one transcription from the
chart to the stage of final analysis. It may
seem almost incredible that follow-up was
complete without loss of a single case, but
this is consistent with the system for han
dling patients and their records at the
Saskatchewan cancer clinics.
Cancer of the colon and rectum is a
common disease that is well understood
in terms of incidence, distribution, clini
cal and pathological presentation, and
mode of spread.1,3'4'6 In this study, the
slight preponderance of men was noted
for cancer at every location, whereas it
is commonly accepted that for cancer of
the colon, as opposed to the rectum, there
is a slight preponderance of women. The
distribution of lesions throughout the
bowel was similar to that reported in
other series.
The prognosis for patients with
colorectal cancer is usually stated in
5-year survival figures,1’5 related to
different stages of the disease on presen
tation. The overall 5-year survival is
reported in the range of 75% for Dukes’
stage A, 60% for stage B and 30% for
stage C, where stage A designates tumour
confined to mucosa and muscularis
mucosae, stage B represents full-thickness
wall involvement and stage C includes
malignant lymphadenopathy. This kind
of information is of limited value in that
form, first because the result at 5 years
does not represent the final outcome, and
second because no account is taken of
deaths from causes other than the cancer.
It is often appropriate to include all
deaths in the statistics when dealing with
a relatively young population, but in
colorectal cancer the patient population
is older and the cause of death more likely
to be unrelated to the cancer as the com
peting causes of death assume greater
importance.
In Figs. 2 and 3, the overall results may
be followed for 30 years. The unbroken
line traces the actual survival, taking into
account all causes of death. The broken
line is derived from deaths caused only
by the cancer, representing at annual
intervals the cumulative probability of
survival if no cause of death other than
the cancer is included. These figures

demonstrate that in the first 5 years
almost all of the deaths that occurred
were due to cancer, whereas after 10 years
cancer is rarely the cause of death, while
deaths from other causes continue to
occur regularly as would be expected in
a group of patients in this age range.
Using the semilogarithmic scale in Fig. 3,
the rate of dying of all causes is quite
different in years 0 to 5 from that in years
5 to 30. In the early period the annual
mortality is about 20% compound, while
in the later period it is about 5% because
of the relative absence of cancer deaths
after 10 years. These results contrast
markedly with those of long-term follow
up in patients with breast cancer. Mueller
and his colleagues9'10 showed that the
rate of dying of breast cancer remained
quite constant at 8% per year compound
for 20 years, although competing causes
of death also became more frequent with
increasing age.
This study shows that about one third
of the patients have no further problem
with the colorectal cancer after the
primary management (Figs. 2 and 3) and
that sex (Fig. 4) and primary cancer site
(Fig. 5) do not influence the outcome.
The results for rectal cancer are margi
nally but insignificantly worse than for
the other sites.
In this retrospective study it was not
possible to stage the patients accurately
according to Dukes’ classification because
of those who had limited resections or
inadequate sampling of lymph nodes. It
would be unreasonable, for example, to
assign a patient to Dukes’ stage B with
negative lymph-node status if only three
nodes were examined. The results accord
ing to nodal status (Fig. 6) and depth of
bowel-wall involvement (Fig. 7) had to be
assessed independently. It is noted that
the cumulative probability of survival at
30 years for patients with no lymph
adenopathy was 47%, and for patients
with stage A lesions, 57%. This suggests
that the disease has been eradicated in
these patients by whatever primary oper
ative procedure was performed, or that
removal of the primary tumour has
allowed the patient to regain control of
the disease process.
From what is known about the growth
rate of colorectal cancers, the tumour
doubling time may range from 30 to 400
days, with a mean of around 100
days.11,12 This suggests that the cancer
has been present from 5 to 15 years before
diagnosis and helps to explain the shape
of the life-table curves in the figures.
There appears to be a group of patients
in whom the disease is widespread at the
time of diagnosis and it appears that the
presence of malignant mesenteric lym
phadenopathy is simply a manifestation
of this. Fig. 6 suggests that 90% of node
positive patients must have had dissemi
nated disease at the time of primary sur-
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gery because they died within such a short
time. It also suggests that attempts to
achieve better results by more radical sur
gery will not succeed. The small group of
patients with involved lymph nodes who
survived longer than 10 years may
represent disease confined to the bowel
and lymph nodes without widespread dis
semination, but there are other possible
explanations involving the unexplained
but paramount factors in the balance of
power between tumour and host. Figs. 6
and 7 suggest that in 50% of patients who
are node-negative, or who have shallow
tumours, removal of the primary has
arrested the disease. Once again, it may
be suggested that this has occurred
because the cancer was already confined,
by whatever mechanism, to the bowel
wall. In addition to the obvious advan
tages of preventing death from hemor
rhage and intestinal obstruction, remov
ing the primary tumour may also change
the balance of power in favour of the
host.
The data available for this study do not
permit comparison of different proce
dures, or extents of resection performed,
but the results encourage the continued
application of most current surgical prin
ciples in the management of cancer of the
colon and rectum. The data, however, do
not support an aggressive policy in the
management of the regional lymph nodes.
I thank Mr. Sanjay Dhingra who was
involved in the data collection and the statisti
cal analyses, and the staff of the Saskatoon
Cancer Clinic who gave their enthusiastic
support.
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Management of Chronic Perineal Sinuses by Wide Excision
and Split-Thickness Skin Grafting
Nine patients who had chronic perineal
sinuses following proctectomy for inflam
matory bowel disease underwent wide
excision of the sinus and split-thickness
skin grafting. All patients had persistent
pain and discharge. All but one had
undergone multiple surgical procedures
previously. Fibrous tissue was excised
from the sinus tract and the wound was
grafted either immediately (six patients)
or at a later date (three patients). Five
patients had complete healing of the
wound initially while four required further
procedures. Eight patients have been fol
lowed up for an average of 4.6 years
(range from 5 months to 12 years).
Complete healing was achieved in seven
patients; all are free of pain and can
work or are unrestricted in their daily ac
tivities. One patient is improved but still
requires analgesia and is disabled by the
persistent pelvic pain.
Neuf patients porteurs de sinus
perineaux chroniques consecutivement a
une proctectomie pour maladie intestinale inflammatoire ont subi une exci
sion large du sinus avec greffe de peau
d'epaisseur partielle. Tous souffraient de
douleur chronique et prdsentaient un
ecoulement suppure. Tous sauf un
avaient eu des interventions chirurgicales
multiples au preaiable. Le tissu fibreux
fut excise du sinus et la plale fut greffee
soit tout de suite aprfes (six patients),
soit a une date ulterieure (trois patients).
Une guerison complete de la plaie fut
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obtenue chez cinq patients alors que les
quatre autres devaient subir de nouvelles
operations. Huit patients ont fait I'objet
d’examens de contrdle sur une periode
moyenne de 4.6 annees (allant de 5
mois h 12 ans). Une guerison complete a
ete obtenue chez sept patients; tous
sont exempts de douleur et peuvent
travailler ou n'ont aucune entrave & leurs
activites quotidiennes. L'etat d’un
patient est ameliore mais il a encore
besoin d'analgesiques et est handicappe
par une douleur pelvienne persistante.

A major complication of proctectomy is
failure of perineal wound healing. By
definition, a chronic perineal sinus is one
that remains unhealed 6 months after sur
gery. Unfortunately, it is a frequent com
plication in patients with inflammatory
bowel disease and is associated with high
morbidity. Usually, the patient suffers
from persistent perineal drainage and pel
vic pain. The drainage may be so profuse
and malodorous that a pad or dressing
must be worn constantly. Analgesia
requirements may be great and narcotic
addiction is not infrequent. The chronic
perineal sinus tract is usually long and
narrow, lined by unyielding fibrous tis
sue and covered by granulation tissue. At
this stage, conservative measures such as
irrigation or curettage are of little benefit.
Healing is unlikely unless the fibrotic tis
sue is widely excised.
We review the experience at the
Toronto General Hospital with wide exci
sion followed by split-thickness skin
grafting in the treatment of chronic
perineal sinuses.

All patients complained of persistent
perineal drainage and pelvic pain. Three
were addicted to narcotics. One patient
was bedridden by pain from the perineal
wound. With one exception, all patients
had previously undergone multiple surgi
cal procedures (between 3 and 25) in
attem pts to achieve healing. These
included curettage of the sinus in seven,
drainage of abscesses in four, use of
gracilis muscle flaps in two, and coccygectomy, skin grafting and use of a silicone
mould in one patient each.
Procedure
Patients are placed in the lithotomy
position. A Foley catheter is inserted into
the bladder. Broad-spectrum antibiotics
are administered prophylactically before
operation and continued postoperatively.
The perineum and both thighs are pre
pared with antiseptic cleaning solution.
The skin graft is taken from the pre
selected donor site on the thigh and
preserved while the perineal sinus is
excised.
Typically, the sinus has a small exter
nal opening (Fig. 1) and a long tract (Fig.

Patients
Nine patients (six male, three female)
were treated by this method between 1974
and 1984 at the Toronto General Hospi
tal. Their average age was 31 years (range
from 16 to 48 years). Five patients had
ulcerative colitis and four Crohn’s dis
ease. The average time from proctectomy
to treatment was 2.7 years (range from
2 months to 7 years).

FIG. 1—Appearance of typical chronic
perineal sinus. External opening is small, but
tract is long and narrow.
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2), which may extend to the midsacral
area. A probe is inserted into the tract.
A wide elliptical incision is made around
the opening using electrocutting to
minimize bleeding. The tract is excised,
removing all of the thick fibrous tissue
until normal healthy tissue is encountered
(usually subcutaneous tissue of the
ischiorectal fossa). Almost always the
tract extends further than anticipated
preoperatively. At the apex of the sinus,
the fibrous tissue may be adherent to the
sacrum and impossible to excise, in which
case it is curetted and left. Bleeding may
be profuse and transfusion of several
units of blood is not uncommon. While
performing the dissection, care must be
taken to prevent inadvertent damage to
vital structures, particularly if there is a
long sinus tract whose apex is close to
loops of small bowel lying low in the
pelvis. By inserting a Foley catheter into
the bladder and inserting a finger into the
vagina in females, the risk of damage to
these structures can be minimized.
When the dissection is complete, the
defect is usually cone shaped (Fig. 3). The
wound is irrigated liberally and hemosta
sis is achieved before applying the graft
which is sutured with absorbable suture
material. If the apex of the defect is inac
cessible, it may be left ungrafted or the
graft may be held in place with a pack.
The wound is packed snugly with fluffed
gauze, held in place with silk skin sutures
tied over it. Excess skin may be stored and
used later to graft the wound if there is
incomplete “ take” .
Postoperatively, the patient is placed
on bed rest for 5 to 7 days, when the
dressings are removed (Fig. 4). If graft
healing is incomplete, the wound may be
regrafted or left to granulate depending
on the size of the area involved.

dary intention. The fourth patient under
went several subsequent procedures
including repeated excisions and split
thickness skin grafting, rotational flap
and curettage of the wound. These were
only partially successful.
At present, the perineal wounds in
seven patients are completely healed.
These patients have been followed up for
an average 4.6 years (5 months to 12
years). No one uses analgesia. In most
patients there is some mucus discharge
from the wound but it is not malodorous
and can be controlled using a 4 x 4-inch
gauze and changing it once daily. All
seven patients are fully employed or are
unrestricted in their normal daily activi
ties. One patient, who was bedridden
preoperatively and who required multiple
surgical procedures, has had incomplete
healing of the wound although it is
improved. Unfortunately, he is still
addicted to analgesics and is completely
debilitated due to the perineal wound.
One patient was lost to follow-up.

fibrotic tissue, preventing healing of the
wound. Patients with inflammatory
bowel disease are at high risk of having
perineal abscesses and thus chronic
perineal sinuses, probably because they
often have perianal sepsis or residual
inflammation in the pararectal tissues, or
both, at the time of proctectomy. The
reported frequency of unhealed perineal
wounds in these patients has varied from
7% to 33%.2’3 In a consecutive series of
44 patients with inflammatory bowel dis
ease who underwent proctectomy at our
institution, the perineal wound failed to
heal in 2 (4.5%).4 However, none of
these patients have significant symptoms
and have not required further surgery.

Discussion

The pelvic anatomy is of paramount
importance in the failure of perineal
wound healing.1 Following proctectomy,
a large cavity remains, bounded by the
fixed bony structures and relatively
immobile soft tissues of the pelvis. Thus,
little tissue can migrate to obliterate this
space. Instead, fluid accumulates in a
manner analogous to that seen in the
chest following pneumonectomy. In time,
the fluid and blood organizes, there is
some migration of tissue, the space is
obliterated and healing occurs. However,
if the fluid becomes infected, the abscess
cavity may become surrounded by thick

FIG. 3—All fibrous and granulation tissue
is excised right to apex of tract. Split-thickness
skin graft is applied immediately or at later
stage as in this patient.

Results

Using this method, six patients under
went excision and primary split-thickness
skin grafting while in three the skin graft
ing was delayed — from 1 to 2 weeks in
two and 8 weeks in the third.
The wound healed completely in five
patients. Four patients required further
procedures. One of them underwent
curettage of the wound on three subse
quent occasions. The second patient
required grafting again after 2 months
and this was followed by debridement 10
months later. There was virtually no heal
ing of the initial skin graft in the third
patient. This probably was due to a delay
in grafting that resulted in the presence
of overgrown granulation tissue when the
graft was applied. A second skin graft
was applied but became infected with
Pseudomonas sp, resulting in a “ take”
of approximately 25%. However, over
the next several weeks, the remainder of
the wound healed completely by secon
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FIG. 2—Sinogram illustrates long, narrow
sinus tract that extends from perineum (arrow)
to midsacral region.

FIG. 4—Dressings are removed 5 to 7 days
after skin grafting. There is further contrac
tion of wound with time.
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The chronic, unhealed perineal wound
may be a large shallow defect, but more
commonly there is a small external open
ing and a long narrow tract. There is per
sistent low-grade sepsis that results in a
continuous malodorous discharge and
chronic pain. At times, the external open
ing may close and pus accumulate, requir
ing drainage. However, conservative
measures such as drainage, irrigation or
curettage of the wound are of temporary
benefit only when a chronic tract forms.
To achieve permanent healing, it is essen
tial that all the thick fibrous tissue be
excised until only normal tissue remains.
Once this has been accomplished, the
wound may be handled by several meth
ods, including primary closure, secondary
healing, skin grafting or by rotation of
a myocutaneous flap using the gracilis
or gluteus maximus muscle to fill the
defect. Our preference has been to skin
graft the wound. It has several advan
tages. Healing time is shorter than leav
ing the wound open to heal by secondary
intention. Prolonged dressing changes are
unnecessary and patients can return to
work more quickly. Furthermore, pa
tients with Crohn’s disease tend to form
exuberant granulation tissue so complete
healing may not occur. Primary wound
closure and healing are usually not suc
cessful because there is a large defect and
continuing sepsis.
Several authors5,6 have reported good
results using myocutaneous flaps. Woods
and Beart5 achieved complete healing in
13 of 14 patients, using either unilateral
or bilateral gracilis muscle flaps. In five
of these patients, a second procedure was
necessary. It is our preference, however,
to use a split-thickness skin graft if pos
sible, since excellent results can be
achieved with this relatively simple tech
nique which is associated with less mor
bidity. In particular, if the initial graft
fails, grafting can be repeated with little
added morbidity. This is not true for a
myocutaneous flap.
The dissection may be difficult because
of dense fibrous tissue. In most situa
tions, the tract extends further than antic
ipated preoperatively, but it can be iden
tified and followed quite easily if a probe
is inserted into it. It may be impossible
to remove the most proximal part of the
tract because of the dense fibrous tissue
adherent to the sacrum and, indeed, one
must be careful at this level to avoid
injury to the small bowel lying in the
pelvis. It appears that complete excision
of the tract is unnecessary as long as only
a short tract remains and the remainder
of the wound is saucerized. Coccygectomy was not performed in any of our
patients and is not advocated because it
may increase pain postoperatively. When
the dissection is completed, one may be
surprised by the size of the resulting
cavity. However, over several months, it

contracts dramatically and the residual
defect has been acceptable to all our
patients. In our experience, the skin graft
does not prevent the wound from con
tracting as was suggested by Silen and
Glotzer.1
Antibiotics were given prophylactically
to only four of our patients, but after one
graft became infected and sloughed, we
began to administer antibiotics preoper
atively and postoperatively for several
days. No patient received adrenocorticotropin as advocated by Anderson and
Turnbull.7.
The unhealed perineal wound was a
major disability for all patients in this ser
ies. As mentioned previously, many
patients with persistent perineal sinuses do
not have significant symptoms and do not
require surgical treatment. In this series,
however, three patients were unable to
work and required large amounts of nar
cotics to control the pain. The rest of the
patients had less severe symptoms. All but
one patient had undergone multiple sur
gical procedures previously. Thus, it is
gratifying that the procedure was success
ful in seven of eight patients even though
four required a second procedure. Ander
son and Turnbull7 used a similar tech
nique and reported that 40 of their 44
patients had a good result although only
7 of these had complete healing of the
wound.
In summary, nine patients with chronic
perineal sinuses following proctectomy
for inflammatory bowel disease under
went wide excision of the sinus and split
thickness skin grafting. Five patients had
initial, complete healing of the wound
whereas further surgery was required in
the others. After an average follow-up of
4.6 years, the wound is completely healed
in seven patients (one was lost to follow
up). All of these patients are free of pain
and are not restricted by their perineal
wounds.
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Changing Patterns in the Management of Locally Advanced
Breast Cancer: a Preliminary Report
Over the 8 years from 1976 to 1983, 28
patients with stage IIIB (T4a,b,c, IMX-2,
MO) and inflammatory breast cancers
without evidence of disseminated dis
ease at the time of diagnosis were
treated at Ellis Fischel State Cancer
Center in Columbia, Mo. This group com
prised 4% of all cases of primary breast
cancer seen during that period. Radio
therapy was the primary treatment in
one half of the group during the first 4
years of the study (group A). Since
1981, locally advanced breast cancer
has been treated by multidrug
chemotherapy followed primarily by
mastectomy (group B). The rate of local
control was the same for both groups
(78% ). However, the median survival for
group A was 11 months, only one
patient being alive 5 years after diagno
sis, whereas in group B, 12 of 14
patients were alive and clinically free of
disease 9 to 31 months after diagnosis
with a median follow-up of 16.5 months.
This preliminary report confirms recent
findings, supporting the use of poly
chemotherapy followed by mastectomy
in the management of patients with
locally advanced breast cancer.
En 8 ans, de 1976 a 1983, 28 patientes
ayant un cancer du sein au stade IIIB
(T4a,b,c, N X -2 , MO) ou un cancer inflammatoire du sein sans signes de dissemi
nation au moment du diagnostic ont ete
traitees au Ellis Fischel State Cancer
Center de Columbia, Mo. Ce groupe
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comptait pour 4% de tous les cas de
cancer primaire du sein vus au cours de
cette periode. Au cours des 4 premieres
annees de I'etude, la radiotherapie fut le
traitement primaire pour la moitie du
groupe (ce qui constitue le groupe A).
Depuis 1981, les cancers localement
avances du sein ont ete tra ils par polychimiotherapie suivie d'une mastectomie
(gioupe B). Le taux de controle local a
ete le meme pour les deux groupes
(78% ). Toutefois, la survie mediane du
groupe A fut de 11 mois alors que seulement une patiente a survecu 5 ans apres
le diagnostic. En comparaison, dans le
groupe B, 12 des 14 patientes sont
vivantes sans manifestations cliniques de
maladie de 9 a 31 mois apres le diagnos
tic; la surveillance mediane est de 16.5
mois. Ces resultats preliminaires confir
m e d des observations recentes soutenant I'emploi de la polychimiotherapie
preparative a la mastectomie dans le trai
tement des patientes atteintes d'un can
cer localement avance du sein.

By the turn of the 20th century, Halsted’s
radical mastectomy had become the stan
dard management for primary breast
cancer regardless of the local extent of the
disease. Inflammatory cancer o f the
breast, the most aggressive form of this
neoplasm, was recognized as early as 1807
by Bell,1 the clinical characteristics were
described by Bryant2 in 1887 and the
term was coined by Lee and
Tannenbaum3 in 1924. Early experience
in the surgical treatment of locally
advanced breast cancer was uniformly
dismal. Data from our institution pub
lished by Donegan4 revealed a local
recurrence rate of 45.8% and only one
5-year survivor following surgery alone.
These poor results of surgery alone in the
management of inflammatory cancer of
the breast or of the noninflammatory type
that had either ulcerated, was fixed to the
chest wall, developed satellite nodules or
produced edema of the breast prompted
Haagensen and Stout5 in 1943 to develop
criteria for inoperability. Their contribu
tion to our understanding of the limita
tions of primary surgical management in
these patients has become a classic.

As early as 1949, Baclesse6 advocated
radiotherapy as the sole method of treat
ment for cancer of the breast. During the
following 35 years, radiotherapy domi
nated as the primary and often the only
form of management. The results of
treatment improved somewhat as radiotherapeutic technology and dosimetry
advanced. Data published between 1924
and 1964 revealed that radiotherapy alone
resulted in a mean survival between 4 and
20 months but practically no 5-year sur
vival. One of the first reports o f super
voltage radiation in the management of
locally advanced breast cancer was that
of Wang and Griscom7 who, in 1964,
reported a mean survival o f 30 months
among 10 patients with inflammatory
breast cancer. More recently, results of
radiotherapy alone for inoperable breast
cancer have shown local control rates
ranging from 10% to 46% .8,9 Local con
trol was further enhanced by twice-daily
fractionated irradiation9’10 and, in
another study, with the application of
interstitial implants.11 Doses greater than
6000 rad have given improved local con
trol and have been advocated by several
investigators.8,1013 Despite a progressive
improvement in local control rate, sur
vival in locally advanced carcinoma of the
breast rem ained poor. Zucali and
associates8 reported that the median sur
vival in a retrospective study o f 454
patients was 2.1 years. Bruckman and
colleagues13 studied 116 patients with
stage III disease treated by primary radio
therapy and obtained a 5-year survival of
25%. In their opinion, the addition of
mastectomy to effective radiotherapy was
unnecessary. However, in one recent
study, the addition of mastectomy to
radiotherapy increased the survival from
2.5 to 3.9 years.8 A multimodal ap
proach to the management o f locally
advanced carcinoma of the breast that
includes multiagent chemotherapy as the
first line of therapy has gained popular
ity in the last decade.14-24 Encouraging
data showing better local control and sur
vival rates have changed the patterns of
care in the management o f locally
advanced breast cancer.
The purpose of this paper is to share
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our results obtained during two recent
periods in which comparable groups of
14 patients with locally advanced and
inflammatory cancer of the breast were
treated by different methods.

Group A

between 1980 and 1983. The mean age
was also 61 years (ranging from 40 to 76
years). All patients in this group were ini
tially given an average of 4.6 cycles (rang
ing from 3 to 9) of chemotherapy consist
ing of the following: cyclophosphamide,
Methods and Results
100 mg/m2 orally, on days 1 to 14; Adriamycin, 25 mg/m2 intravenously, on
From 1976 to 1983, approximately 700
days 1 and 8; and 5-FU, 500 mg/m2
new cases of primary breast cancer were
intravenously on days 1 and 8 (CAF).
treated at Ellis Fischel State Cancer
Two patients also received vincristine,
Center in Columbia, Mo. The most
two received methotrexate and two pred
locally advanced tumours without evi
nisone. Mastectomy was then performed
dence of disseminated disease are those
in 10 patients. Simple mastectomy was
that fall into the stage Illb category
performed in six, modified radical
(T4a,b,c, NX-2, MO) and inflammatory
mastectomy in two and radical mastec
breast cancer. This group accounted for
tomy in two patients. Surgery was aimed
8% of all cases of cancer seen during the
at resecting all gross disease; cancer-free
same period. One half of the patients with
margins were obtained histologically in all
locally advanced disease were found to
patients. In this group, 11 women were
have clinical evidence of dissemination at
estrogen receptor-negative and 7 had
the time of initial visit and are not
inflammatory cancers. Radiotherapy was
included in this report. The remaining 4%
administered to two patients who refused
(28 cases) were analysed and form the
mastectomy. Two others who refused
basis of this report. Histologic documen
both surgery and radiotherapy were
tation and complete follow-up was
managed by chemotherapy. The overall
obtained for all patients. The stage was
local control rate, defined as total clini
defined in accordance with the 1983
cal absence of chest-wall disease, was
manual for cancer staging of the Ameri
78%, the same rate as in group A.
can Joint Committee on Cancer. The
However, the three patients in whom the
TNM classification and the Columbia
primary tumour was not controlled have
clinical classification are compared for
had a stable course in contrast to the rapid
clarity in Table I. The therapeutic
progression of disease in group A women.
Group B
approach to the care of these women is
Tumour size was reduced by more than
shown in Table II.
Group B consisted of 14 women treated 50% in eight (57%) patients following
preoperative chemotherapy. The tumour
regressed, but by less than 50% from the
Table 1—Comparison of the Columbia Clinical Classification and
original tumour size, in five patients who
TNM Staging of the American Joint Committee on Cancer (1983)
received chemotherapy preoperatively,
TNM Staging
and in one patient local disease progressed
Haagensen's criteria of inoperability (1943)
during the initial chemotherapeutic regi
Stage Illb
Stage C - grave signs of advanced breast carcinoma
men. The three failures of local control
T4b
Edema of skin involving less than one third of the breast
T4b
Skin ulceration
occurred in one of two patients who
T4a
Solid fixation of tumour to chest wall
received radiotherapy after chemotherapy
N2
Massive involvement of axillary lymph nodes
and in two patients who had refused local
N2
Fixation of axillary nodes
control measures. There were no local
Stage Illb
Stage D - signs of more advanced breast carcinoma
recurrences in 10 patients who underwent
T4c
Combination of any two of the grave signs
mastectomy following chemotherapy.
T4b
Edema of skin involving over one third of the breast
After a mean follow-up of 16.5
T4b
Satellite skin nodules
months, two group B women had died;
T4d
The inflammatory type of carcinoma
one had inflammatory cancer and
N3
Supraclavicular nodal involvement
N3
Internal mammary metastases
progressive disease and had refused local
N3
Edema of the arm
control measures, and one died of sepsis
Stage IV
24 months after diagnosis without evi
Ml
Distant metastases
dence of metastatic breast cancer. At the
time of writing, 10 of the remaining 12
From 1976 to 1979, 14 women were
treated. Their ages ranged from 32 to 89
years (mean 61 years). Twelve of these
patients were treated primarily by radio
therapy consisting of 6000 rad of cobalt
60 delivered in 6 weeks. A simple mastec
tomy was performed as primary treat
ment in two patients. Chemotherapy,
consisting o f cyclophospham ide,
methotrexate and 5-fluorouracil (5-FU),
was given to six patients following radio
therapy while radiation followed surgery
for the two patients who refused
chemotherapy. Ten of the 14 women were
estrogen receptor-negative and 8 had
inflammatory cancers defined as such by
a combination of rapid onset of classic
signs and symptoms and histologic con
firmation of lymphatic cutaneous involve
ment. Overall, the local control of chestwall disease was 78%. In three women,
the chest-wall disease progressed rapidly
following completion of radiotherapy.
With one exception, clinical manifesta
tions of disseminated disease developed
in all and the mean survival was 11
months. The only survivor, a patient with
inflammatory cancer, is alive and clini
cally free of disease 62 months after diag
nosis.

Table 11-Management of Locally Advanced Breast Cancer. Ellis Fischel State Cancer Center - Preliminary Report
No. of
Mean age,
Primary
No. of
Subsequent
No. of
Group
patients
yr (range)
treatment
patients
treatment
patients
Group A
14
61 (32-89)
Radiotherapy
12
Chemotherapy
6
(1976-1979)
Surgery
2
Radiotherapy
2
Group B
14
61 (40-76)
Chemotherapy
14
Mastectomy
10
(1980-1983)
(3 to 9 cycles)
Radiotherapy
2
Chemotherapy
12
*3 uncontrolled tumours were progressive.
t3 uncontrolled tumours are stable.
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Local
control, %
78*
78t
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appeared to be as effective. Barker and
associates12 reported on 31 women with
inflammatory breast cancer treated with
preirradiation CAF chemotherapy. They
failed to show improvement in local con
trol; however, Buzdar and associates17
from the same group later reported that
on further follow-up the combined moda
lity of treatment improved the diseasefree interval in all patients. The lack of
improvement in survival in patients youn
Discussion
ger than 50 years was attributed to the
high incidence of central nervous system
Unfortunately, the majority of patients
recurrence.
with locally advanced breast cancer will
Although multidrug chemotherapy as
die of their disease. Nevertheless, in recent
the initial therapy is to be credited for the
years it has been recognized that antirecent improvements in control and sur
neoplastic chemotherapy not only can
vival, mastectomy has regained a definite
produce a remarkable initial response but
place in the management of this disease.
also allows other modalities of local con The randomized prospective study by De
trol to be more effectively applied. The
Lena and the Milan group18 showed that
rationale in favour o f m ultidrug
although the total response rate was the
chemotherapy initially is also to control
same (75%), 100% of the women ran
micrometastases, since locally advanced
domized to the mastectomy arm obtained
breast cancer is clearly a systemic disease.
complete remission compared with 60%
Data published during the last 5 years
for the radiotherapy arm. In our
have generated considerable optimism for
experience to date, no local regional
the primary use of chemotherapy. In an
recurrences have occurred in the 10
initial report, Morris and colleagues14 patients who underwent mastectomy.
studied three patients with untreated,
Although the literature suggests that welladvanced, local and distant disease. There
planned and executed radiotherapy can
was marked regression of the primary
achieve similar local control rates, in our
lesions, and all patients underwent
opinion radiotherapy should be reserved
mastectomy with good results. In 1982,
for patients who refuse surgery, are poor
the same group19 reported on 27
candidates for operation, have residual
patients, 13 of whom had inflammatory
tumour following surgery and dissemi
cancer. After four cycles o f CAF
nated disease with short life expectancy
chemotherapy, the tumour had become
or whose tumour remains inoperable fol
operable in 24 women and 22 of them
lowing chemotherapy.
underwent mastectomy. These workers
Recently, Fastenberg and colleagues24
claimed 70% partial response and good
have used surgery and radiotherapy
surgical results. Further follow-up of this
postoperatively following initial chemo
group of patients was recently pre
therapy. No local relapses were observed
sented23 and the encouraging results con
in this group and the overall survival com
tinue, including those women with
pared favourably to that after radiother
inflam m atory cancer. P e rlo ff and
apy alone. The combination of all modal
Lesnick20 have recently reported their
ities of treatment may yield a modest
experience with 17 patients with stage III
increase in local control rates but is also
disease treated with two to four cycles of
likely to result in higher morbidity par
combination chemotherapy followed by
ticularly if radiotherapy is used before
modified radical mastectomy. All patients
surgery.
were considered to have operable disease
Multidrug chemotherapy that includes
following chemotherapy even though
tumour size was reduced by more than doxorubicin (Adriamycin) should be used
50% in only 10 patients. The median sur as the primary modality of management,
vival in this group was longer than 40 but further chemotherapy alone does not
maintain local control. After four cycles
months.
Radiotherapy in conjunction with or of induction chemotherapy, mastectomy
preceded by chemotherapy has also been should be done if tumour-free margins
studied recently. Sponzo and col can be obtained without extensive recon
leagues15 treated 13 patients with high- struction. It is essential to achieve local
dose radiotherapy (7000 to 9000 rad) fol control so that chemotherapy can be
lowed by combination chemotherapy and resumed within 2 to 3 weeks of operation.
obtained complete remission in 85% with Chemotherapy should then be continued
a median duration of response of 38 indefinitely to a maximum dose, unless
months. More recently22 they have pre severe toxicity occurs. Our data also sup
sented results of a randomized trial sug port the current literature which suggests
gesting that a lower radiotherapeutic dose that in this group of patients, menopausal
(5000 rad) given during the third and or estrogen receptor status does not
fourth cycles of induction chemotherapy influence therapy or survival.

patients were alive and free of clinical dis
ease from 10 to 31 months after diagno
sis and 2 were alive with stable chest-wall
disease. All had continued multidrug
chemotherapy. Among the six surviving
women with inflammatory cancer, five
were clinically disease-free; all of them
underwent mastectomy after chemother
apy. The sixth woman had stable disease
following chemotherapy alone.

Recent progress in the management of
locally advanced breast cancer has
resulted in a substantial improvement in
local control and meaningful survival for
a disease once considered to be uniformly
and rapidly fatal.
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Is Age Alone a Contraindication to Major Cancer Surgery?

The question o f w h e th e r m ajor cancer
operations are w o rth w h ile in elderly
patien ts is becom ing m ore im p o rta n t, as
w e are faced w ith a progressively aging
population.
From Jan. 1, 1 9 7 8 to Dec. 3 1 , 1 9 8 3,
2 6 8 elderly patients u n d e rw e n t m ajor
operations fo r esophageal, ga stric, in te s
tin a l, pancreatic and retroperitoneal
cancer. The patients w ere divided into
three age groups: group A , 6 5 to 74
years (1 6 3 patients), group B, 7 5 to 84
years (81 patients) and group C, 8 5 to
9 2 years (24 patients). The overall oper
a tive m o rta lity w a s 1 1 .2 % , 8 .6 % in
group A , 1 3 .6 % in group B and 2 0 .8 %
in group C. The higher rates in groups B
and C resulted fro m tw o m ajor fa cto rs:
(a) the presence o f serious ca rd io p u lm o 
nary disease preoperatively and (b) the
d e velopm ent o f one or m ore serious
com p lica tio n s p o stop e ra tively. W hen
these tw o fa cto rs w ere com pensated
fo r, the rates became com parable at
6 .1 % , 6 .6 % and 8 .3 % , respectively.
The e ffe c t o f preexisting cardiorespira
to ry com prom ise w a s app ro xim ate ly
equal in each group. The e ffe c t o f
postoperative surgical com p lica tio n s
became m ore pronounced w ith a dvanc
ing age.
M ost patients enjoyed su b stan tia l palli
ation o f sym ptom s. The average length
o f hospital stay w a s n o t unduly
prolonged. M ajor cancer surgery can be
safe and beneficial fo r elderly patients,
b u t concerted a tte m p ts m ust be m ade to
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im prove th e ir sta tu s preoperatively. The
m inim um e ffe c tiv e operation sh ould be
perfo rm e d and postop e ra tive care should
be in tensified.

A ve c le vie illisse m e n t progressif de la
p o p ula tio n , il d e vie n t im p o rta n t de se
dem ander s 'il v a u t la peine de so u m e ttre
les p a tien ts geriatriques cancereux a des
o p erations majeures.
Du 1er ja n vier 1 9 7 8 au 31 decem bre
1 9 8 3 , 2 6 8 patien ts ag6s o n t subi des
o p erations m ajeures pour des cancers
oesophagiens, gastriques, in te stin a u x,
pancreatiques et retro p e rito n e au x. Ces
p a tien ts o n t ete repartis selon I'age: le
groupe A age de 6 5 a 7 4 ans (1 6 3
p a tie n ts), le groupe B, de 7 5 & 8 4 ans
(81 patients) e t le groupe C, de 8 5 a 9 2
ans (24 patien ts). La m orta lite o p e ra to ire
a ete de 1 1 .2 % ; 8 .6 % dans le g ro u p e A ,
1 3 .6 % dans le groupe B e t 2 0 .8 % dans
le groupe C. Les ta u x plus eleves
observes dans les groupes B et C resulta ie n t de deux fa cte u rs im p o rta n ts: a) la
presence preop6ratoire de maladies
cardiopulm onaires serieuses et b) le
d e veloppem ent d 'u n e ou de plus d 'u n e
co m p lica tio n postop e ra toire . Q uand ces
deux fa cte u rs so n t pris en co m p te , les
ta u x devie nn e n t com parables so it 6 .1 % ,
6 .6 % e t 8 .3 % respectivem ent. L 'e ffe t
des a ffe ctio n s cardiorespiratoires preexista n te s a ete a peu pres egal dans
chaque groupe. L 'e ffe t des c o m p lica tio n s
ch iru rg ica le s p o sto p ^ra to ire s s 'e s t to u te fo is accentue avec I'age.
La plu p art des p a tien ts o n t b enefici£
d 'u n e ffe t p a llia tif m arque sur les sym pto m e s. La duree m oyenne d 'h o sp ita lisa tio n n 'a pas ete prolongee outre m esure.
La chirurgie anticancereuse m ajeure pe u t
etre sure pour les p a tien ts ag6s e t leur
e tre p ro fita b le m ais to u s d o ive n t te n te r
d 'a m e lio re r leur e ta t preoperatoire. On
d e vra it s'e n te n ir a I'op e ra tion m inim u m
e ffica ce e t in te n sifie r les soins p o stop e ratoires.

Elderly patients are frequently denied
major cancer operations because they are

considered too old. Reasons cited include
an unacceptably high operative risk,
unnecessary pain and suffering, long
hospital stay and little benefit in view of
their relatively short life expectancy. In
the light of recent advances in anesthesia
and perioperative care, this view may be
outdated. Certainly, in the anecdotal
experience of most general surgeons,
elderly patients have survived their proce
dures and enjoyed a better quality of life
afterwards. Even if life expectancy is not
increased, substantial palliation has been
achieved. This study was undertaken to
determine if these impressions are correct
or if, indeed, age should be considered a
contraindication to major cancer surgery.

Patients and Method

Two-hundred and sixty-eight patients
(137 women, 131 men), 65 years of age
and older (mean 73.8 years), were studied
retrospectively. All had undergone major
operations for cancer of the esophagus
and cardia, stomach, colon, rectum, pan
creas and retroperitoneum, between Jan.
1, 1978 and Dec. 31, 1983. The patients
were chosen consecutively without regard
to the stage of the disease, to whether dis
tant metastases were present or whether
the procedure was considered palliative or
curative. They were divided into three
groups on the basis of age. Group A com
prised 163 patients aged 65 to 74 years,
group B, 81 patients from 75 to 84 years
of age and group C, 24 patients 85 to 92
years old.
Serious preoperative cardiac or respira
tory disease was judged to be present or
serious surgical complications to have
developed from information in the chart.
Criteria for serious cardiorespiratory dis
ease were modified from the risk index
of Goldman and associates.1 The criteria
included frequent angina, recent myocar
dial infarction, shortness of breath on
climbing less than one flight of stairs,
obvious clinical evidence of cardiac fail
ure or arrhythmia and the need for regu
lar medication for cardiac or respiratory
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symptoms. Serious surgical complications
included anastomotic leakage and seque
lae, intraperitoneal infection, wound
dehiscence, postoperative hemorrhage
and pulmonary embolism. Operative
deaths were those occurring during the
hospital stay following operation.

was especially evident in group C patients,
over 85 years of age. Some of this time
was due to complications and prolonged
convalescence. There was also a problem
in transferring these people to a chroniccare facility or nursing home since beds
are not readily available. There was no
important difference in duration of hospi

tal stay with respect to the various tumour
sites.
Discussion
The need to treat elderly cancer patients
is a problem of increasing importance.
First, there are more older people because

Results
Of the 268 patients, 33 were considered
to have serious cardiac or respiratory dis
ease preoperatively, serious surgical com
plications developed postoperatively in
22; 8 of these patients had both cardiac
or respiratory disease and serious surgi
cal complications.
Operative Mortality
In all there were 30 operative deaths
(11.2%) (Fig. 1). The mortality for group
A was 8.6% , for group B 13.6% and for
group C 20.8%. The rate increased
markedly in those who had preexisting
serious cardiorespiratory disease or seri
ous surgical complications. If these
patients were eliminated, the mortality in
each group became approximately equal
and comparable to that of patients under
65 years of age subjected to similar proce
dures. Closer study of these patients
(Table I) showed that 59% of those with
serious surgical complications subse
quently died. This effect became more
pronounced with advancing age. The
patients with cardiac or respiratory dis
ease preoperatively were also at risk, with
30% dying postoperatively. This factor
affected each group approximately
equally and was not apparently affected
by advancing age. Of the eight patients
who had both preexisting cardiorespira
tory disease and a serious surgical com
plication, only one survived.
Fig. 2 shows the mortality by anatomic
site of the cancer. This ranges from no
deaths for the five patients with
retroperitoneal tumours to a high opera
tive mortality of 37% for bile duct and
pancreatic cancers.

FIG. 1—Operative mortality by age group. CR = cardiorespiratory disease.

T a b le 1— M o r t a li t y in 4 7 P a t ie n t s W it h S e r io u s C a r d io r e s p ir a t o r y
D is e a s e o r S u r g ic a l C o m p lic a t io n s
S u r g ic a l

C a r d io r e s p ir a t o r y

O v e r a ll,

c o m p lic a tio n s ,

d is e a s e ,

e it h e r o r b o t h ,*

G ro u p

n o . /t o t a l n o . (% )

n o . /t o t a l n o . (% )

n o ./t o t a l n o . (% )

A

5 /1 2 (4 2 )

2 /6

B

5 /7

(7 1 )

5 /1 6 (3 1 )

7 /2 0 (3 5 )

C

3 /3

(1 0 0 )

3 /1 1

(2 7 )

4 /1 2 (3 3 )

1 0 /3 3 (3 0 )

1 6 /4 7 (3 4 )

T o t a ls

Palliation o f Symptoms

1 3 /2 2 (5 9 )

(3 3 )

5 /1 5 (3 3 )

* 0 f t h e 8 p a t ie n t s w h o h a d b o th p ro b le m s , 7 d ie d .

Of the 268 patients, 238 survived oper
ation. The substantial relief of major
symptoms is evident in Table II. Ninetyfour percent noted relief of dysphagia,
vomiting, bleeding and tenesmus. In addi
tion, the effects of gastrointestinal and
biliary obstruction were overcome in the
majority of patients. Relief of pain and
anorexia, and the sense of well being were
not considered since they are less easy to
define.

T a b le I I — P a llia t io n o f S y m p t o m s in 2 3 8 S u r v iv o r s
P a llia t io n ,
S it e o f t u m o u r
E s o p h a g u s a n d c a r d ia
S to m a c h

n o ./t o t a l n o . (% )
1 0 /1 0

D y s p h a g ia

3 1 /3 4

(9 1 )

V o m itin g , a n e m ia

1 2 3 /1 3 1

(9 4 )

O b s t r u c t io n , b le e d in g ,

R e c tu m

3 3 /3 5

(9 4 )

O b s t r u c t io n , d ia r r h e a ,

P a n c re a s an d

2 7 /2 8

(9 6 )

J a u n d ic e , in t e s tin a l

C o lo n

a n e m ia

Hospital Stay

t e n e s m u s , b le e d in g

The average length of stay was longer
than for younger patients (Table III). This
324

S y m p to m s

(1 0 0 )

r e t r o p e r ito n e u m

o b s t r u c t io n
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of population trends and longer life
expectancy.2 Second, this group is
statistically more likely to have malignant
lesions. Current population estimates and
projections clearly indicate that the fre
quency of geriatric procedures in general,
and cancer operations in particular, will
increase rapidly for the rest of this
century.3’4
Although more elderly patients are
being operated upon, many physicians
remain reluctant to refer patients, even
those with potentially curable tumours,
preferring a more conservative approach.
The impression is that operation repre
sents a high risk with little potential
benefit. This view is based on the pre
sumed frailty of these patients and their
relatively short life expectancy. These
concepts are based on historical facts or
simple bias. They fail to take into account
recent advances in preoperative prepara
tion, techniques of surgery and anesthe
sia and postoperative care and monitor
ing, which have all combined to make
major surgery common and safe. In fact,
recent data show that the operative mor
tality for elective general surgical proce
dures of all kinds is not appreciably
different in the elderly.5 It is also impor
tant to note that at age 80 full life expec
tancy has not necessarily been reached.
Fifty percent of octogenarians will live
another 5 years.6
The results of the present study show
that in this group of elderly patients who
undergo operations of major magnitude
for various types of cancer, the mortal
ity is within acceptable limits. Only 14 of
221 patients who did not have either seri
ous cardiorespiratory disease preoperatively or surgical complications postoperatively died following operation. This rate
(6.3%) is comparable to that of younger
patients who undergo similar procedures.
As would be expected, those with serious
cardiac or respiratory problems had a
markedly increased operative mortality.
Each age group was affected approxi
mately equally, indicating that it was
probably the intercurrent disease, rather
than the age of the patient, that was the
deciding factor. Similarly, the develop
ment of surgical complications was poorly

Site of tumour
Esophagus
and cardia
Stomach
Colon
Rectum
Pancreas
Retroperitoneum
Means

tolerated by all groups. However, this
effect seemed to increase with advancing
age, demonstrating that there is a lesser
margin of safety as one gets older. Even
though the primary operative traum a is
well handled, a second insult resulting
from a serious complication can alter the
precarious balance and put into motion
a chain of events that cannot be reversed.
The results also indicate that the aver
age length of hospital stay, although
longer than would be expected for youn
ger patients, is not unreasonable consider
ing the disease processes and the magni
tude of the procedures performed. The
differences are certainly not great enough
to justify withholding surgery on an eco
nomic basis. Although the study did not
examine specific complications, there is
ample evidence that the higher rate of
morbidity seen postoperatively in older
patients is due to the associated disease
rather than age.7"9
The strikingly effective palliation of
symptoms in the patients who survived
operation is perhaps the most important
aspect. Operation is often the only good
method of palliation. If these patients had
been denied this, they would likely have
remained symptomatic and uncomforta
ble for the rest of their lives. This benefit
alone represents a strong argument for
subjecting the elderly individual to the
pain and risk of operation.
On the evidence from this study, it
appears that denial of major cancer sur
gery on the basis of age alone is not justi
fied. However, it is equally apparent that
the status of these patients preoperatively
must be improved. Cole10 emphasized
the necessity of getting elderly people into
good nutritional condition preoperatively,
in order to minimize morbidity and m or
tality. This is strikingly illustrated by the
disproportionate number of deaths from
bile duct, pancreatic and esophageal
cancers in our study. Patients with these
tumours are traditionally malnourished
when they are admitted for operation.
Elderly cancer patients are also more
prone to infections and handle them
poorly.11 They should be given antibi
otics prophylactically. The use of sub
cutaneously adm inistered h ep arin 12

Table Ill-M ean Length of Hospital Stay (Days) by Tumour Site
Group
A
B
Overall
22.2
18.0
22.3
26.5
20.6
26.4
22.2

23.4
18.9
14.8
19.8
20.1
18.5
17.4

16.0
17,1
21.0
29.2
19.1
20.0
21.4

C
26.0
17.0
27.4
94.0
29.3
55.0
32.1

prophylactically to reduce thromboem
bolic events is more controversial, but is
recommended in these patients for simi
lar reasons. It is obvious that patients
with serious cardiorespiratory disease are
at high risk. This should be reduced
preoperatively by intensive treatm ent of
congestive heart failure, arrhythmias,
bronchoconstriction and other reversible
conditions. If the condition cannot be
adequately controlled, then these patients
should not undergo major cancer opera
tions. Each case must be considered
individually. Meticulous attention to
detail in the diagnosis and physiologic
management of all primary and intercur
rent diseases, as well as their interactions,
is the cornerstone of success in the surgi
cal treatment of the aged.13
Intraoperatively, a basic rule should be
to do as little operating as possible in an
attempt to shorten the procedure and
decrease complications. The minimum
effective operation should be performed.
Radical resections should rarely be under
taken. The object should be to clear
enough gross tum our to prevent local
recurrence. If an obstructing lesion is
unresectable, it should be bypassed or
decompressed by the simplest means
available.
Postoperatively, the patient should be
kept in an intensive care setting and ven
tilation and invasive monitoring liberally
utilized. These measures should be used
for prophylaxis against cardiac arrhyth
mias, myocardial infarction and other
problems before they arise. There should
be no hesitation in continuing ventilation
until the pain and distension caused by
the operation have subsided. Physiother
apy and early mobilization should be
instituted to prevent the complications of
prolonged bed rest which are more com
mon in the elderly.
Is there an age limit beyond which
operation is contraindicated? The answer
is probably no, since the physiologic age
is a more important determinant than the
chronologic age. There are many spec
tacular examples of surgical success in
patients 85 years of age and older who
have gone on to live useful lives, free of
symptoms and able to enjoy their remain
ing years. In essence, one should make the
decision to operate on the same basis as
in the younger patient, that is, whether
the potential benefits justify the risks.
One must also ensure that the operation
does not prolong dying rather than liv
ing. Substantial palliation must be the
goal, and it can be realistically achieved.
Finally, mental status is also an impor
tant factor to be considered in deciding
whether a patient will be capable of
enjoying a productive, happy life. If these
principles are effectively used, the results
can be gratifying for both patient and
surgeon.
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Conclusions
Well nourished and otherwise healthy
elderly patients tolerate major cancer sur
gery well if no serious complications
develop. Denial o f the benefits o f major
cancer surgery on the basis o f age alone
is not justified. If there are serious preex
isting cardiorespiratory problems or seri
ous surgical complications, the mortality
markedly increases. The development of
serious surgical complications was poorly
tolerated by all groups in this study and
the effect was greater with advancing age.
Preoperative cardiorespiratory disease
affected each age group approximately
equally. Substantial relief o f symptoms
was achieved in most patients. The aver
age length of hospital stay was longer

than would be expected with younger
patients, but was not unreasonable for
procedures o f such magnitude.
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Manipulation of Tissue Forces in Treating the Adult
Respiratory Distress Syndrome
In 1 6 anesthetized d ogs, low -pressure
p ulm on ary edem a w a s induced by the
in tra ve n o u s infusion of oleic acid (0 .0 2
mL/kg). O ne grou p of four anim als
se rve d a s controls. In the rem aining 12
anim als, the pulm onary capillary w edge
p re ssu re (Pcw p) w a s low ered in an effort
to d ecrease the accum ulation of
e xtra vascu lar lung w ater (EVLW ). In
eight d o gs, the E V L W value decreased
a s m e asured by the thermal green dye.
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double-indicator method. The low Pcw p
w a s m aintained until the E V L W reached
a minim um . In four dogs, reduction of
the Pcw p did not decrease the accum ula
tion of E V L W but did reduce the rate of
accum ulation. In anim als in w hich the
E V L W reached a minimum, restoration of
P cw p to baseline values did not increase
edema, w hile the control animals c o n 
tinued to deteriorate. Presumably,
ch a n ge s in tissu e and lym phatic
d yn am ics com pensated for the increased
capillary permeability.
O n a pro voqu e chez 16 chiens anesthe
sia s un oedem e de b asse pression pulmonaire par perfusion intraveineuse
d 'a cid e oleique (0 .0 2 mL/kg). Quatre
chiens ont servi de groupe temoin. Chez
les 12 autres anim aux. la pression capillaire pulm onaire (PCP) a ete abaissee
d a n s une tentative pour diminuer ('a c
cum ulation de liquide extravasculaire
d a n s les p o u m o n s (LEVP). Chez huit
chiens, la m esure du L E V P par la
methode du double indicateur au
colorant vert thermique a ete abaissee.
La PCP a ete gard£e b a sse ju sq u 'a ce
que le L E V P atteigne un minimum. Chez
quatre c h ie n s la reduction du P C P n 'a pu
diminuer I'accum u lation de L E V P mais

reduisit la vitesse d'accum ulation. Chez
les anim aux chez qui le L E V P atteignit un
m inim um , le retablissement, du P C P aux
valeurs de depart n 'a pas entra?n£ d 'a u g m entation de I'oedem e alors que les
a nim aux tem oins continuerent de se
deteriorer. Presum 6m ent, des changem ents d a n s la dynam ique des tissu s et
du sy ste m e lym phatique ont com pense
pour ('augm entation de la permeabilite
capillaire.

Adult respiratory distress syndrome is
associated with a number o f clinical con
ditions in which the common denomina
tor is the development of hemorrhagic
pulmonary edema secondary to damage
o f the pulmonary capillary endothelium.
Important causes of adult respiratory dis
tress syndrome include trauma, shock,
sepsis and pulmonary fat embolism. Con
sequently, the treatment of this disease is
very important to staff working in surgi
cal intensive care units. It is now generally
accepted that pharmacologic treatment
directed against the pulmonary endothe
lial damage is usually unsuccessful once
the lesion is established, so alternative
approaches are necessary.
At the root of pulmonary edema
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the lung tissues are “ refractory” to edema
form ation.1 It has been shown5 that this
refractory state is related to lung hydra
tion. In this study, I tested the possibil
ity that lungs afflicted by adult respira
tory distress syndrome can be rendered
refractory to edema.

associated with adult respiratory distress
syndrome is the inability of the pulmo
nary capillaries to maintain the colloid
osmotic gradient across the membrane.
Normally, the colloid osmotic gradient
represents a safety factor, keeping the
lungs dry,1 opposing filtration of edema
fluid. When this safety factor is interfered
with, hydrostatic forces prevail and
edema forms. Several authors2,3 have
proposed lowering the pulmonary capil
lary wedge pressure (Pcwp) in an effort
to combat edema. This approach is gener
ally successful. However, the questions as
to how much and for how long the Pcwp
should be lowered remain unanswered. In
the present study, I have taken this
approach further. It is known from previ
ous studies1,4 that the relation between
Pcwp and edema is biphasic. In normal
lungs, the Pcwp can be increased up to
25 mm Hg without appreciable edema.
Further elevations result in precipitous
accumulation of pulmonary fluid. In
other words, over a given range of Pcwp,

M eth od

FIG. 1—Extravascular lung water (EVLW)
in three groups is plotted against time in base
line (1), steady state after adult respiratory dis
tress syndrome is induced (2), after decreases
in pulmonary capillary wedge pressure (Pcwp)
(3) and after Pcwp is normalized (4) in group
III. Arrow at 100 minutes represents lowering
of Pcwp from 10 mm Hg to near zero and
arrow at 300 minutes represents return of Pcwp
to baseline value of 10 mm Hg.

Sixteen mongrel dogs were anesthetized
with sodium pentobarbital (30 mg/kg),
intubated and ventilated at a tidal volume
of 15 m L/kg with 60% oxygen, using a
Harvard ventilator (Harvard Apparatus
Co. Inc., S. Natick, Mass.) and a Ben
nett air-oxygen mixer (Puritan-Bennett
Corp., Los Angeles, Calif.). Additional
sodium pentobarbital was administered as
required. The left jugular vein was
exposed and a thermistor-tipped SwanGanz catheter was flow directed into the
pulmonary artery to measure pulmonary
artery pressure and Pcwp. A second
catheter was flow directed into the right
atrium for the injection o f indicators.
Extravascular lung water (EVLW) was
measured in vivo by means of the ther
mal green dye, double-indicator, dilution
technique. A thermistor tipped catheter
(femoral artery lung water catheter,
model 96-020-5F; Edwards Laboratories,
Santa Ana, Calif.) was directed into the
abdominal aorta through the left femoral
artery. This catheter was also used to
measure arterial pressure. It was con
nected to a dye densitometer cuvette
(model DC401, Waters Instruments Inc.,
Rochester, Minn.), which in turn was
coupled to a densitometer (model D402A,
Waters Instruments Inc.). Blood was
withdrawn through the cuvette by a pump
and immediately reinfused after the meas
urements were made. Both the femoral
catheter and the densitometer were con
nected to a model 9310 Edwards lung
water computer for processing the ther
mal and dye signals. To obtain the meas
urements, 10-mL boluses of ice-cold 5%
dextrose containing 2 mg of indocyanine

green were administered into the right
atrium. The computer obtained the ther
mal and green-dye mean transit times, as
well as cardiac outputs. The volume of
extravascular lung water was calculated,
multiplying the indicator mean transit
time difference by the cardiac output as
described by Chinard.6
Plasma colloid osmotic pressure was
measured with a membrane oncometer
(PM30, Amicon Corp., Danvers, Mass.).
Arterial and mixed venous blood samples
were obtained for partial pressure of oxy
gen and carbon dioxide and pH mea
surements.
Experimental Protocol
After the instrumentation was com
pleted, the animals were volume loaded
with Ringer’s lactate solution to obtain
an initial Pcwp of about 10 mm Hg. A
set of baseline hemodynamic, EVLW and
gas-exchange measurements was obtained.
Oleic acid (0.02 mL/kg) was then given
intravenously and the EVLW value moni
tored during the development of the capil
lary leak syndrome until a new steady
state was achieved at about 2 hours, when
all measurements were repeated. One
group of four animals (group I) was
observed until the end of the experiment
and served as a control. In all other
animals the Pcwp was lowered by phle
botomy to about 2 mm Hg and the
EVLW value monitored. Group II com
prised four dogs in which the accumula
tion of EVLW did not decrease. In the
eight animals in which the EVLW
decreased (Group III), all measurements
were repeated at about 300 minutes, the
shed blood and crystalloid solution were
reinfused to restore Pcwp to baseline
values, and the EVLW value was moni
tored for 2.5 hours. Thereafter, a new set
of values was obtained. Group II dogs
were observed for comparable times.
At the end of the experiments, the
animals were killed with an overdose of
potassium chloride, their chests quickly
split and their lungs excised and weighed.

T a b le 1 - M e a s u r e m e n t s (M e a n ± S t a n d a r d E r r o r ) in 1 6 D o g s D u rin g E x p e rim e n t
E x t r a v a s c u la r
lung w a t e r ,

C o n d itio n
a s in d ic a te d
in F ig . 1
1

2

3

4

G ro u p

T im e , m in

_

1
II
III
1
II
III
1
II
III
1
II
III

_
—

129 + 20
121 ± 3 4
13 4 ± 28
321 ± 25
31 7 ± 56
311
472
483
502

±
±
+
±

47
26
32
76

m U kg
3 .6
2 .4
2 .9
2 0 .4
2 0 .4
1 8 .6
29.1
2 6 .8
15 .8

± 3 .3
± 2 .8
± 2 .7
± 1 0 .7
± 1 1 .0
± 1 1 .4
+ 1 6 .9
+ 7 .9
± 1 7 .4

C a rd ia c o u tp u t,
L/m in
6 .4 ± 1.6
6 .9 ± 2 .2
8.1 ± 3 .2
5 .9 ± 1.0
4 .9 ± 1.8
6 .2 ± 1.7

3 8 .3 ± 1 9 .5
2 9 .4 ± 2 1 .4

5.1
3 .7
4 .1
6 .6
5.1

±
±
±
±
±

2 .5
1 .2
1.2
5 .0
0 .7

14.0 ± 3 .8

5 .0 ± 2 .3

M e a n blood
p re s s u re ,
m m Hg
161
165
177
154

±
±
±
±

20
50
35
12

1 4 3 ± 16
1 5 6 ± 41
141 ± 4
138 ± 8
131 ± 26
141 ± 11
1 2 9 ± 25
1 2 8 ± 29

M e a n p u lm o n a ry
a r t e r y p re s s u re ,
mm Hg
1 4 .5
1 6 .8
1 4 .9
1 8 .7
1 6 .2

±
±
±
±
±

5 .9
1 .7
0 .9
6 .5
3 .0

1 5 .9 ± 2 .0
1 9 .0 ± 1.7
1 2 .2
1 0 .5
2 2 .3
1 3 .7
1 0 .9

±
±
±
±
±

1.3
2 .9
2 .0
2 .0
3 .0
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P u lm o n a ry
c a p illa r y w e d g e
p r e s s u re , m m H g
1 1 .3 ± 2 .3
9 .3 ± 1.8
1 0 .4 ± 2 .0
9 .7 ± 0 .6
8 .6 ± 3.1
9.1 ± 3 .0
9 .0 ± 0 .5
1 .3 ± 0 .8
2 .4 ± 1 .7
1 0 .2 ± 2.1
2 .0 ± 3 .0
1 0 .5 ± 3 .5

P a r t ia l
p re s s u re o f
o xyg e n , m m Hg
302 ± 47
30 6 ± 35
326 ± 44
195
196
212
61
113

±
±
±
±
±

80
55
117
24
54

2 1 5 ± 109
4 9 ± 17
74 ± 35
165 ± 49
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Results
Fig. 1 represents the time course of
mean EVLW, normalized for the ani
m al’s weight, in the three groups. For
clarity, standard deviations are omitted.
Note how, following the infusion of oleic
acid (1 in Fig. 1), the EVLW increased six
times in all groups by about 2 hours (2
in Fig. 1). In the control group, EVLW
continued to accumulate to an average of
38 mL/kg by 8 hours. After the Pcwp was
lowered, EVLW decreased substantially
(p < 0.01, Student’s (-test) in group III
animals to 16 m L/kg (3 in Fig. 1) and
remained lower once the Pcwp was
returned to baseline values (4 in Fig. 1).
There were no further increases until the
end of the experiment. In group II,
EVLW continued to accumulate after the
Pcwp was lowered. However, it did so at
a lower rate (p < 0.05). At the end of the
experiment, the EVLW value in this
group was no different from that in group
I.

All results are summarized in Table I.
The hemodynamic parameters remained
stable throughout the experiment, unless
they were changed as part of the
experimental design. Oleic acid induced
comparable amounts of edema in all
groups. Only in group III, where the
EVLW value decreased, was there an
improvement in the gas exchange. There
were no changes in colloid osmotic pres
sures after the baseline determinations.
To validate the in-vivo measurements
of EVLW, values obtained in all groups
before the termination of the experiments
were plotted against the excised lung
weights (Fig. 2). There was a good corre
lation (thermal [mL/kg] = 1.74 x
excised [mL/kg] - 12.1 mL/kg, r = 0.9,
p < 0.001).
Discussion
In this study, lowering the Pcwp as a
therapeutic approach to adult respiratory
distress syndrome was explored. This
approach has previously been advocated
by Prewitt and associates2 in an attempt
to decrease the forces driving edema fluid
across the damaged capillary membrane.
They demonstrated significant reductions
in EVLW values as well as improvement
in the gas exchange. However, there were
several drawbacks: in one group of
animals, in which the Pcwp was lowered
by giving diuretics, there were significant
reductions in cardiac output. Because
such reductions are to be expected when
the Pcwp is drastically lowered, these
authors and others have tried hemo
dynamic manipulations to maintain car
diac output at a lower Pcwp. Among
other combinations, reduction of after
load and inotropism, with or without diu
resis, plasmapheresis and ultrafiltra
328

tion have been tried.2'3 In many cases,
when vasoactive drugs are used to
manipulate afterload or support cardiac
output, paradoxical deteriorations in gas
exchange occurred, presumably because
these drugs interfered with the redistribu
tion of local pulmonary flow. In addition,
these studies failed to consider: (a) the
magnitude of the reduction in Pcwp, (b)
how long this reduction should be main
tained, particularly in the light of poten
tially serious side effects, and (c) whether
edema would reaccumulate once the inter
ventions were discontinued, unless heal
ing of the endothelial membrane had
occurred.
In the present study, this approach is
taken one step further. Previous work in
our laboratory suggests that the suscep
tibility of lung tissue to accept edema is
directly related to its state of hydration.
The drier the lung tissue, the more refrac
tory it is to edema formation.4 A num
ber of osmotic and mechanical hypo
theses have been advocated to explain this
phenomenon, but they are beyond the
scope of this discussion. It has been
shown by Gee and Spath7 and by
Adcock and colleagues8 that the ability
of the pulmonary lymphatics to remove
edema fluid increases about 10 times as
edema forms. Presumably, edema in
creases interstitial hydrostatic pressure,
lymphatic channels are opened and dis
tended (primed) by the edema flow. These
authors have demonstrated that the
increased draining capacity of the pulmo
nary lymphatics persists even when the
Pcwp is lowered. It is conceivable that the
combination of pulmonary tissues more
refractory to edema and an increased lym
phatic draining capacity could keep lung
tissue dry despite the presence of adult
respiratory distress syndrome. Conse
quently, in this study, the Pcwp was
lowered as much as possible and kept low
as long as further reductions in EVLW
occurred. Once a minimum EVLW value

was achieved, the Pcwp was returned to
normal levels without reaccumulation of
edema for an additional observation
period of 2.5 hours. This is equivalent to
the initial time needed for edema to accu
mulate. In all dogs in which the EVLW
value was reduced, gas exchange im
proved substantially. This outcome was
probably a direct result of the therapeu
tic intervention, since the control dogs
deteriorated progressively. In group II,
the EVLW value was not reduced when
the Pcwp was lowered. No firm conclu
sions can be drawn from the present data
to explain this phenomenon. It is known,
however, that the lesion produced by oleic
acid administration is variable. Perhaps
in these animals the lesion was so severe
that the reductions in the Pcwp were not
sufficient to reverse the balance of forces
in the direction of edema reabsorption.
Given the good correlation between ther
mal and autopsy EVLW determinations,
I am confident that the in-vivo technique
is adequate to follow changes in EVLW
during the course of the experiments.
Based on these results, it seems
appropriate to attempt reductions in
Pcwp in the clinical situation by whatever
means necessary, with the goal of reduc
ing the EVLW value to a minimum. Once
this condition is achieved, therapy could
be withdrawn, and the EVLW value
monitored as the Pcwp returns to levels
compatible with a normal cardiac output
without pharmacologic support. If
EVLW reaccumulates or fails to decrease
in the first place, the lesion would seem
beyond pulmonary compensatory me
chanisms. In that case, perhaps the treat
ment of choice is the support of gas
exchange by mechanical ventilation,
rather than complicated and potentially
dangerous hemodynamic manipulations,
until the lesion improves.
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Intraoperative Localization of Occult Breast Tumours
Mammographic examination of the clini
cally normal breast can identify some
breast masses before they become palp
able. In order to remove them success
fully, a surgeon requires the help of
some localization procedure. The only
method recommended to date has been
preoperative needle localization under
radiologic control by a radiologist. A
technique of intraoperative needle locali
zation by the surgeon without radiologic
control has been developed at St.
Michael's Hospital, Toronto. The method
saves time, avoids complications and is
very accurate. Because of the possibility
that the mass is malignant, the excisional biopsy is performed as a definitive
lumpectomy. Of 112 consecutive occult
tumours so localized, only 3 required remo
val at a second operation. Twenty-six (23% )
of the lesions proved to be cancer (16%
invasive, 7 % noninvasive).
La mammographie du sein cliniquement
normal peut identifier certaines masses
mammaires avant meme qu'elles ne
deviennent palpabies. Pour pouvoir en
reussir la resection, le chirurgien doit
s'en remettre a une operation localisee.
A ce jour, la seule methode recommandee a ete la localisation preoperatoire a
I'aiguille sous surveillance radiographique
par un radiologiste. Une technique de
localisation peroperatoire a I'aiguille par
le chirurgien sans controle radiologique a
ete mise au point au St. Michael's
Hospital de Toronto. Cette methode tres
precise permet d'epargner du temps et
d'eviter des complications. A cause de la

possibility d'avoir affaire a une tumeur
maligne, I’excision biopsie prend la forme
d'une "tumorectomie" definitive. Sur
112 tumeurs occultes consecutives ainsi
localisees, seulement 3 ont ndcessite
une seconde operation. Des 112 lesions,
26 (2 3 % ) se sont averees cancereuses
(1 6 % d'invasives contre 7 % de loca
lisees).

Mammography can detect some cancers
of the breast before they become clinically
palpable. Most recommended techniques
for localization of these tumours require
that a needle or wire be inserted into the
breast preoperatively in the radiology
department and the patient then be trans
ferred to the operating room with the nee
dle secured in position. We have deve
loped a simple, accurate technique for
inserting the needle in the operating room
without any need for radiologic control.

tively and the following tneasurements
recorded: the distance of the lesion (either
medial or lateral) from the centre o f the
nipple in the craniocaudad view (Fig. 1),
the distance of the lesion (either superior
or inferior) from the centre of the nipple
in the mediolateral view (Fig. 2), the
diameter of the lesion, the distance of the
lesion to the closest skin in either view and
the distance of the lesion from the
posterior margin of the breast in the
craniocaudad view (Fig. 3).
The first three measurements can be
transposed to the skin of the breast with
the patient sitting up on the operating
table before anesthesia (Fig. 4). Although
the measurements from the nipple will
change in the supine anesthetized patient,
the relation of the lesion to the skin mark
ing will remain constant and a needle
passed perpendicular to the table top (Fig.

Method

The m ammogram m ust first be
reviewed with the radiologist preopera-

FIG. 3—Craniocaudad view of right breast
to measure distance of lesion from chest wall
and to nearest skin.

FIG. 1—Craniocaudad view of right breast.
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FIG. 4—Measurements from Figs. X and 2
are transposed to skin of breast with patient
sitting upright on operating table in same posi
tion as when mammography was performed.
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5) will track very close to the lesion. An
estimate of the depth of the lesion in the
breast tissue can be made from the last
two measurements in Fig. 3 and a needle
of suitable length selected (usually a plas
tic disposable 2.5 cm no. 22 needle). The
tip should be a bit deeper than the calcu
lated depth of the lesion and usually fairly
close to the posterior edge of the breast.
My policy has been to treat any occult
cancers discovered with this technique by
lumpectomy and axillary dissection.
Usually the lack of a palpable lesion in
the specimen renders frozen section
examination impossible. Consequently,
all the lesions are removed with a cylinder
of tissue around the localizing needle
which will provide a margin of normal
breast tissue around the lesion if it should
prove to be cancerous on subsequent
examination by paraffin sections. This
entails the removal of a relatively large
specimen but the cosmetic results are
excellent as long as the defect in the breast
tissue is not repaired and no drains are
used.
The greatest problem is to keep the
needle in position during the entire proce
dure. This can be done only by suturing
the needle securely to the skin or to the
subcutaneous tissue. We do the latter by
passing a second needle parallel to the

first into the exposed subcutaneous tissue
after the skin incision has been made (Fig.
6). A hole is made in the plastic hub of
the needle with a towel clip (Fig. 7) and
a 0 braided silk suture is passed through
the hole and anchored in the subcutane
ous tissue around it (Fig. 6). The origi
nal needle can then be withdrawn and dis
carded.
To remove the required cylinder of tis
sue, the needle must be palpable at all
times during the operative procedure. The
sharp point of the needle inevitably leads
to puncture of at least the surgeon’s glove
if not the finger, so it should be blunted
before insertion by cutting off the tip with
a wire cutter (Fig. 8). Plastic needles
(Angiocath) and hooked wires (Frank
wire) cannot be palpated and are unsatis
factory.
A mammogram is taken of the speci
men to make sure it contains the lesion.
The needle is left sutured in position and
an extra film is taken for the pathologist
to serve as a reference point in identify
ing the location of the lesion. (If the lesion
contains no microcalcifications, it may be
very difficult to detect on the roent
genogram.)
The technique of excision of the breast

tissue is simple. The upper edge is defined
first by an incision down to the pectoral
fascia. A finger passed along the posterior
aspect of the breast can then feel the
blunted tip of the needle and the remain
ing edges of the cylinder can be incised
and defined. The edges of the specimen
are identified by suturing labels before the
specimen is completely removed from the
breast (Fig. 9). A tantalum clip is placed
in each of the four walls and in the base
of the excision cavity for localization pur
poses in case adjuvant radiotherapy is
given subsequently. Meticulous hemosta
sis is essential. The incision is closed with
interrupted sutures in the subcutaneous
layer and a continuous subcuticular
suture and Steristrips in the skin. The
defect in the breast tissue must not be
repaired nor drains used if a good cos
metic result is to be assured.
Results
From July 1, 1972 to Feb. 29, 1984 at
St. Michael’s Flospital in Toronto, 112
consecutive occult tumours were localized
and excised by the techniques described.
In three cases the occult tumour was not
removed with the specimen and a second
operation was required. Of the lesions, 26
(23%) proved to be cancer, 18 (16%) were
invasive and 8 (7%) noninvasive cancers.
Discussion

FIG. 7—Hole is made in plastic hub of
needle with towel clip to facilitate passage of
retaining silk suture.

FIG. 5— Needle o f suitable length is passed
perpendicular to table top to sufficient depth
to reach posterior edge of breast.

FIG. 8—Sharp point of needle is cut off with
wire-cutter.

To date, the recommended methods of
needle localization of nonpalpable breast
tumours have required that the needle be
placed under radiologic control in the
radiology department and the patient then
be transferred to the operating room with
the needle in place.1'3 As the benefits of
mammographic screening become more
widely appreciated, more and more non
palpable lesions will be detected and
referred to general surgeons for biopsy in
surgical units separate from the mammo
graphic facility.
Our method requires close cooperation
between the mammographer and the sur
geon to make the necessary measurements
but this can be done at a mutually con
venient time before the biopsy is per
formed. The needle is placed by the sur
geon in the operating room with no need
for any imaging procedure preoperatively
and the operating room schedule is not
subject to change because of scheduling
in other departments and transfer of the
patient.
References

FIG. 6— Incision into skin and subcutane
ous tissue centering on entry point of needle
marked on skin. Second blunted needle is
introduced into exposed subcutaneous tissue
parallel to first and secured in position with
silk suture.
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FIG. 9—Specimen ready for transfer to
pathologist. Needle is still sutured in position
to serve as reference mark for comparison with
specimen mammogram if necessary. Edges are
clearly and precisely marked by suturing plas
tic labels to them before specimen is removed
from breast.
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Should Obese Patients Not Undergo Coronary
Artery Surgery?
To assess the effect of obesity on the
patient's recovery from coronary artery
bypass surgery, a prospective study was
performed on 200 patients. Group 1
comprised 101 nonobese patients and
group 2, 99 obese patients. The mean
percentage over the ideal weight was
8.2% in group 1 and 33.4% in group 2
(p < 0.001). Preoperative assessment
revealed no difference in age, sex,
height, incidence of diabetes, family his
tory or smoking habits between the two
groups. Group 2 had a higher incidence
of hypertension (p < 0.01) and hyper
lipidemia (p < 0.02). The average num
ber of grafts placed per patient was 3.4
± 0.8 in group 1 and 3.5 ± 0 .0 8 in
group 2. Operative mortality was 2.9%
and 2.0% in groups 1 and 2 respec
tively. Obesity was a predictive factor in
postoperative hypertension (p < 0.025),
in the development of wound infection (p
< 0.01) and in an increased requirement
of bronchodilators Ip < 0.01). The
postoperative progression of physical
activity and length of hospital stay was
similar, being 10.9 ± 5.8 days and 9.7
± 9.5 days in groups 1 and 2 respec
tively. The authors conclude that bypass
grafting is an acceptable therapeutic
option for obese patients with coronary
artery disease.
Pour evaluer I'obesite comme facteur de
risque lors de chirurgie coronarienne, une
etude prospective a ete entreprise sur
200 patients. Le groupe 1 incluait 101
patients normaux, et le groupe 2, 99
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patients obeses. Le pourcentage moyen
d'embonpoint etait de 8 .2 % dans le
groupe 1 et de 33 .4% dans le groupe 2
(p < 0.001). II n'y avait pas de diffe
rence significative pour les paramfetres
suivants: age, sexe, taille, incidence de
diabete, d'histoire familiale et de tabagisme. L'incidence d'hypertension
(p < 0.01) et d'hyperlipidemie
(p < 0.02) etait plus elevee dans le
groupe 2. Une moyenne de 3.4 ± 0.8
greffons furent implantes chez les
patients du groupe 1 et de 3.5 ± 0.08
chez ceux du groupe 2. La mortalite operatoire fut respectivement de 2.9% et
2.0% . L'obesite preoperatoire fut un fac
teur de prediction d'hypertension postoperatoire (p < 0.0 25), d'infections de
plaies (p < 0.01) et d'une utilisation
accrue de bronchodilatateurs (p < 0.01).
La progression de I'activite postoperatoire et la duree du sejour a I'hopital
furent semblables, etant de 10.9 ± 5.8
jours pour les patients du groupe 1 et de
9.7 ± 9.5 jours pour ceux du groupe 2.
Les auteurs concluent que la chirurgie
coronarienne est une option therapeutique acceptable pour le patient obese.

Obesity is a major health problem in the
West, affecting approximately one fifth
of the North American population.1'5
The association between obesity and
increased incidence of coronary artery
disease is well known.2'6' 13 Some physi
cians have doubts about subjecting obese
patients to cardiac catheterization and
coronary artery surgery despite little or
no support from objective study. Obese
patients are often counselled to lose
weight before undergoing complete inves
tigation and surgical treatment for coro
nary artery disease. Weight loss is often
not successful and is especially impracti
cal in patients with limiting angina. With
the establishment of coronary artery
bypass grafting as an effective procedure
for the management of coronary artery
disease, one questions the ethics of deny
ing a potentially beneficial treatment to

these patients. It is im portant, therefore,
to determine if obese patients have higher
morbidity or mortality, or both, than
nonobese patients after bypass grafting.
Our purpose was to study the peri- and
postoperative courses of obese and non
obese patients to determine if there is any
difference in the two groups in terms of
early mortality, morbidity and length of
hospital stay.
Method
A prospective study of 200 patients
aged 40 to 65 years who underwent elec
tive coronary artery bypass grafting was
carried out at the University of Ottawa
Heart Institute, Ottawa Civic Hospital,
between October 1982 and February
1983. There were 101 nonobese (group 1)
and 99 obese (group 2) patients. The
study was blinded in that the health-care
professionals involved in the management
of these patients postoperatively were not
aware of the study. Patients who under
went postoperative care at other facilities
were excluded.
Obesity was defined as weight more
than 20% over the ideal (based on
Metropolitan Life ideal weight standards,
1959, corrected to nude weight), con
firmed by a body mass index (BMI =
w eight/height2, k g /m 2) greater than
27_i-io.i4.i5 p reoperatively, the major risk
factors — diabetes, hypertension, family
history and smoking — were docu
mented. The patient’s height and weight
were recorded. Serum triglyceride and
cholesterol levels were measured. Coro
nary angiography and left ventriculogra
phy were carried out.
All patients underwent coronary artery
bypass grafting with or without coronary
endarterectomy under systemic hypother
mia and cold potassium cardioplegic
arrest. Keflin, 1 g, was administered
intravenously 1 hour before operation
and subsequently at 6-hour intervals for
48 hours.
The patients were followed through
their postoperative recovery to the day of

VOLUME 28, NO. 4, JU L Y 1985 / THE CANADIAN JOURNAL OF SURGERY

331

discharge. Postoperative data collected
included length of time on the ventilator
and the frequency of need for bronchodilators for respiratory wheeze and as an
adjunct to effective physiotherapy. Use
of inotropic agents or the intra-aortic bal
loon pump, or both, were noted. Peri
operative myocardial infarction was
determined by electrocardiographic evi
dence of new 0.04 Q waves and serum
creatine phosphokinase levels over 1500
U /L.
Infections were designated as general
ized or wound, respiratory and urinary
tract. All required documentation of clin
ical findings and growth of organisms on
culture. “ Iatrogenic infections” were all
superficial phlebitis secondary to insertion
of catheters intravenously; they were
diagnosed as a local cellulitis, without cul
ture, and treated locally.
The frequency of the following com
plications was noted: (a) reopening in the
recovery room because of cardiac arrest,
tamponade or bleeding; (b) disturbances
of the central nervous system, including
psychoses, seizures and encephalopathies;
(c) renal impairment; and (d) develop
ment of pressure sores. Postpericardi
otomy syndrome was defined by clinical
findings of pleuritic chest pain, fever and
malaise, as well as an erythrocyte
sedimentation rate greater than 54 mm/h.
Serious arrhythmias requiring drug inter
vention were noted.
The stage of ambulation was a team
decision of the surgeon, nursing and
physiotherapy staff based on the overall
condition of the patient. The time
postoperatively to the various levels of
ambulation — walking a full corridor,
climbing flights of 9 and 18 stairs — was
recorded. Length of stay was determined
from day of surgery to day of discharge.
The differences in the results were ana
lysed according to the unpaired Student’s
t-test.
Findings
Forty-three of the 99 obese patients
were 20% over ideal weight, 34 more than
30%, 8 were 40% and 14 more than 50%

FIG. 1—Distribution of patients by percen
tage over or under ideal weight (Iw).
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over their ideal weight (Fig. 1). All obese
patients had a body mass index greater
than 27. There was no significant differ
ence in age, sex or height between the two
groups (Table I). Weights and body mass
indices were significantly different (as
expected) (p < 0.001). Of obese patients,
56% were more than 30% over their ideal
weight and had a body mass index greater
than 30. The mean percentage over the
ideal weight in nonobese patients was
8.2% and in the obese group was 33.4%.
With respect to preoperative risk fac
tors for coronary artery disease, hyper
tension and hyperlipidemia were signifi
cantly more common in the obese group,
p < 0.01 and p < 0.02 respectively (anal
ysis of variance). The incidence of dia
betes, family history, smoking and hyper
cholesterolem ia did
not differ
substantially between the two groups
(Table II).
The intraoperative data were similar
for both groups with the exception of
mean total perfusion time which was
elevated in the obese group (84 minutes
versus 79 minutes, p < 0.05) (Table III).

Characteristic
Age, yr
Sex
M
F
Height, cm
Weight, kgt
Body mass indext
% overweight!

The body mass index correlated closely
with percentage over the ideal weight
(r = 0.98).
Postoperatively, the two groups were
similar with respect to the time the
patients were on the ventilator, use of
bronchodilators, duration of inotropic
support and the incidence of myocardial
infarction perioperatively (Table IV).
The infection rate was low in our sam
ple group and no significant difference
was found between the two groups. The
sternal incision was rarely reopened and
there were few central nervous system or
renal complications. The incidence of
postpericardiotomy syndrome and post
operative arrhythmias was similar in the
two groups. Hypertension was more com
mon postoperatively in group 2
(p < 0.05) (Table IV).
There was no significant difference in
time taken to mobilize patients in the two
groups (Fig. 2). A test for sensitivity re
vealed that our sample size could detect
a difference of 0.5 days between the two
groups with a power of 80%. Similarly,
there was no difference between the

Table 1-Distribution of Characteristics*
Group 1
(n - 101)
54.0 ± 7.0

95
6
170.5 ± 8.4
72.7 + 9.2
24.9 ± 1,8
8.2 ± 7.9
* Where applicable, figures are mean + standard error of the mean.
tp < 0.001.

Group 2
(n - 99)
5 4 .2 + 6.4
83
16
169.1 ±
87.5 ±
30.5 ±
33.4 ±

7.8
10.4
2.9
12.1

Table 11-Risk Factors*
Group 1
(n - 101)
11
67
31
86
47 (85)
7(92)
’ Numbers in parentheses indicate number of patients who underwent the test
tp < 0.01.
tp < 0.02.
Risk factor
Diabetes
Family history
Hypertensiont
Smoking
Hyperlipidemia!
Hypercholesterolemia

Table Ill-Intraoperative Characteristics*
Group 1
Characteristic
(n - 101)
No. of grafts
3.4 + 0.8
No. of endarterectomies
14
Total perfusion time, mint
79 ± 22.1
Anoxic time, min
38.7 ± 11.7
‘ Where applicable, figures are mean + SEM.
tp < 0.05.

Group 2
(n - 99)
12
67
48
82
66(87)
7(95)

Group 2
(n - 99)
3.5 ± 0.08
19
84.4 ± 22.2
40.4 ± 10.1
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groups in time taken to achieve walking
up 9 and 18 stairs. The obese group had
a similar length of stay compared to the
nonobese group — 10.9 and 9.7 days
respectively (Fig. 2). Sensitivity testing for
this variable revealed a power of 80% to
detect a difference of 1 day between the
two groups.
The mortality was similar for both
groups at 2.9% for group 1 and 2.0% for
group 2. These rates and the sample size
are too small to detect any statistical sig
nificance.
Discriminant analysis was performed
on the data. Obesity was a predictive fac
to r in p ostoperative hypertension
(p < 0.025). Although there was no sig
nificant difference using analysis of var
iance, obesity appears to be a factor in
the development of wound infections by
discriminant analysis (p < 0.01). Simi
larly, obesity was a significant variable in
the use of bronchodilators (p < 0.01).
By discriminant analysis, there was
direct correlation between ambulation
and wound infection as well as perioper
ative myocardial infarction. Chi-square
contingency table analysis showed no
difference in total number of infections
between the two groups.
D iscussion

Obesity has long been related to
decreased longevity, various disease states
and psychologic problems in adjusting to
being grossly overweight. Studies on
insurable people show rising mortality
with increasing weight.1'2 Obesity has

been associated with coronary artery dis
ease as well as hypertension, diabetes,
gallbladder disease and arthritis.2’6,7
Although mortality secondary to coro
nary artery disease is declining,16 it is still
prevalent and the obese are at risk. In
spite of initial contrary findings,8 recent
analysis of data from the Framingham
Study suggests that obesity is an indepen
dent risk factor for the development of
coronary artery disease.13 For those
obese patients with symptomatic disease,
some physicians are reticent about recom
mending operation. Some of the reasons
for this are that the diagnostic or ther
apeutic procedures are considered tech
nically difficult, rehabilitation is awkward
and there is supposedly an increased mor
bidity and mortality.
Patients are often told that they must
lose weight before surgery will be per
form ed.17,18 A reducing plan involves
restricting calories and increasing expen
diture of energy.4 Exercise may be
difficult in most, impossible in some and
potentially lethal in a few. By dieting, a
substantial catabolic state would have to
prevail to effect weight loss and this might
lead to malnutrition despite excess weight.
Feigal and Blaisdell19 and others20 have
expressed concern about operating on
those with a weight loss greater than 10%
or existing malnutrition, for fear of
increased mortality. There is, however,
little in the literature on obesity and its
effects on morbidity and mortality for
cardiac surgery. Paiement and colleagues21
stated that obesity is not usually men
tioned as a major risk factor in cardiac

Table IV—Postoperative Characteristics
Group 1
(n - 1011

Characteristic
Respiratory
Ventilatory support, d*
Use of bronchodilators
Reintubation
Cardiac
Intra aortic balloon pump assistance
Inotropes
Digoxin
Myocardial infarction perioperatively
Reopening
Hypertensiont
Arrhythmias
Premature ventricular contractions
Supraventricular tachycardia
Infections
Wound infection
Sepsis
Respiratory infection
Urinary tract infection
Iatrogenic infection
Other
Dysfunction of central nervous system
Acute renal failure
Postpericardiotomy syndrome
Pressure sores
*Mean ± SEM.
tp < 0.05.

Group 2
In - 99)

1.3 ± 2.1
28
1

1.54 ± 4.9
42
1

5
15
4
18
9
37

6
11
6
17
6
50

28
17

32
16

3
1
3
2
1

6
2
1
3
6

6
2
14
8

2
1
8
9

surgery. According to Vaughn,22 patients
with a body mass index greater than 30
are more likely to die, but supportive data
are still lacking. Mortality for the general
population is often considered to be the
same as surgical mortality.
In assessing cardiac patients for sur
gery, one should note that a stronger rela
tion exists among direct indicators of
coronary artery disease such as abnormal
findings on the electrocardiogram and
poor outcome than with indirect indica
tors such as obesity.23 Mason24 noted
that obese patients are at much greater
risk than others for the development of
wound infections because of the poor
resistance of fat and increased disruptive
forces. He found that the morbidly obese
had a 14% wound infection rate, requir
ing increased hospital stay. In our study,
which was not confined to morbidly obese
patients, we found no significant differ
ence in infection rates and length of
hospital stay between obese and nonobese
patients who underwent cardiac surgery.
Pathophysiologic changes in obesity of
particular interest to the anesthesiologist
include an absolute increase in blood
volume and cardiac output, but when
adjusted for weight these values are only
60% o f expected.4 There is myocardial
hypertrophy that is proportional to the
increase in body weight, systemic hyper
tension that is more prevalent in the obese
as well as increased right heart pressure.
From a respiratory viewpoint, obese
patients have decreased functional
residual capacity and chest-wall compli
ance which may lead to atelectasis and
shunting. Also, with an increased meta
bolic rate, obese patients have increased
oxygen consumption; both of these pre
dispose to hypoxemia. Intubation and
insertion of intravenous and arterial lines
are technically difficult and there is an

FIG. 2—Mobilization and length of hospi
tal stay among obese (black bars) and nonobese
(white bars) patients (mean ± standard error
of mean).
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increased risk of aspiration.18,22’25’26
Although these are serious concerns, data
relating these parameters with overall
morbidity and mortality are minimal.
W arner and Garrett26 noted many years
ago that definitive studies assessing risks
of obesity were lacking and this observa
tion holds true today.
Modern advancements in techniques of
anesthesia, surgery and rehabilitation
compel the team treating the obese patient
with coronary artery disease to consider
operation. Our obese population was
defined in terms of two popular criteria:
relative body weight and body mass
index. The ideal weights were taken from
1959 Metropolitan Life tables, but before
our study was complete these tables were
revised upwards so that a healthy person
weighed more. We have continued to use
the 1959 tables believing that the revision
is premature based on other data concern
ing morbidity and mortality of obese peo
p le.10 We have also used the more
trusted body mass index and the correla
tion between the two criteria was high
(r = 0.98) in our population. Over 50%
of our obese patients were more than 30%
over the ideal weight and had a body mass
index greater than 30. We think this
represents an adequate sample of obese
patients.
O f the risk factors for coronary artery
disease, hypertension and hyperlipidemia
were more prevalent in the obese
patients.27 These findings have been well
documented in the past and it is not sur
prising that these patients also had a
higher incidence of hypertension
postoperatively. Hypercholesterolemia
did not differ between the two groups,
but this may be owing to inaccuracies in
measuring serum cholesterol levels as
opposed to levels of low- and very lowdensity lipoproteins.2 The incidence of
diabetes was comparable in the two
groups.
Postoperatively, respiratory status was
assessed by the length of time the patient
was kept on the ventilator, use of bronchodilators and frequency of respiratory
infection. Most patients in both groups
were extubated the day after operation;
only two (one obese and one nonobese
patient) required reintubation. Both had
severe heart failure. Although the groups
did not differ statistically according to
analysis of variance, discriminant analy
sis showed an increasing tendency to use
bronchodilators with increasing weight.
There were only four cases of postopera
tive respiratory infections in our series;
three were in long-term ventilator-dependent
patients, in the other the length of stay
was not affected.
Only one obese patient had a respira
tory infection. According to the phys
iotherapists, obese patients require more
chest physiotherapy and are generally
harder to work with because of their size.
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This problem as well as the increased ten
dency to use bronchodilators should not
be a deterrent to operation.
Our rate of myocardial infarction
postoperatively was similar in both
groups. The high figures in each group
may reflect the number of endarterecto
mies performed at our institution.
Overall, the infection rate postopera
tively was low in both groups. In obese
patients, veins were preferentially har
vested from the lower leg to avoid the
groin area. There were three wound infec
tions in the nonobese group and six in the
obese group, a difference that was not sig
nificant. Discriminant analysis showed an
increasing risk of wound infection with
increasing weight, with a related increase
in duration of hospital stay. Identifying
the obese patients with wound infections,
we found that there were two vein-site
infections and one sternal wound infec
tion. All required local treatment and the
hospital stay (40 days) was not prolonged.
Therefore, the analysis findings must be
tempered by these facts.
Patients in both groups were mobilized
at the same time and had similar lengths
of hospital stay. The Heart Institute has
an early discharge program that allows
patients who meet specific criteria to go
home early. Both groups of patients met
these criteria and were discharged at simi
lar times.
The mortality for both groups was
within acceptable limits: 2.9% and 2.0%
for nonobese and obese patients respec
tively. Of the obese patients, two died of
perioperative myocardial infarction.
Similarly, in the nonobese group, two of
the three patients died after myocardial
infarction while the third had a brain
stem infarction. Both of the obese
patients were less than 30% over ideal
weight (20% and 24%). Although mor
tality is stated to be greater among obese
patients postoperatively, our findings do
not support this belief.
Summary and Conclusions

Obese patients have a high frequency
of coronary artery disease but many
biases exist that make physicians and sur
geons reluctant to recommend these
patients for bypass grafting. In our study
of 200 nonobese and obese patients who
underwent elective coronary artery bypass
grafting, we did not find any major, sig
nificant differences in the perioperative
courses of the two groups. Infection rate,
respiratory complications, length of stay
and mortality were similar for both
groups. Modern techniques of surgery
and anesthesia, as well as aggressive phys
iotherapy postoperatively in a specialized
cardiac surgical unit, make the procedure
a therapeutic option with reasonable risks
for the obese patient with coronary artery
disease.

The study looked at the perioperative
courses of obese patients who underwent
coronary artery bypass grafting up to the
time of their discharge. Long-term results
should be the subject of further study.
We acknowledge the assistance o f the sur
geons, nursing and physiotherapy staff o f the
University of Ottawa Heart Institute involved
in the care of the patients in this study. Spe
cial thanks go to Mrs. Evelyn Fry for secretarial
help in preparing the manuscript, and Dr. J.B.
Freeman for his suggestions.

References
1. D u b l in LI: Symposium on obesity; relation o f obesity
to longevity. N Engl J M ed 1953; 248: 971-4
2. ARMSTRONG DB, DUBLIN LI, WHEATLEY GM , MARKS
HH: Obesity and its relation to health and disease. JAM A
1951; 147: 1007-14
3. Bray G A , J o r d a n H A , S im s E A H : Evaluation o f the
obese patient. 1. An algorithm . JAM A 1976; 235:
1487-91
4. B ray GA: The Obese Patient. Vol. IX: Major Problems
in Internal Medicine, Saunders, Philadelphia, 1976
5. Idem (ed): Obesity in America, US Department o f Health,
Education and W elfare, Public H ealth Service, National
Institutes o f H ealth, Bethesda, M d (NIH publ no.
79-359), Novem ber 1979
6. ANGEL A: Sym posium on obesity. 1. Pathophysiologi
cal changes in obesity. Can M ed Assoc J 1978; 119:
1401-6
7. ANGEL a , RONCARI DAK: Sym posium on obesity. 2.
Medical com plications o f obesity. Ibid: 1408-11
8. Ka n n el w b , L e Ba u e r E J, D a w be r TR, M c N a m a r a
PM : R elation o f body weight to developm ent o f coro
nary heart disease. The Fram ingham study. Circulation
1967; 35: 734-44
9. C h ia n g BN, P e r l m a n LV, E p s t e in FH : Overweight
and hypertension. A review. Circulation 1969; 39: 403-21
10. H u ber t HB, F e in le ib M, M c N a m a r a PM , C a stelli
W P: Obesity as an independent risk factor for cardiovas
cular disease: a 26-year follow -up o f participants in the
Fram ingham Heart Study. Circulation 1983; 67: 968-77
11. H e y d en S, H a m e s C G , Ba r t e l A, C a sse l JC ,
T y ro ler HA , CORNONI JC : Weight and weight history
in relation to cerebrovascular and ischemic heart disease.
Arch Intern Med 1971; 128: 956-60
12. KEYS A , A r a v a n is C , B l a c k b u r n H, et al: C oronary
heart disease: overweight and obesity as risk factors. Ann
Intern Med 1972; 77: 15-27
13. K e n n e l l y BM , G e r s h B J, L a n e GK, Beck W: The
relationship between angiographic findings and risk fac
tors in young m en with m yocardial infarction. S A fr Med
J 1982; 61: 508-12
14. M a n n GV: The influence o f obesity on health (first of
two parts). N Engl J M ed 1974; 291: 178-85
15. BENDIXEN H H : M orbid obesity. In HERSHEY SG (ed):
Refresher Courses in Anesthesiology, Vol. 6, Lippincott,
Philadelphia, 1978: 1-13
16. STERN M P: The recent decline in ischemic heart disease
m ortality. Ann Intern Med 1979; 91: 630-40
17. ESTAFANOUS FG: R espiratory care following open heart
surgery. Surg Clin North A m 1975; 55: 1229-41
18. REISIN E, FROHLICH ED : Obesity. Cardiovascular and
respiratory pathophysiological alterations. Arch Intern
Med 1981; 141: 431-4
19. FEIGAL DW , BLAISDELL FW : T he estimation o f surgi
cal risk. Med Clin North A m 1979; 63: 1131-43
20. ABEL RM , FISCH D, HOROWITZ J , VAN GELDER HM ,
GROSSMAN M L: Should n u tritio n al status be assessed
routinely prior to cardiac operation? J Thorac Cardiovasc
Surg 1983; 85: 752-7
21. P a ie m e n t B, P e l l e t ie r C, D y r d a I, M a il l e JG ,
Bo u l a n g e r M, T a il l e f e r J, S a h a b p , D e l o r m e M,
DUPONT E: A simple classification o f the risk in cardiac
surgery. Can A nest h Soc J 1983; 30: 61-8
22. VAUGHN RW: A nesthetic m anagem ent o f the obese
patient. Weekly Anesthesiology Update 1978; 1: 1-8
23. SCHNEIDER A JL : Assessm ent o f risk factors and surgi
cal outcom e. Surg Clin North A m 1983; 63: 1113-26
24. Mason EE: Surgical Treatment o f Obesity. Vol. X X V I:
Major Problems in Surgery, Saunders, Philadelphia, 1981
25. a g a r w a l N, S h ib u t a n i K, Sa n F il ip p o JA , D el
GUERCIO LRM : H em odynam ic and respiratory changes
in surgery o f the m orbidly obese. Surgery 1982; 92:
226-34
26. W a r n e r W A, G a r r e t t L P: T he obese patient and
anesthesia. JAM A 1968; 205: 102-3
27. Ka n n el w b , B r a n d N, Sk in n e r JJ j r , Da w ber TR,
M c N a m a r a PM : The relation o f adiposity to blood
pressure and development o f hypertension. The Framing
ham study. Ann Intern M ed 1967; 67: 48-59

VOLUME 28, NO. 4, JU L Y 1985 / THE CANADIAN JOURNAL OF SURGERY

Jean -Franqois Marquis, md, frcpc ; Leonard Schwartz, md , frcpc ; Robert Brown , md , frcpc ;
Esther Matushinsky, rn; Linda M ickleborough, md, frcsc; H arold A ldridge, md , frcpc ;
Mark H enderson, md, frcpc

Percutaneous Transluminal Angioplasty of Coronary
Saphenous Vein Bypass Grafts
Between December 1981 and August
1983, percutaneous transluminal
angioplasty of saphenous vein grafts
was performed in 14 men and 4 women,
selected because of recurrent anginal
symptoms and graft stenosis. The inter
val from bypass to angioplasty was
41 ± 36 months. Of 24 lesions, 9 were
at the proximal anastomosis, 13 in the
distal segment and 2 in the middle seg
ment of the vein graft. The primary suc
cess rate was 7 9 % . Failure to cross the
stenosis occurred in three patients and
failure to dilate in one. The stenosis was
reduced from a mean of 8 2 % ± 13% to
2 6 % ± 1 5 % . No patient required emer
gency coronary artery bypass grafting
but two underwent elective grafting after
the angioplasty had failed. No patient
sustained a Q-wave myocardial infarction
and all who had a successful angioplasty
were asymptomatic or much improved
after the procedure. Angiographic follow
up was available in 12 of 14 patients
(8 6 % ). Six patients had significant
symptoms (Canadian Cardiovascular
Society class II to III) and five of these
had evidence of restenosis. Among the
six patients who were asymptomatic,
two had angiographic evidence of reste
nosis. The overall rate of restenosis was
5 8 % (7 of 12). Repeat angioplasty was
successful in three of the five patients in
whom it was attempted.
The authors conclude that percutane
ous transluminal angioplasty of a
saphenous vein graft for a localized area
of stenosis is effective and safe, but
there is a high rate of restenosis that
possibly is due to intimal fibrous prolifer
ation in saphenous vein grafts.
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Entre decembre 1981 et aout 1983, une
angioplastie transluminale percutanee de
greffes de veines saphenes a ete pratiquee chez 14 hommes et 4 femmes
choisis pour cause de recidive des symptomes angineux et stenose du greffon. II
s'etait ecoule 41 ± 36 mois entre le
pontage et I'angioplastie. Sur 24 lesions,
9 etaient situees a I'anastomose proximale, 13 au segment distal et 2 au
milieu du greffon. Le taux de succes primaire a ete de 7 9 % . Chez trois patients,
il fut impossible d'aller au-dela de la ste
nose et, dans un cas, on ne reussit pas a
dilater le greffon. La stenose fut reduite
en moyenne de 8 2 % ± 1 3 % a 2 6 % ±
1 5 % . Aucun patient n'a du subir un pon
tage aorto-coronarien d’urgence mais
deux recurent une greffe de facon non
urgente apres I'echec de I'angioplastie.
Aucun patient ne subit d’infarctus a
onde Q et tous ceux chez qui I'angioplastie fut reussie devinrent asymptomatiques ou virent leur etat s'ameliorer sensiblement. Un controle angiographique
fut obtenu pour 12 des 14 patients
(8 6 % ). Six ont presente des symptomes
importants (classification II ou III de la
Societe cardiovasculaire canadienne)
dont cinq qui montrerent des signes
d'une nouvelle stenose. Parmi les six
patients asymptomatiques, deux ont pre
sente des signes angiographiques de restenose. Globalement, le taux de restenose fut de 5 8 % (7 sur 12). Une
deuxi6me angioplastie reussit chez trois
des cinq patients chez qui elle fut tentee.
Les auteurs concluent qu'en presence
d'une region de stenose localis^e,
I'angioplastie transluminale percutanee
d'une greffe de veine saphene est efficace et sure. Toutefois, ils constatent un
taux eleve de restenose possiblement
due a une proliferation fibreuse de
I'intima des greffons de veines saphenes.

Percutaneous transluminal coronary
angioplasty was first performed as a nonsurgical treatment for coronary artery dis
ease by Griintzig and associates1in 1977.
The application and efficacy of this tech

nique in selected patients is well estab
lished.
Coronary artery bypass grafting is
widely used in patients with symptoms of
ischemic heart disease. After successful
bypass grafting, recurrent symptoms can
be due to narrowing or occlusion of the
saphenous vein graft, to progression of
disease in the grafted artery or to the
appearance of new disease in ungrafted
vessels.
The saphenous vein graft may become
stenosed as a result of thrombosis, early
intimal fibrous proliferation, medial
fibrosis or atherosclerotic changes, which
occur most frequently in older grafts.2,3
Intimal fibrous proliferation is a common
change. It is thought to be compressible,
m aking it potentially amenable to
angioplasty. Percutaneous transluminal
angioplasty of saphenous vein grafts has
been performed successfully in a small
number of patients, accounting for 4%
of cases in the National Heart, Lung, and
Blood Institute Registry.
This report will describe the initial and
long-term results of angioplasty of
saphenous vein grafts at the Toronto
General Hospital and compare our
experience to that of other centres.

Patients and Methods
Between December 1981 and August
1983, 18 patients (14 men, 4 women) who
suffered angina pectoris after coronary
artery bypass grafting were found to have
localized stenosis of the graft or anasto
mosis that was considered amenable to
angioplasty; there were 24 lesions. The
patients ranged in age from 33 to 69 years
(mean 54.8 ± 9.1 years). The mean inter
val between the bypass procedure and
angioplasty was 41 ± 36.6 months (rang
ing from 3 to 132 months) (Fig. 1). The
mean duration of symptoms was 10.4 ±
11 months.
The procedure was performed, accord
ing to methods previously described,1,4
before the advent of the steerable catheter
system at our institution. Griintzig Dilac-
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tica (USCI International, Division, C.R.
Bard Inc., Burlington, Mass.) 20-30,
20-37 and 20-47 G dilating catheters were
used. The inflation pressure and duration
of the inflation were individualized
according to vessel size, tolerance of
ischemia and degree of residual stenosis.
Our protocol included (a) a calcium
blocking agent given orally before the
procedure and (b) low-molecular-weight
dextran, 500 mL, and 10 000 units of
heparin intravenously given at the onset
of the procedure. Antiplatelet agents
(acetylsalicylic acid, with or without
dipyridamole or Anturan) were given 24
hours before the procedure and continued
for 6 months thereafter.
Results
Immediate
Nineteen of the 24 lesions were dilated
with a primary success rate of 79% (15
lesions). Fourteen of 18 patients had at
least one graft dilated. The procedure was
unsuccessful in four patients (five
lesions). In three instances, the dilating

catheter could not cross the lesion and in
two instances, the graft could not be
dilated after proper positioning of the bal
loon. Nine lesions were located in the
graft just beyond the proximal anastomo
sis, 13 were in the area of the distal
anastomosis and 2 were in the middle of
the graft. The primary success rate was
essentially the same regardless of the loca
tion of the stenosis. Eight of 9 success
fully managed lesions were in the prox
imal segment and 10 of 13 in the distal
segment. Nor was the age of the graft a
factor in primary success (Fig. 2). In the
successful group, the mean stenosis was
reduced from 82% ± 13% (standard de
viation) to 26% ± 15%. After angio
plasty, all patients who had successful
dilatations were either improved or
asymptomatic. No patients required
emergency coronary artery bypass graft
ing. Of the four patients who had failed
angioplasty, two underwent repeat elec
tive bypass surgery, less than 1 week after
the procedure; the other two patients were
treated medically.
Complication Rate
There were no deaths or major com-
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FIG. 1—Number of patients and age of their
grafts at time of angioplasty.

Fig. 3a

FIG. 2—Primary success (hatched areas) and
age of grafts.

Fig. 3b

plications. The complication rate in the
successful patients was comparable to
that for native vessel angioplasty.
Although our group is small, this may
indicate that the procedure is relatively
safe. One patient had a dissection and
occlusion of the bypass graft during
angioplasty. The area of dissection was
immediately recrossed and successfully
redilated. Repeat angiography showed a
good flow. There was no evidence of a
myocardial infarction and he was dis
charged from hospital without any fur
ther intervention. At the time of dis
charge, he had Canadian Cardiovascular
Society class I angina.
Follow-up
Angiographic follow-up after angio
plasty was available in 12 of 14 patients.
The mean follow-up was 7.25 ± 2.5
months (range from 4 to 11 months).
Continued success of the dilated segment
was seen in five patients but there was evi
dence of restenosis in seven (58%). The
definition we used for restenosis was the
one previously described by Hollman and
colleagues.5 Restenosis did not correlate
with the age of the graft nor with the site
of stenosis. The rate of restenosis was
63% (five of eight) for proximal segments
and 57% (four of seven) for distal anasto
motic segments. At the time of follow-up,
six patients had minimal or no symptoms
(Canadian Cardiovascular Society class 0
to I); four of these patients had no evi
dence of restenosis on angiography. Six
patients had moderate symptoms (Cana
dian Cardiovascular Society class II to
III); five of these patients had angio
graphic evidence of restenosis. Percutane
ous transluminal angioplasty was re-

Fig. 3c

FIG. 3—Angiographic demonstration of primary and long-term successful balloon dilatation, (a) Left anterior oblique view of right coronary
saphenous vein graft showing 85% stenosis at site of distal anastomosis, (b) Left anterior oblique view of same graft taken immediately after
angioplasty, with 3.7-mm diameter balloon. Lesion has been successfully dilated and there is no residual stenosis, (c) Follow-up angiogram
(left anterior oblique view) obtained 6 months after angioplasty showing continued success with minor irregularity at site of previous lesion.
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peated in five of seven patients with a
success rate of 60%. The other two
patients who showed evidence of resteno
sis had class I and II angina; therefore,
angioplasty was not repeated.
Fig. 3 depicts angiographically the
excellent primary and long-term results in
a patient who had distal anastomotic ste
nosis of a vein graft in the right coronary
artery. This patient began to suffer angina
5 months after bypass surgery and the
angioplasty was performed 1 month later.
Discussion
Our primary success rate of 79% is
comparable to that recently reported by
Block and associates6 but is higher than
the 62% quoted by the National Heart,
Lung, and Blood Institute Registry.7 The
primary success rate was not altered by
the site, degree of stenosis or the age of
the graft. There were no deaths and no
patient required emergency coronary
artery bypass grafting.
Spray and Roberts2 have described the
occurrence of fibrous intimal prolifera
tion in all layers of the vein wall. Fibrous
intimal proliferation is presumed to be a
major cause of stenosis of the saphenous
vein graft within the first few years after
surgery. Mural ischemia, arterial intralu
minal pressure and wall shear stress may
lead to chronic injury of the vein intima,
resulting in this process. The process
appears to have no predilection for prox
imal or distal anastomotic sites. Our
primary success rate suggests that these
intimal changes are compressible.
By 5 years after bypass grafting,
atherosclerosis becomes a common cause
of graft stenosis. These lesions, if local
ized, may also be dilatable. Four of our
patients who had successful angioplasty
had grafts longer than 5 years and two of
these patients have continued to do well.
A higher incidence of intimal layer ulcer
ation and thrombosis has been reported
in older grafts,8 suggesting a risk of
embolization on passing a dilatation
catheter down the graft. We encountered
no such complication in our patients, pos
sibly because no patient selected for per
cutaneous transluminal angioplasty had
an angiographic appearance consistent
with ulceration or thrombus; such an
appearance is a contraindication to
angioplasty at our institution.
Restenosis of the saphenous vein graft
after percutaneous transluminal angio
plasty is a major problem. Of our 12
patients who had follow-up angiography,
7 (58%) exhibited restenosis. Considering
individual lesions, restenosis was present
in 9 of 15 (60%). This is higher than the
30% restenosis rate of current native ves
sel angioplasty. Since the initial process
causing the stenosis in the vein graft may
be related to trauma (i.e., tension of vein

graft or overdistension with saline), then
perhaps it is not surprising that there is
a high frequency of recurrence after the
trauma produced by balloon inflation.
Other groups have found high restenosis
rates as well. In Block’s series,6 12 of 22
patients (54%), who underwent repeat
angiography, had restenosis and in
Douglas’s series9 of 62 graft dilatations,
38% of lesions were found to have
restenosed at follow-up angiography after
angioplasty.
Regarding the location of the lesion,
Block and colleagues6 found the resteno
sis rate in the proximal and middle seg
ments to be 56% versus 15% in the dis
tal segments. We did not note such a
difference.
Repeat angioplasty was carried out in
some of our patients who had restenosis,
but the small number prevents us from
drawing any conclusions. In two of five
cases, dilatation could not be accom
plished despite a high balloon pressure
and an appropriately sized catheter,
indicating a hard plaque.
Conclusions
Percutaneous transluminal angioplasty
can be used successfully in patients with
stenosis of saphenous vein grafts
associated with symptoms. The primary
outcome is similar to native-vessel
angioplasty. Further studies are necessary
to elucidate the mechanism of restenosis
in these patients and how it might be
prevented.
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Readaptation post-pontage aorto-coronarien
et retour au travail
Au Quebec, a peine plus de la moitie des
patients qui ont subi un pontage aortocoronarien retournent sur le marche du
travail. Le retour au travail est encore
plus faible si les sujets sont ages de 55
a 64 ans, travailleurs manuels ou ont ete
absents du travail pour 13 semaines ou
plus.
Depuis le 1er janvier 1983, tous les
patients de 64 ans et moins, qui ont subi
avec succes un pontage aortocoronarien, sont invites a un programme
de readaptation de 6 semaines, debutant
6 semaines apres leur chirurgie. Le but
du programme est d'ameliorer le retour
au travail par une activite physique en
groupe de faible intensite (60% a 70%
de la capacite maximale et gymnastique).
Du 1er janvier 1983 au 31 mars 1984,
68 patients ont participe au programme
apres pontage aorto-coronarien. La pro
portion de patients retournant au travail
a ete amelioree statistiquement (p <
0.01). La meme tendance a ete observee
quel que soit le groupe d'age, le type
d'emploi et ou la duree d'absence du tra
vail avant la chirurgie.
In Quebec, deceptively few patients who
have successfully undergone coronary
artery bypass have been returning to
work. Those aged 55 to 64 years, blue
collar workers or those who were off
work for 13 weeks or more were likely
not to return to work after surgery.
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From Jan. 1, 1983, all patients aged
64 years and younger, who successfully
underwent coronary artery bypass graft
ing were invited to attend a 6-week re
habilitation program, starting 6 weeks af
ter operation. The aim of the program
was to improve the rate of return to
work through a low-intensity physical ac
tivity course (60% to 70% maximal
working capacity and calisthenics).
Up to Mar. 31, 1984, 68 patients had
participated in the program. The propor
tion of patients returning to work was
significantly (p < 0.01) improved and
the trend was observed in all age
groups, and for all types of employment
and length of time off work before oper
ation.

Le retour au travail apres pontage aortocoronarien demeure un aspect generalement decevant du pronostic postpontage.1-3 La proportion de ceux qui
retournent au travail varie de 60% a
95%.4 Dans notre milieu, les resultats
d’une etude retrospective effectuee aupres
de 239 patients de moins de 65 ans, ope
res pour pontage aorto-coronarien entre
janvier 1982 et mars 1983 (suivi moyen
de 10.5 mois), a montre un taux de retour
au travail de 1’ordre de 56%.
Un programme d’activite physique,
supervise medicalement et administre au
cours de la phase intermediaire de con
valescence (i.e, avant la 12eme semaine),
pourrait influencer favorablement le
retour au travail.4,5 Ce genre de pro
gramme, en plus d’assurer une continuity
logique aux exercices de rehabilitation
entrepris lors de l’hospitalisation, peut
aider physiquement et psychologiquement
a mieux traverser cette periode et consequemment influencer favorablement le
retour rapide a une vie active.6-11
Le rapport qui suit rend compte des
resultats obtenus aupres de 68 patients
operes pour pontage aorto-coronarien
entre janvier 1983 et mars 1984 et qui ont
suivi, trois fois par semaine, de la 6eme
a la 12eme semaine post-pontage, un pro
gramme supervise d’exercices physiques
en gymnase.

Sujets et methode
L’etude portant sur le retour au travail
des sujets qui ont subi un pontage aortocoronarien, seuls les sujets susceptibles de
reprendre un travail en postoperatoire ont
ete retenus pour analyse. Ainsi sont exclus
les sujets de 65 ans et plus, les deces operatoires, les retraites et invalides pour
cause autre que cardiaque, de meme que
les patients qui ont subi un remplacement
valvulaire associe au pontage. Le nombre
de femmes admissibles etant trop petit
pour permettre une analyse separee, elles
ont aussi ete exclues de l’etude.
Groupe temoin
Du ler janvier 1982 au 31 mars 1983,
Pequipe de chirurgie cardio-vasculaire de
l’lnstitut de Cardiologie de I’Hopital
Laval a pratique 497 pontages aortocoronariens. Des facteurs d ’exclusion
etant presents chez 198 sujets, 299
patients ont ete retenus pour l’etude. De
ce nombre, 239 ont pu etre rejoints par
telephone au cours de l’ete 1983. Le
retour au travail a ete evalue par un ques
tionnaire simple. Dix-neuf pourcent des
sujets avaient moins de 45 ans, 39% de
45 a 54 ans et 42% de 55 a 64 ans. La
duree d’arret de travail avant la coronarographie avait ete de moins de 12 semai
nes pour 65% des patients, de 13 semai
nes et plus pour 21%, tandis que 14% des
sujets etaient sans emploi. La repartition
des patients selon le type d ’emploi etait
la suivante: 56% de collets bleus, 29% de
collets blancs et 14% de professionnels.
La periode moyenne de suivi entre la
chirurgie et la redaction du questionnaire
a ete de 10.5 mois. Au cours de cette
periode, les etapes de convalescence et de
reintegration au marche du travail se sont
effectuees de faqon traditionnelle et sans
intervention particuliere.
Groupe d ’intervention
A compter du ler janvier 1983, les
sujets ages de moins de 65 ans operes pour
un pontage aorto-coronarien ont ete invi
tes a un programme de conditionnement
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physique supervise en gymnase. L’invitation a participer a ce programme etait
faite au moment du depart de l’hopital
aux patients residant dans la region
metropolitaine de Quebec et qui presentaient tous les signes exterieurs d ’une con
valescence normale. Seize des 84 ponta
ges inscrits se sont retires du programme
sans y avoir participe; 7 pour des raisons
medicales (angine, infarctus, haute ten
sion arterielle, cholecystectomie, accident
d’automobile, recommandation du medecin), 7 pour des raisons diverses et non
medicales et 2 par manque d’interet. Finalement, 68 hommes operes pour une chirurgie coronarienne sans procedure chirurgicale associee ont constitue le groupe
d ’intervention en gymnase; 24% des
sujets avaient moins de 45 ans, 42% de
45 a 54 ans et 34% de 55 a 64 ans. Dans
ce groupe, la duree d ’arret de travail
avant la coronarographie avait ete de
moins de 12 semaines pour 80% des
patients, de 13 semaines et plus pour
19%, tandis qu’un sujet etait sans emploi.
La repartition des sujets selon le type
d’emploi etait 37% de collets bleus, 46%
de collets blancs et 17% de profes
sionals.
L’evaluation clinique pre-entrafnement

Pour participer au programme d’entrainement en gymnase, les patients
devaient obligatoirement obtenir l’autorisation de leur medecin traitant, etre
exempt d ’angine residuelle et subir un test
d’effort sur tapis roulant a la cinquieme
semaine post-pontage. Les niveaux
d’adaptation cardiovasculaire a Peffort et
de capacite physique ont ete determines
a l’aide d’un test d’effort progressif, selon

le protocole de Naughton m odifie,9
poursuivi jusqu’a 90% de la frequence
cardiaque predite selon Page ou, le cas
echeant, jusqu’au niveau d ’effort sousmaximal libre de symptomes limitatifs. Ce
seuil individuel de tolerance a l’effort a
servi a la prescription subsequente d ’exercices. Les candidats devaient egalement
se soumettre a une evaluation sanguine:
cholesterol, cholesterol de haute densite
(HDL), triglycerides, glycemie et une formule sanguine complete. Leur statut de
fumeur etait evalue par questionnaire
simple.
Le programme d’intervention
en gymnase

Une fois le test d’effort realise, les can
didats au programme de readaptation
physique devaient se presenter trois fois
par semaine a une seance d’une heure
d ’entrainement physique, entre la 6eme
et la 12eme semaine post-chirurgicale.
Chaque seance d ’entramement durait 60
minutes, etait medicalement supervisee et
comprenait trois parties, soit:
• 15 minutes d ’exercices d’echauffement puis d ’exercices a dominante musculaire, pratiques en groupe. Les mouvements de flexibilite et de mobilisation des
muscles thoraciques etaient rendus plus
vulnerables a cause des manoeuvres chirurgicales recentes.
• 30 minutes d ’exercices a dominante
cardiovasculaire. Une intensity moyenne
de 60% a 70% de la frequence cardiaque
maximale atteinte au test d ’effort
d ’admission et libre de tout signe electrocardiographique limitatif a ete choisie.
Cette periode etait divisee en courtes
sequences de marche ou de bicyclette
ergometrique interrompues de periodes de
repos de 2 minutes pendant lesquelles le
patient pouvait prendre sa frequence car
diaque.
• 15 minutes de retour au calme au
moyen d’exercices de relaxation ou d ’un
jeu de ballon sans competition.
Resuitats

FIG. 1—Retour au travail par strate d ’age.
Colonnes hachurees = groupe temoin, colonnes pleines = groupe intervention.

Dans le groupe temoin, le retour au tra

vail est de 56%. Plus les sujets sont ages
au moment de 1’intervention, plus la fre
quence de retour au travail est faible (76%
chez les moins de 45 ans, 59% chez les
45 a 54 ans et seulement 46% chez les 55
a 64 ans). La duree d ’arret de travail precoronarographie constitue de loin le facteur pronostic le plus fortement lie au
retour au travail: 76% de retour si le delai
est de 0 a 12 semaines comparativement
a 26% si le delai depasse 12 semaines. Le
type d ’emploi est aussi associe a des comportements de retour au travail differents,
ainsi seulement 58% des collets bleus ont
repris leur travail comparativement a 75%
et 79% respectivement pour les collets
blancs et les professionnels.
Dans le groupe d ’intervention en gym
nase, le taux de retour au travail a atteint
75%. Ici encore, le retour au travail des
sujets ages de 55 a 64 ans est moindre que
chez les sujets plus jeunes (57% pour les
55 a 64 ans contre 88% pour les moins
de 45 ans et 86% pour les 45 a 54 ans).
La duree d’arret de travail demeure de
loin le meilleur element pronostic du
retour au travail soit 85% de retour si le
delai est de 12 semaines ou moins contre
46% si le delai est de 13 semaines ou plus.
Enfin, le retour au travail est moins eleve
chez les collets bleus qui ont participe a
l’intervention (64%) que chez les collets
blancs (87%) et les professionnels (75%).
La fig. 1 presente la comparaison du
retour au travail des deux groupes par
strate d ’age. L ’amelioration de la reprise
de travail a ete observee dans les trois strates d ’age, mais cette difference atteint une
valeur statistiquement significative chez
les 45 a 54 ans (p <0.01, l’epreuve t de
Student).
La fig. 2 illustre la comparaison du
retour au travail selon la duree d ’arret de
travail pre-coronarographie. Les sujets
qui ont cesse de travailler moins d ’une
semaine en pre-coronarographie ont
beneficie de l’intervention en gymnase (p
< 0.25). A l’autre extreme, chez les sujets
qui ont cesse de travailler plus de 12
semaines pre-coronarographie, le retour
au travail a presque double dans le groupe
intervention (26% contre 46%), mais
cette difference n ’atteint pas le niveau de
signification statistique a cause du nombre reduit de sujets dans ce groupe
d ’intervention (n = 13).
Enfin, la fig. 3 presente la com parai
son de retour au travail selon le type
d ’emploi. La proportion de patients qui
reprennent le travail est plus grande dans
le groupe intervention que dans le groupe
controle, chez les collets bleus et les col
lets blancs, mais cette difference n’est pas
statistiquement significative.
Discussion

FIG. 2—Retour au travail selon la duree
d'arret du travail pre-coronarographie. Colon
nes hachurees = groupe temoin, colonnes plei
nes = groupe intervention.

FIG. 3—Retour au travail selon le type
d ’emploi. Colonnes hachurees = groupe
temoin, colonnes pleines = groupe inter
vention.

Dans la population temoin, le retour au
travail est inferieur aux taux rapportes par
les etudes recentes 56% contre 60% a
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90% .4 Toutefois, les facteurs determi
nant le retour au travail sont les memes
que ceux cites dans les autres milieux soit
Page, la duree d ’invalidite “ temporaire”
pre-coronarographie (ou pre-chirurgie) et
le type d ’emploi.1-3’6 De plus, ces fac
teurs demeurent d ’importants determi
nants de la reprise du travail dans le
groupe intervention.
La comparaison du groupe temoin et
du groupe intervention demontre que les
sujets du groupe intervention ont repris
leur travail dans une plus grande propor
tion que ceux du groupe temoin. II serait
bien tentant d’y voir une relation de cause
a effet. Toutefois, il convient de rappeler qu’il ne s’agit pas d ’une etude randomisee de sujets egalement eligibles et imp
resses. Lorsque nous avons entrepris
l’intervention en gymnase, nous voulions
demontrer qu’une telle intervention est
faisable, sans risque et peut ameliorer
l’autonomie des sujets et consequemment
influencer favorablement le retour rapide
a une vie active.
Le groupe intervention ne represente
pas le quart des sujets operes avec succes
a cette periode. Cette faible proportion
s’explique par trois facteurs: le pro
gramme est nouveau, pres de 50% des

patients operes a Laval viennent de l’exterieur de la region metropolitaine de Que
bec et enfin, pres de 40% des operes
avaient plus de 65 ans ou une chirurgie
valvulaire associee. Malgre la nouveaute
de l’intervention dans notre milieu, seulement deux des patients eligibles se sont
faits recommander de ne pas participer
par leur cardiologue, sans raison medicale
apparente.
Enfin, une fois inscrit au programme,
l’assiduite etait superieure a 90%. De fait,
seulement quatre patients ont manque 1
des 18 cours et ce, malgre le climat rigoureux des hivers quebecois.
Les resultats communiques dans ce rap
port demeurent partiels puisque l’experience est encore en cours. Neanmoins,
ces resultats suggerent l’idee qu’un pro
gramme de conditionnement physique en
gymnase peut contribuer a influencer
favorablement le retour au travail et fournir au patient convalescent une excellente
occasion de participer plus activement au
succes de sa readaptation.
Nous remercions de leur collaboration, les
chirurgiens cardio-vasculaires et les cardiologues de la region de Quebec et soulignons l’aide
technique de l’equipe du laboratoire d’exercices.
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NOTICES
American Association
for Hand Surgery
The 15th annual meeting of the Ameri
can Association for Hand Surgery will be
held Oct. 24-27, 1985 at the Vista Inter
national Hotel, Kansas City, Missouri.
For further information contact: Myra
Josephson, Central Office Manager,
American Association for Hand Surgery,
Ste. 218, 2934 Fish Hatchery Rd., M adi
son, WI 53713; (608) 272-8940.

Thoracic and Cardiovascular
Surgery
The 17th Asian Congress of Thoracic and
Cardiovascular Surgery will be held Nov.
17-21, 1985, in Bangkok, Thailand. The
meeting is sponsored by the Association
of Thoracic and Cardiovascular Surgeons
of Asia, hosted by the Society of Thoracic
and Cardiovascular Surgeons of Thailand
and supported by the Royal College of
Surgeons of Thailand, the Heart Associ
ation of Thailand and Chulalongkorn
University. English will be the official lan
guage for the congress, which will include
guest speakers, plenary sessions, sympo
sia, scientific films and exhibits.
Information concerning the congress
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and travel arrangements can be obtained
from Interport, Ltd., PO Box 338, Sun
set Beach, CA 90742; (213) 592-4446;
Telex 910-380-5385 (Interport SSBH).

Cleft Palate and
Related Craniofacial Anomalies
The 5th International Congress on Cleft
Palate and Related Craniofacial Anoma
lies will be held Sept. 2-7, 1985 at the
Congress Center in Monte Carlo.
This congress will be of interest to all
practitioners concerned with this subject,
including plastic, dental, pediatric and
maxillofacial surgeons, orthodontists and
otorhinolaryngologists.
For further information contact Dr.
Rene Malek, Chairman, International
Congress on Cleft Palate and Related
Craniofacial Anomalies, 6, rue Erlanger,
75016 Paris France; or write SOCFI, 14,
rue Mandar, 75002 Paris, France.

Review in Gastroenterology
The University of Rochester Medical Cen
ter, Rochester, NY, is offering a course
entitled “ Review in G astroenterol

ogy” to be held Oct. 16-18, 1985. It will
be sponsored by the Gastrointestinal
Unit, Department of Medicine, of the
University of Rochester School of Medi
cine and Dentistry and the course direc
tor will be Dr. Jagdish C. Mangla. The
accreditation will be 22 hours of AMA
Category 1. The registration fee for prac
tising physicians will be $425, for physi
cians in training $300 and for endoscopy
assistants $225.
For further information contact the
Office of Continuing Professional Edu
cation, University of Rochester Medical
Center, 601 Elmwood Ave., Box 677,
Rochester, NY 14642; (716) 275-4392.

Pan-Pacific Surgical
Association
The 18th biennial congress of the PanPacific Surgical Association will be held
Jan. 11-17, 1986 in Honolulu, Hawaii.
The theme of the meeting will be trauma.
The deadline for registration is Nov. 15,
1985.
For more information contact: Dr.
George Bondar, Secretary, Pan-Pacific
Surgical Association, Rm. 402, 10053111th Street, Edmonton, Alta. T6K 2H8.
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Transforming Skeletal Muscle for Myocardial Assist:
a Feasibility Study
Canine experiments were undertaken to
determine the feasibility of transforming
skeletal muscle for myocardial
assistance. Initially, a rectus-muscle
pedicle flap was used to power a ven
tricular assist conduit. A specially
designed "pulse-train" stimulator
produced skeletal muscle contractions
capable of augmenting myocardial func
tion. Statistically significant increases in
either systolic or diastolic pressures were
achieved by appropriate synchronization
and signal delays of the stimulator.
Then, the left rectus muscle was con
ditioned by stimulating it at low frequen
cies (2 to 10 Hz) for 6 to 12 weeks. The
degree of transformation from type II
(fast) to type I (slow) fibres was exa
mined and the resultant tolerance to
fatigue studied. Preliminary data show
that a greater proportion of type I fibres
is associated with increased resistance
to fatigue. Such transformed skeletal
muscle should therefore be more suited
to power the cardiac assist devices.
Des experiences chez le chien ont ete
realisees afin de verifier la possibility de
transformer le muscle strie pour assister
le myocarde. Au debut, un lambeau du
pedicule du muscle grand-droit fut utilise
afin d'actionner un conduit d'assistance
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ventriculaire. Un stimulateur special
engendrant un "train d’onde" servit a
provoquer des contractions du muscle
strie capables d’ameliorer la fonction
myocardique. Une augmentation statistiquement significative des tensions systolique et diastolique fut enregistree grace
a une synchronisation appropriee du sti
mulateur.
Par la suite, le grand-droit gauche a
ete conditionne par stimulation a basse
frequence (2 a 10 Hz) pendant de 6 a 12
semaines. On a examine le degre de
transformation des fibres de type II (rapides) a des fibres de type I dentes) et on
a etudie la tolerance a la fatigue qui en a
resulte. Les donnees preliminaires revelent qu'un plus grand nombre de fibres
de type I est associe a une augmentation
de la resistance a la fatigue. Un muscle
strie ainsi transforme devrait done §tre
plus apte a actionner les instruments
d'assistance cardiaque.

myocardial contraction by a newly
devised “ pulse-train” muscle stimulator,
which generated greater contractile force
in the skeletal muscle. We were able to
show a 19.3% increase in left ventricular
pressure and an increase of 38.3% in left
ventricular d p /d t (rate of rise of ventric
ular pressure). However, two primary
limitations to this approach were identi
fied. First, in order to obtain an optimal
relation of length to tension with the
skeletal muscle graft, a relatively high
end-diastolic pressure was required.
Second, when skeletal muscle was sub
jected to the stimulation required to aug
ment myocardial function, it rapidly
fatigued. To address these problems, we
attempted in this study to use skeletal
muscle to power a valved balloon conduit
passing from the left ventricle to the
thoracic aorta (Fig. 1). In addition, we
examined the feasibility of transforming
canine rectus muscle, type II, rapidly

Efforts to provide mechanical assistance
for a failing heart have been focused prin
cipally in two areas: cardiac transplanta
tion and devices for ventricular assistance.
With the evolution of better immunosup
pression, cardiac transplantation has
played a definite therapeutic role but will
always be limited by cost and availabil
ity of donors. The majority of left ven
tricular assist devices and artificial hearts
have been pneumatically, hydraulically or
electrically powered, their primary limi
tation being the power source.1'3 Only a
few attempts have been made to utilize
skeletal muscle for the power source.4'5
The innate advantage of using autologous
material and energy seems to be out
weighed by the immediately apparent
problems of strength and fatigability.
Kantrowitz, as early as 1955, tried wrap
ping the aorta with skeletal muscle.6
Others7 have used diaphragmatic muscle
flaps to replace portions of the hemodynamically less-demanding right ventricle.
In our laboratory, Dewar and associates8
used a rectus-muscle pedicle flap to
replace a portion of the left ventricle. It
was stimulated in synchrony with the

FIG. 1—Diagrammatic representation of
valved balloon conduit wrapped with skeletal
muscle passing from left ventricle to aorta.
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fatiguing muscle fibres, to type I fatigueresistant skeletal muscle fibres, and the
resultant effects on muscle fatigue in
response to “ pulse-train” stimuli.
Methods and Materials

The capabilities of our pulse-train
stimulator have been described previ
ously.8 Briefly: (a) it provides variable
duration of stimuli lasting from 50 to 320
ms, (b) the stimulus can be subdivided
into multiple pulses, (c) it can sense R
wave, (d) the stimuli can be delayed to
make the contraction synchronous with
systole or diastole and (e) it provides a
variable refractory period allowing 1:1,
1:2 and 1:3 pacing.
Experiment 1: Skeletal-Muscle-Powered
Ventricular Assist Conduit
Nine dogs weighing 20 to 35 kg were
anesthetized with sodium pentobarbital,
intubated and ventilated. The cardiac and
hemodynamic status of the dogs was
monitored continuously by electrocardi
ography, an aortic arch arterial line and
arterial blood-gas measurements. A mid
line abdominal incision was made and the
left rectus muscle was cleared of sub
cutaneous tissue, transected at approxi
mately two thirds of its length and dis
sected from the posterior sheath. The flap
was then wrapped in saline-soaked gauze.
A left thoracotomy was done through
the sixth intercostal space. The aorta was
cleared for a distance of three intercostal
arteries, which were ligated and divided.
The pericardium was opened to expose
the apex of the left ventricle. The
diaphragm was incised to pass the con
duit through from the rectus site to the
heart and aorta, after the rectus muscle
had first been sewn around the balloon.
The proximal end of the conduit (Fig. 1)
was then inserted into the left ventricu
lar apex using the partial inflow occlusion
technique, and the distal end was
anastomosed to the descending thoracic
aorta. The sensing electrodes were passed
from the left atrium to our prototype
pulse-train stimulator described above.
Stimulating electrodes were passed from
the stimulator to the rectus muscle. The
muscle was then stimulated with varying
parameters in repeated on-off experi
ments to see whether appreciable aortic
pressure could be generated. Only experi

ments in which there were no technical
difficulties, such as excessive bleeding,
were analysed. The on-off experimental
design allowed for paired Z-test analyses
of the data. No attempt was made to
achieve long-term survival of the dogs.
Experiment 2: Skeletal Muscle
Transformation Study
Four mongrel dogs under Nembutal
anesthesia had either an internal re
ceiver or an atrioventricular sequential
pacemaker implanted. Medtronic epicardial electrodes (Medtronic Inc., Min
neapolis, Minn.) were placed in the
middle portion of the left rectus muscle.
The dogs that had internal receivers were
then stimulated with an external transmit
ter and antenna sewn into closely fitting
canine jackets, for a period of 6 to 12
weeks at a frequency of 2 to 10 Hz. The
pulse width was 0.35 ms and voltage was
8 V. The dogs were checked daily by pal
pation to ensure continued functioning of
the pacemaker.
After 6 to 12 weeks, the dogs were
anesthetized. Their cardiac and
hemodynamic status was monitored by
electrocardiography, Foley catheter and
femoral arterial line. The stimulating elec
trode was removed. A biopsy specimen
was taken from the rectus muscle and
stained histochemically for myosin
ATPase.9 These stains at different pH
can clearly differentiate type II from
type I fibres. A rectus-muscle pouch was
then fashioned using the technique previ
ously described by Dewar and associ
ates.8 Two temporary pacing electrodes
stripped for approximately 7.5 cm were
passed transversely through the muscle
about 5 cm apart. The latex balloon was
inflated to a baseline pressure of 75 to 80
mm Hg. Variable stimulating parameters
were tried until one was found that
produced maximal pressures in the
pouch. The muscle was rested for 15
minutes, then the fatigue study was
undertaken. With the parameters estab
lished earlier, continuous pulse-train
stimulation was begun. The pressures
generated were recorded at 30-minute
intervals. During the experiments, 500 mL
of dextrose in water were given and the
muscles were kept moist with saline.
Rectus muscles from four dogs which had
received no long-term stimulation were
used as controls.

Table 1-Augmentation of Systemic Pressure With Stimulation of a
RectusMusclePowered Ventricular Assist Device
Increase in mean
Phase of
No. of
aortic arch
Range of
augmentation
dogs
pressure, mm Hg*
augmentation, mm Hg
Systole
5
11 ± 1.66
7.2-16.8
Diastole
8
9.5 ± 1.75
2.7-16.5
*SEM, p < 0.05.
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Results

Experiment 1: Skeletal-Muscle-Powered
Ventricular Assist Conduit
With appropriately timed impulses
(Table I), either the systolic or the
diastolic aortic pressures can be aug
mented. A tracing demonstrating systolic
augmentation with 1:2 pacing is shown in
Fig. 2. If the delay from R wave to stimu
lation was less than 160 ms, systolic pres
sure was augmented. If the delay was
greater than 160 ms, diastolic pressure
was augmented. The stimulating para
meters used to achieve these augmenta
tions are listed in Table II. One dog was
assisted while still on cardiopulmonary
bypass. Fig. 3 shows that the skeletal
muscle accessory ventricle was able to
pump at least 25 mm Hg over pump
pressure.
Experiment 2: Skeletal Muscle
Transformation Study
The results of the fatigue study on mus
cle stimulated for 6 to 12 weeks are shown
in Fig. 4. The increase in proportion of
type I fibres in a stimulated dog compared

FIG. 2—Synchronous pressure and stimu
lus tracing, illustrating augmentation of sys
tolic pressures with appropriately timed stimu
lation.

FIG. 3—Synchronous pressure and stimu
lus tracing shows greater augmentation of sys
temic pressures over pump pressures at low sys
temic pressures.
Table 11-Range of Stimulating Parameters
Capable of Achieving Systolic o Diastolic
Augmentation
Range
Stimulation parameters
50
Pulse width, ms
20
Burst frequency, Hz
200-500
Duration, ms
36-60
Bursts/min
2.5-6
Voltage, V
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with a control dog is shown in Figs. 5 and
6. Although a greater magnitude of con
version of type II to type I fibres appears
to be associated with increased fatigue
resistance, more animals must be studied
before statistical correlations can be
established.
Discussion

FIG. 4—Relation between degree of fatigue
in response to stimulation and proportion of
type I fatigue-resistant fibres.

In this study, we demonstrated that a
valved balloon conduit powered by skele
tal muscle can improve systemic systolic
or diastolic pressures. The left ventricu
lar, apex-to-aorta, valved balloon conduit
can function as an auxiliary ventricle
when it is timed to provide systolic
assistance. The balloon fills during dia

FIG. 5—Muscle biopsy from control canine rectus muscle (unstimulated), stained for myosin
ATPase at pH 4.3. Dark fibre bundles are type I, slow-contracting fatigue-resistant fibres and
pale fibre bundles are type II fibres (reduced by 30% from x 450).

FIG. 6—Muscle biopsy from canine rectus muscle subjected to long-term, direct muscle
stimulation at low frequency, stained for myosin ATPase at pH 4.3. Note increased proportion
of type I muscle fibres compared with Fig. 5 and the appearance of grey staining intermediate
fibres (reduced by 30% from x 450).

stole and thus reduces the left ventricu
lar end-diastolic pressure and empties
during systole to augment aortic pressure.
In the 1:2 assist mode, the balloon can be
filled during every other systolic phase,
thus achieving greater muscular stretch to
generate greater tension upon stimu
lation.
The benefits of diastolic counterpulsa
tion are well established and our conduit
would be ideally suited to this type of left
ventricular assist, by timing the muscu
lar contraction during the diastolic
period. It would also be useful in a wider
variety of clinical settings such as diffuse
cardiomyopathies. In contrast, the
myocardial patch studied by various
investigators in the past7,8’10 can be used
only in the presence of regional, discrete
areas of myocardial infarction, scars and
aneurysms, or for hypoplastic right or left
ventricles. By using the approach reported
here, we overcome two m ajor problems
encountered in using skeletal muscle to
assist a failing heart. Skeletal myograft
replacing ventricular muscle requires a
high (greater than 20 mm Hg) diastolic
pressure to generate maximal contractile
force. For counterpulsation, however, the
muscle-wrapped balloon fills during the
higher systolic pressure phase, thus
stretching the skeletal muscle and increas
ing the resting tension required to develop
efficient contraction. The diastolic aug
m entation achieved in this study,
although still less than optimal for effec
tive cardiac assist, is statistically signifi
cant (paired t-test, p < 0.05). This aug
mentation could in the future be increased
by using a larger muscle pouch. Ours was
limited by the size of the rectus muscle.
Other muscles being studied are the latissimus dorsi and pectoralis major. It was
apparent that with a normal heart and
systemic pressure, as in our dogs, it would
be more difficult to show an improvement
in cardiac function. In general, with heart
failure and reduced systemic pressures, a
greater augmentation of pressure could be
more readily demonstrated. The tracing
of the dog assisted while on cardiopulmo
nary bypass clearly shows this.
The optimal stimulating parameters for
generating the pressures required to aug
ment myocardial function are still under
investigation. With a narrower pulse
width, lower frequency, decreased voltage
and direct nerve stimulation, muscle
fatigue may be minimized. Glenn and
colleagues11 have shown that diaphrag
matic muscle can be stimulated at slow
rates for over a year with no fatigue.
In our preliminary study (experiment
2), only two dogs stimulated for 6 to 12
weeks showed a clear increase in the
proportion of type I fatigue-resistant
muscle fibres when compared with con
trols. The number is too small for statisti
cal analysis. Other investigators12 have
achieved greater success in transforming
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type II to type I muscle fibres with direct
muscle stimulation, but it appears that
more complete transformation can be
obtained by direct nerve stimulation.1315
Many investigators16,17 have shown that
the type I fibres are more fatigue resis
tant than type II fibres. The answer to
muscle fatigue in this setting most likely
lies in a concerted approach, making
optimal use o f aerobic enzymes of
metabolism and o f stimulating parame
ters, and increasing the percentage of
fatigue-resistant fibres.
Since skeletal muscle fatigue is highly
rate-dependent, the capability of deliver
ing 1:2 or 1:3 mode assists can also delay
the onset o f fatigue. Recently, Medtronic
Inc., in conjunction with our group, has
developed a more advanced, potentially
implantable pulse-train stimulator. Fur
ther work is in progress with this new
stimulator, which has better timing capa
bility than the prototype stimulator used
in this study. The goal is to use the
endogenous energy source o f skeletal
muscle to achieve prolonged cardiac assist
in patients with heart failure.

Conclusions
Myocardial function can be augmented
with either a skeletal muscle patch or a

balloon conduit powered by skeletal mus
cle from left ventricle to aorta.
In preliminary studies, we partially
transformed rapidly fatiguing type II
skeletal muscle fibres to type I fatigueresistant fibres in some dogs. The impor
tance of this transformation when such
muscle is used to augment ventricular
function is currently under investigation.
The optimal stimulating parameters to
achieve adequate pressures and minimum
fatigue must now be identified.
We appreciate the technical assistance o f
Miss Wynanne Bindon, Miss Celine Lemay,
Mr. David MacDonald, Mr. Roger Samson,
Mrs. Maureen Smith and Mrs. Emma Lisi.
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Two-Dimensional Echocardiography for Diagnosing
Acute Ascending Aortic Dissection
The diagnosis o f ty p e A aortic dissection
(involving th e ascending aorta) can be
made w ith tw o -d im e n sio n a l echocardio
graphy, b u t surgeons usually demand
angiographic c o n firm a tio n . Betw een
Ja n u ary 1 9 8 3 and February 1 9 8 4 , 10
p a tien ts presented at St. M icha e l's
H ospital in T o ro n to w ith typ e A aortic
disse ctio n . Six p a tien ts u n d e rw e n t tw o dim ensional echocardiography early in
th e ir e valuation. A p ositive diagnosis
w a s made in fo u r, based upon visualiza
tio n o f an in tim a l fla p or a false lumen.
In th e o th er tw o pa tien ts, the fin d in g s o f
an enlarged ascending aorta and
pericardial e ffu s io n w ere suggestive but
n o t dia g no stic. Three patients survived
operation and are alive and w ell (fo llo w 
up ranging fro m 3 to 5 m onths). One
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p a tie n t died w h ile a w a iting surgery, one
died d uring aorto g rap h y and one died
d u rin g o peration. A ll echocardiographic
and a n g iographic fin d in g s w e re co n 
firm e d at su rg e ry or at au top sy. It is
co n clu de d th a t tw o -d im e n sion a l
e ch o card io g ra p h y can diagnose ascend
ing a o rtic d isse ctio n q u ickly, accurately,
easily and w ith o u t risk to th e patient. In
selected cases th e presence o f a false
lum en or o f an in tim a l flap m akes it pos
sible to proceed w ith operation w ith o u t
delay or th e p o ten tia l hazards o f a o rto 
graphy.

p a tie n t e st decede en a tte n d a n t la c h iru rgie, un d u ra n t I'a o rto g ra p h ie et un d u ra n t
I'o p e ra tio n . Tous les re su lta ts d 'e c h o c a rd io g ra p h ie et d 'a n g io g ra p h ie o n t pu e tre
c o n firm e s a la chirurgie ou a I'a u to p s ie .
On c o n c lu t que I'e ch o ca rd io g ra p h ie bidim e n sio n n elle peut d ia g n o stiq u e r une
d is s e c tio n de I'ao rte ascendante rapidem e n t, fa cile m e n t, avec precision e t sans
risque p o u r le malade. Dans des cas
c h o isis, la presence d 'u n e fausse lum iere
ou d ’ un lambeau d 'in tim a p e rm e t d 'e n tre p re n d re I'op e ra tion sans delai ou sans
le risqu e d 'u n e aortographie.

Le d ia g n o stic des d isse ctio n s aortiques
de ty p e A (im p liq u an t I'aorte ascendante)
pe u t etre fa it par echocardiographie bid im ensionnelle, m ais les chirurgiens e xi
ge n t h a b itu e lle m e n t une co n firm a tio n
a n giographique. De janvier 1 9 8 3 a
fe vrie r 1 9 8 4 , 10 patien ts o n t ete h ospi
talises au St. M icha e l's H ospital de
T o ro n to s o u ffra n t de d issection aortique
aigue de ty p e A. Six patien ts ont subi
une echocardiographie bi-dim ensionnelle
au d e b u t de leur evaluation. Un dia g no s
tic p o s itif a ete pose chez quatre apres
visu a lisa tio n d 'u n lambeau d 'in tim a ou
d 'u n e fausse lum iere. Chez les deux
a utres p a tie n ts, les observations d 'u n
re n fle m e n t de I'a o rte ascendante et
d 'u n e e ffu sio n pericardique etaient in d i
ca tive s mas non diagnostiques. Trois
p a tie n ts o n t survecu a I'op e ra tion ; ils
s o n t m a in te n a n t retablis (les exam ens de
co n tro le s 'e ta le n t sur de 3 a 5 mois). Un

Type A dissection (involving the ascend
ing aorta) is among the most common
catastrophic events involving the thoracic
aorta. Survival depends upon rapid diag
nosis and operation. Clinical manifesta
tions, including severe chest pain radiat
ing through to the back, neurologic
sequelae, absent or changing pulses and
the presence of a new aortic diastolic mur
mur may suggest type A dissection. Chest
films may demonstrate a dilated ascend
ing aorta or a left pleural effusion, fur
ther supporting the diagnosis. These
desperately ill patients usually undergo
retrograde aortography to confirm the
presence of a dissection, its location and
its extent. Noninvasive methods of
diagnosis, such as M-mode echocardio
graphy1 and computerized transaxial
tomography,2 have been tried but are
not satisfactory. Two-dimensional echo
cardiography, another noninvasive mo-

Table I— Patient Characteristics and Results of Treatment*
Age,
Aortic
EchoSex
insufficiencyt
cardiogramt
Aortogramf
V
1
+
58
+
M
2
+
61
F
Not done
+
+
3
M
63
+
4
+
76
M
?
+
5
62
M
Not done
?
+
6
38
F
+
'Patients 5 and 6 had the aortic valve resuspended at time of surgery.
= present, - = absent,
t + = positive, - = negative.
§Autopsy showed type A dissection with intrapericardial rupture.
Patient
no.

Operation

Results

USCI graft
USCI graft

Alive, well
Alive, well
Dead
Dead§
Dead, operation
Alive, well

-

USCI graft
USCI graft

t+
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dality, can be used at the bedside and can
definitively establish the diagnosis of aor
tic dissection.3 We report our experience
with this technique in a small series of
patients with type A aortic dissection.

1
2
3

Patients and Results
Between January 1983 and February
1984, 10 patients were seen at St.
Michael’s Hospital in Toronto with type
A aortic dissection. Six underwent twodimensional echocardiography early in
their evaluation and they form the basis
of this report. Clinical and two-dimen
sional echocardiographic data are sum
marized in Tables I and II.
In four patients a definitive diagnosis
was made with two-dimensional echocar
diography ;>based upon visualization of an
intimal flap (Figs. 1 and 2) with localiza
tion to the ascending aorta. One other
patient had a dilated ascending aorta
associated with a pericardial effusion
which was highly suggestive, but not diag
nostic, of aortic dissection since an
intimal flap could not be seen. The
remaining patient had a normal ascend
ing aorta with a markedly dilated aortic
arch. Catheterization confirmed the
presence of a dissection localized to the
aortic arch. All patients had a dilated
aorta; in four the ascending aorta only
was involved, in one the ascending aorta,
aortic arch and descending aorta were all
involved, and in one the arch only was
involved. Four of the six patients had
pericardial effusion and one demon
strated echocardiographic evidence of
cardiac tamponade with diastolic collapse
o f both the right ventricle and right
atrium .4,5 The presence of intrapericardial thrbmbus was also demonstrated
in one patient.
One patient who had a definitive
echocardiographic diagnosis and another
with an echogram that suggested dissec
tion were operated on immediately be
cause of hemodynamic deterioration. One
of them survived and remains alive and
well, the other died intraoperatively of
uncontrollable aortic bleeding. The
remaining four patients underwent retro
grade aortography. The aortograms
showed a dissection in three patients but
not in the fourth. This patient, who had
a positive two-dimensional echocardio
gram, also had a negative computerized
tomogram; surgery was deferred and he
died 48 hours later of hemopericardium
and cardiac tamponade. This patient had
a pericardial effusion documented on the
initial two-dimensional echocardiographic
study. Autopsy confirmed the presence of
type A dissection with rupture into the
pericardial space. Of the three remaining
patients, one died during aortography and
the other two underwent surgery. Both
were alive and well, 6 and 8 months
346

T a b le l l - S u m m a r y o f T w o - D im e n s io n a l E c h o c a rd io g ra p h ic F in d in g s in A ll P a tie n ts
P a tie n t
no.

4
5
6

F la p
v is u a liz e d

A o rta
d ila te d

A o r t ic
in s u f fic ie n c y

P e ric a rd ia l
e ffu s io n

Yes
Yes
Yes

Yes
Yes
Yes

Yes
No
No

Yes
Yes
Yes

Yes
No
No

Yes
Yes
Yes

No
No
No

Yes
No
Yes

E xte n t
A s c e n d in g a o rta
A s c e n d in g a o rta
A s c e n d in g a o rta
a n d a o rtic a rc h
A s c e n d in g a o rta
A o r t ic a rc h o n ly
A s c e n d in g a o rta

FIG. 1—Suprasternal view of ascending aorta and aortic arch. Arrows indicate intimal flaps.
Ao = aorta, PA = pulmonary artery, LA = left atrium.

FIG. 2—Parasternal long axial view of left ventricle and ascending aorta. Arrows indicate
intimal flap. LV = left ventricle, RV = right ventricle, LA = left atrium, Ao = aorta, fl =
false lumen.

FIG. 3—Apical four chamber view of the heart. Large pericardial effusion with thrombus
is demonstrated. Arrow shows right ventricular diastolic collapse. Th = thrombus, pe =
pericardial effusion, rv = right ventricle, Iv = left ventricle, ra = right atrium, la = left atrium.
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postoperatively. An intraluminal graft
(USCI International, Billerica, Mass.)
was used for repair in all patients. Two
patients. Two patients required resuspen
sion of the aortic valve at operation.
All two-dimensional echocardiographic
findings were confirmed by autopsy or at
operation. There were no false-positive
two-dimensional echocardiographic find
ings during the study period from our
laboratory.
Discussion
Type A dissection of the aorta is a
catastrophic event which is rapidly fatal
if untreated.6 Successful management
depends on a rapid diagnosis and surgi
cal intervention.7'8 The diagnostic
modality selected should not only estab
lish the presence of the dissection, but
also pinpoint the area of aorta involved.
The presence or absence of aortic insuffi
ciency or a pericardial effusion is also
important information for the surgeon.
Retrograde aortography is the most
widely used method of establishing the
diagnosis of type A dissection. It has the
advantages of demonstrating the presence
of true and false lumina as well as localiz
ing the site of the intimal tear. It also
visualizes aortic regurgitation secondary
to annular ectasia. The disadvantages of
this technique concern its invasive nature
and the considerable time delay that is
often unavoidable in performing the
procedure. This technique, however, is
not always definitive as evidenced by one
of our patients in whom the aortogram
appeared normal. Frequently, the aorto
gram does not reveal the exact site of
intimal tear. Moreover, two deaths
occurred either during or while the patient
was awaiting angiography.
Dynamic computerized transaxial
tomography with intravenous contrast
may demonstrate a double lumen and an
intimal tear in aortic dissection. This
method has the advantage of being noninvasive and has been found by some to be
as useful as aortography.2 However, this
technique has several disadvantages. The
equipment, which is expensive and not
readily available in all institutions, is not
portable and is generally located in areas
where the management of unstable
patients may be difficult.
Two-dimensional echocardiography
has added a new diagnostic modality for
the detection of aortic dissection. Several
authors1,3’9 have noted its usefulness in
definitively establishing the diagnosis of
type A dissections involving the aortic
root. The two-dimensional echocardio
graphic diagnosis is based upon visuali
zation of an intimal flap. This was present
in four of our six patients (Figs. 1 and 2).
Associated findings that are also helpful
but not necessarily diagnostic include a

dilated aorta, aortic insufficiency and the
presence of a pericardial effusion (Fig. 3).
In addition, two-dimensional echocardi
ography also provides information re
garding left ventricular function which,
if abnormal, may suggest coexistent
myocardial infarction resulting from dis
section into one of the coronary ostia. If
a pericardial effusion is present, recent
evidence in the literature suggests that the
presence of diastolic collapse of the right
ventricle or right atrium may indicate
cardiac tamponade (Fig. 3).4'5
Failure to establish definitively the
diagnosis of dissection occurred in two
patients. However, both had a dilated
aorta and one had a coexistent pericardial
effusion. Importantly, there were no
false-positive two-dimensional echocar
diograms in this series. Victor and
associates3 reported a low incidence
(2%) of false-positive results using this
technique.
The advantages of two-dimensional
echocardiography are several. First, it is
noninvasive and, therefore, presents no
risk to the patient. Second, it is com
pletely portable so that the patient can be
studied in the emergency room or any
other area of the hospital without
difficulty. Third, the technique is rapid,
there is no need for delay in beginning the
study which takes only minutes to per
form. Fourth, not only can the diagnosis
be confirmed, but associated abnormali
ties can be visualized, myocardial func
tion can be assessed and other nonrelated
cardiac abnormalities documented. The
disadvantages of this technique are that
an intimal flap may not always be
detected and the site of origin of the
intimal tear may not be reliably seen. This
is especially true in patients with chronic
obstructive lung disease in whom ade
quate images cannot always be obtained.
Finally, and perhaps most importantly,
this technique requires an experienced
echographer to perform and interpret the
study.
Conclusions
Two-dimensional echocardiography
can definitively diagnose type A dissec
tion of the aorta. Because the equipment
may be brought to the bedside, the diag
nosis can be made quickly, easily and
without risk to the patient. In selected
cases, the hazards and delays involved in
aortography may be avoided allowing
definitive treatment.
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1. Organization of the Department of Surgery to Facilitate
Undergraduate Education
The chairman of the department of sur
gery is responsible for undergraduate
education and should develop an
organizational structure involving a direc
tor of undergraduate education for the
every-day running of the undergraduate
program and the determination of poli
cies. This person should hold a relatively
senior position and should have under
gone specialist postgraduate training in
educational methods and theory. The
director should be supported by appropri
ate secretarial services and be compen
sated for this; the director should also sit
on the faculty medical curriculum com
mittee to close the circle of policy made
at this committee with departmental
policy.
The departmental undergraduate
education committee should include
representatives from all hospitals
involved in undergraduate education with
representatives from the various sys
tems. Some doubling up of representa
tives can occur. There should be a
review process of both teaching methods
and faculty teaching. The former will
encourage change where appropriate and
F rom the Departm ent o f Surgery, U niver
sity o f Toronto, Toron to, Ont.
Presented as part o f a seminar on the rote
o f the department o f surgery in under
graduate education by the R oya l C ollege o f
Physicians and Surgeons o f Canada, in
cooperation with the Canadian Association
o f General Surgeons, M ontreal, P Q , Sept.
11, 1984
*D irector o f Undergraduate Education,
Department o f Surgery, University o f
Toron to

the latter award individuals for their con
tribution to the teaching process.
Le president d'un service de chirurgie
responsable de i'enseignement de pre
mier cycle doit mettre sur pied une struc
ture organisationnelle comprenant un
directeur de I'enseignement de premier
cycle qui sera charge de faire fonctionner
sur une base quotidienne le programme
de premier cycle et d'etablir des politiques. Cette personne devrait detenir un
poste relativement eleve et avoir acquis
une formation de deuxieme cycle comme
specialiste en theorie et en methodes
d'enseignement. Ce directeur doit recevoir le soutien d’un service de secretariat
appropri§ et etre remunere en conse
quence; il doit sieger egalement sur le
comite du programme scolaire de la
faculte de medecine afin de pouvoir boucler la boucle entre les politiques etablies
par le comite et celles du service de chi
rurgie.
Le comite d'enseignement de premier
cycle du service de chirurgie doit comprendre des representants de chaque
hopital participant & I'enseignement de
premier cycle ainsi que des representants
des divers systemes. Certaines doubles
representations peuvent survenir. II
devrait exister des processus de revue
des methodes d'enseignements de meme
que de I'enseignement dispense par la
faculte. Le premier visera a encourager le
changement s'il y a lieu, alors que le
second r^compensera la contribution de
certains a I'enseignement.

reviewed?, and finally, how is this whole
process perceived by the faculty? T o
facilitate the educational process, a
department directed to undergraduate
surgical education should be organized to
deal with these problems. This organiza
tion will therefore be discussed in the light
o f these three considerations.

Responsibility for Undergraduate
Education
There is a clear line o f responsibility for
undergraduate education. Although it
ultimately rests with the dean o f the
faculty o f medicine, it stops, as far as
departmental responsibilities are con
cerned, with the department chairman.
The chairman needs an executive officer
and others to deal with the day-to-day
organization at hospital and system levels.
The complexity o f this organization will
depend upon the size o f the medical
school.
W hile the chairman o f the department
has final responsibility for undergradu
ate education, he should be able to
delegate the authority for organizing it to
a responsible individual, a director o f
undergraduate education, who has the
ability and authority to make decisions on
an ad hoc basis without reference to him.
The director’ s responsibilities should
encompass all years o f the medical course
and the chosen individual must have
power and authority, adequate support
services and, preferably, specialist post
graduate training in educational methods
and techniques. H e should have experi
ence in the local educational process and
be a teacher o f recognized excellence. H e
should, therefore, be someone o f relative
seniority within the department, having
associate or full professorial status. In
some schools, there is a tendency to assign
this responsibility to a junior staff mem-

Reprint requests to: D r. John L. Provan,
Rm . 308, E .K . Jones Building, The
Wellesley Hospital, 160 Wellesley St. E,
T oron to, Ont. M 4 Y 1J3

Three major questions face a department
o f surgery when undergraduate education
is considered: first, who is responsible for
undergraduate education?, second, how
are the teaching and examination o f med
ical students organized, assessed and
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ber, the principle apparently being that
a junior person has little else to do. Not
only does this devalue undergraduate edu
cation, but it ensures that when tough
decisions are called for, neither he nor the
chairman will be willing to make them.
The director of undergraduate educa
tion will only be as good as his support
services. The organization of a depart
mental office dedicated to undergraduate
education with a full-time secretary will
make his job immeasurably easier and
will raise the level of visibility of educa
tion within the department. He should
have a seat on the faculty undergraduate
curriculum committee, which is the
decision-making body for the whole
faculty, because without this he will be
playing catch-up with those departments
that are represented. He should also have
access to a professional educator, some
one with a doctorate in education. While
such a person need not be appointed to
the department of surgery, he should have
a cross appointment between the depart
ment and the local professional educa
tional body. In addition to relieving the
director o f many day-to-day responsibil
ities, the professional educator will be
able to cut corners in problem-solving and
will give professionalism to what other
wise may tend to be an amateur associ
ation.
A well-organized instructional media
service will support the director by
providing adequate video taping, slide
taping and slide projection facilities. This
should make the job easier and enhance
the ability of director’s teachers to com
municate.
Curriculum Committee
This is the decision-making body of the
whole faculty and, as such, is a policy
determ in an t fo r all d epartm ents.
Representation on this committee is there
fore essential, for by so doing the depart
ment will have input into the decision
making process in one direction and will
be able to react easily once policies are
determined. Moreover, the curriculum
committee, which is concerned with pro
gram assessment, curriculum change, and
teacher and student assessment, will pro
vide valuable input into departmental
programs and useful assistance in improv
ing these programs.
Line of Responsibility

This will be more complex when larger
numbers of hospitals are involved and
when teaching is involved in each under
graduate year. There is, therefore, a ver
tical matrix where the chain of command
passes from the dean through the chair
man of the department to the director of
undergraduate surgical education to the
hospitals and, in each hospital, down to
350

the educational process in each of the
undergraduate years. The horizontal
matrix crosses system and division teach
ing and, in the organization of clinical
skills such as history-taking and physi
cal examination, will cross interdivisional
and also interhospital boundaries. The
organization of the department should,
therefore, deal with this criss-cross of ver
tical and horizontal matrices. These lines
of communication are enhanced when the
director of undergraduate education
chairs an undergraduate education com
mittee comprising the coordinators of
undergraduate education for each teach
ing hospital. Depending on the size of the
school, the undergraduate education
committee may include those responsible
for specific activities, such as clinical
skills, electives or the clerkship.
The hospital coordinator who is the
representative on the undergraduate edu
cation committee should, at his own
hospital, chair a committee comprising
surgical representatives from each of the
undergraduate years, who may represent
university or department-wide systems or
divisional committees that cross hospi
tal boundaries and facilitate communica
tion in the horizontal matrix. For exam
ple, the person responsible for Year II in
an individual medical school may be a
general surgeon teaching the gastrointes
tinal system to that year’s students and
representing a hospital on a gastrointes
tinal systems committee that ensures coor
dination of such teaching at all consti
tuent hospitals. The horizontal matrix will
also involve communication at hospital or
university level with members of other
departments, particularly the department
of medicine, who share an interest in the
specific system under consideration, that
is, gastroenterologists and gastrointesti
nal surgeons.
With this format, communication from
the lowest of hospital systems teacher to
the dean is ensured upwards, while acrossthe-board communication with associated
departments and hospitals within the
same system is also facilitated.
Review of Teaching

The educational process is never static
and the departmental organization should
reflect this by having a committee struc
ture that looks at curriculum change, the
current patterns of teaching and at new
methods that may be required to respond
both to curriculum change and to changes
in teaching methods. The use of com
puters for problem-solving is an example
of this and the increasing or decreasing
involvement of basic science courses in
the overall curriculum is an example of
curriculum change that requires continu
ing investigation.
The assessment of teaching skills is
important. While it may be difficult to

assess an individual’s teaching ability, it
is essential that some attempt be made to
assess his contribution to the overall
educational process in relation to the
department’s goals. A method of evalu
ating teachers must be developed by the
department and this should be done in
association with a professional educator.
Students are the best assessors of teach
ing and it is recognized that peer assess
ment has distinct limitations. The recog
nition of teaching will help to enhance its
value in the eyes of the department. It
may take the form of awards, promotion,
salary increments or tenure where these
are appropriate.
It is ironic that few of our medical
schools do anything to enhance the value
of teaching by the individual members of
their department. Seldom are new faculty
members appointed for their teaching
skills and very few departments have a
program to initiate new faculty into the
department. An annual course held in
association with professional educators in
the university can direct itself to the
improvement of teaching skills at bedside,
in seminars and in the lecture room. It
may provide a means of upgrading the
skills o f teachers whose performance has
been shown to be substandard and, at
worst, will indicate the commitment the
department has to undergraduate edu
cation.
In conclusion, it might be worth refer
ring to some of the results obtained by the
Association for Surgical Education in its
survey of undergraduate education in the
medical schools of the United States and
Canada.1 Surprisingly, 57% of the direc
tors of undergraduate education were full
professors, but only 55% of the 140
schools surveyed had a director of under
graduate education. In three quarters of
these, the directorship was held on a per
manent basis and the average time of
holding this appointment was 7 years.
This certainly indicates that in those
schools where a director is appointed,
undergraduate education is taken seri
ously by those departments. By contrast,
less than half the schools surveyed had an
office of undergraduate education or an
undergraduate education committee and
only 18% had a professional educator
appointed to the department of surgery.
The quality of faculty teaching was
evaluated in nearly 90% of departments,
the students (97%) being the most com
mon means of evaluation, although time
spent teaching by individual teachers was
also used as the evaluating process in
about half the schools. There was a
faculty development program in only one
quarter of the medical schools in North
America and in three quarters of these
medical schools the chairman carried out
this development himself. In general, the
programs were poorly attended and only
about half had a new faculty program.
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It was of interest that less than one faculty
appointment for teaching had been made
per department in the previous 5 years.
Conclusions
These findings point out that all is far

from well in undergraduate education. It
seems that the most major contributions
a departmental chairman can make are,
first, to give an unequivocally firm com
mitment to undergraduate education and,
second, to organize his department to
facilitate the whole process of under

graduate education, in planning, execu
tion and assessment.
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2. Evaluation of Surgical Faculty and Surgical
Undergraduate Teaching
Surgical teachers are interested in being
evaluated. In a survey of 89 such
teachers at the University of Manitoba,
most (7 9 % ) preferred having their under
graduate teaching evaluated by their stu
dents to other methods of evaluation.
Eighty-seven percent of North American
departments of surgery had a mechanism
for assessing the quality of undergradu
ate teaching; 9 7 % used student feed
back. In order for the evaluation to be
effective in improving undergraduate
teaching, there must be serious faculty
commitment, the teachers must know
the criteria for evaluation, and feedback
to the teachers should be early and
preferably coupled with teacher selfassessment. This paper lists criteria for
the evaluation of surgical undergraduate
teachers and outlines the evaluation
instrument currently used in the Depart
ment of Surgery at the University of
Manitoba.
Les professeurs de chirurgie desirent
faire I'objet d'une evaluation. Lors d'une
enquete menee chez 89 d'entre-eux a
I'Universite du Manitoba, une majorite
(7 9 % ) a declare preferer voir son enseignement de premier cycle etre evalue par
ses propres etudiants plutot que de toute
autre facon. Quatre-vingt sept pourcent
des services nord-americains de chirurgie
possedent un mecanisme d'appreciation
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de la qualite de I'enseignement de pre
mier cycle; 9 7 % utilisent revaluation des
etudiants. Pour que cette evaluation
serve a ameliorer I'enseignement de pre
mier cycle, il faut I'engagement du corps
professoral et la pleine connaissance par
les professeurs des criteres d'evaluation;
et les rSsultats doivent etre transmis
rapidement aux professeurs, de prefe
rence couples & leur propre auto
evaluation. Get article dresse une liste
des criteres d'evaluation de I'enseigne
ment de chirurgie de premier cycle et
trace les lignes generates de I'instrument
d'evaluation presentement utilise dans le
service de chirurgie de I'Universite du
Manitoba.

Evaluation is an important aspect of med
ical undergraduate education. Usually it
is medical students who undergo evalua
tion. Now there is increasing interest in
evaluating faculty and their teaching
standards.
The idea of teacher evaluation will be
threatening to some of the surgical
faculty. Others, often the better teachers,
will welcome being evaluated.

Surgical Faculty Survey
In a recent survey of 89 faculty mem
bers of the Department of Surgery,
University of Manitoba (Loewen EN,
Postuma R: Unpublished data, 1983), 11
programs of instructional development
activity were listed (Table I). Members
were asked to indicate those activities in
which they would be interested in par
ticipating as a method of improving their
teaching. The first choice was a critique
of their teaching by their students; 79%
chose this method. Interestingly, critique
by their peers was favoured by only 56%
of the respondents.
The Association for Surgical Education
recently conducted a survey of North
American departments of surgery.1 It
found that 87% of the schools had a
mechanism for evaluating the quality of
undergraduate teaching. Evaluation by
students was the most widely used method
(97%).'
Evaluation Model
Doyle2 suggested the following model
for evaluating teaching:
• Establish the purpose of evaluation.

T a b l e 1— I n s t r u c t io n a l D e v e lo p m e n t A c t i v i t y , F a c u lt y S u r v e y ,
D e p a r t m e n t o f S u r g e r y , U n i v e r s i t y o f M a n it o b a , 1 9 8 3
R e s p o n d e n ts w ith
m o d e r a t e - s t r o n g in te re s t
in p a r t i c ip a t in g , %

P ro g ra m o f a c t iv it y
C r it iq u e o f m y t e a c h in g b y m y s t u d e n t s

79

O b s e r v a t io n o f m a s t e r t e a c h e r s ( liv e o r o n v id e o t a p e )

70

S e m in a r s o n in s t r u c t io n a l s k ills c o n d u c t e d b y r e s e a r c h e r e x p e r t in
66

a r e a o f u n i v e r s i t y in s t r u c t io n
O b s e r v a t io n a n d c r it iq u e o f m y t e a c h in g b y e d u c a t io n a l c o n s u lt a n t s

64

A r t i c le s a n d r e s e a r c h r e p o r t s o n t h e i m p r o v e m e n t o f t e a c h in g

62

L e c t u r e s d e a lin g w i t h a s p e c t s o f t e a c h in g a n d h o w

th e y can

b e im p r o v e d

61

O b s e r v a t io n a n d c r it iq u e o f m y t e a c h in g b y f a c u l t y c o lle a g u e s

56

S e m in a r s o n c lin ic a l s k ills

55

O n e - t o - o n e c o n f e r e n c e s w i t h e d u c a t io n a l c o n s u lt a n t s t o d i s c u s s
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p a r t ic u la r i n s t r u c t io n a l c o n c e r n s

52

R e le a s e t im e t o w o r k a t i m p r o v in g m y t e a c h in g

46

R e s e a r c h o n t e a c h in g a n d le a r n in g

44
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• Determine the focus of evaluation;
that is, what is to be evaluated.
• Establish the sources of the evalua
tive information.
• Determine the methods by which
information can be gathered.
• Decide upon the technical properties
or quality of the information.
In proposing this model, three assump
tions need to be understood: (a) teaching
does make a difference, (b) teaching
behaviour is changeable and (c) evalua
tion of teaching is possible. Studies from
the literature3 indicate that all three
assumptions are valid.
Table 11-Rank Order of Importance for
Promotion and Tenure
ASE,
AAMC,
Activity
1983, %'
1977, %5
Research
62
67
Clinical service
30
19
Teaching
21
18

Rippey3 has added another dimension
to this model, namely, the importance of
ascertaining the goals (written or inferred)
of the institution. Robins4 pointed out
that “ Without institutional goals, each
medical school teacher is free to pursue
his or her own bent.” He suggested that
medical schools should inventory the cur
rent activities of their faculty, that these
activities should be related to the goals of
the school, that ambiguities and dis
crepancies in the goals should be clarified
and that evaluation of teaching should
reflect these reconsidered goals.
Shils recommended that the overall
goal or ethos of the institution should be
“ a serious commitment to the attainment
and teaching of important serious
truths” .3 Thus, research and teaching
are vital components of the goals of an
academic medical institution. Unfor
tunately, in the minds of faculty mem
bers, teaching is often placed well behind
other activities. In both the recent Associ
ation for Surgical Education1 and

Association of American Medical
Colleges5 surveys, the rank order of
importance of teaching in determining
promotion and tenure placed it well
behind research (Table II). Thus, in the
institution where research is a major goal,
it may be difficult to obtain a serious
commitment to teaching and to its
improvement.
Purpose o f Evaluation
Some of the purposes of faculty evalu
ation are to: improve instruction, provide
feedback for the teacher, determine pro
motion and tenure, evaluate the teaching
program, carry out research on teaching
and make decisions on the allocation of
teaching resources. It is important that
the purpose of the evaluation be made
clear at the outset. Also, the greater the
potential for harm to individual faculty,
the more rigorous must be the data col
lected by the evaluation. Evaluations that
are to be used for administrative decisions

Table Ill-Instructional Evaluation Sheet, Possible Items
□rganization/clarity
III. Enthusiasm/stimulation
Explains clearly
Has interest in and concern for the quality of his/her teaching
Is well prepared
Is a dynamic and energetic person
Gives lectures that are easy to outline
Has an interesting style of presentation
Seems to enjoy teaching
Summarizes major points
Is enthusiastic about the subject
States objectives for each session
Seems to have self-confidence
Identifies important points
Varies the speed and tone of voice
Makes good use of examples and illustrations
Has a sense of humour
Covers an amount of material appropriate to the allotted time
Seems interested in teaching
Presents material in an organized manner
Stimulates interest in the subject matter
Gives explanations that are clear and to the point
Attempts to stimulate creative abilities
Is careful and precise in answering questions
Is humorous at appropriate time
Clarifies thinking by identifying reasons for questions
IV. Knowledge
II. Group instructional skill
Is well informed on the material presented
Relates the material to other areas of knowledge
Answers questions carefully and precisely
Discusses recent developments in the field
Is available for individual help
Appears to possess a good mastery of the material
Welcomes questions from students
Discusses points of view other than his/her own
Encourages discussion
Contrasts implications of various theories
Invites criticism of his/her ideas
Presents origins of ideas and concepts
Knows if the students are understanding or not
Gives references for more interesting and involved points
Is aware when students are having difficulty understanding a topic
Presents facts and concepts from related fields
Presents or allows various points of view
V. Clinical supervision
Exhibits a sense of proportion and humour
Demonstrates clinical procedures
Encourages critical thinking and analysis
Provides practice opportunities
Encourages relevant student involvement
Offers professional support and encouragement
Welcomes student expression of varying viewpoints
Observes student performance
Is concerned with whether students have learned the material
Identifies student clinical strengths and weaknesses objectively
Appears receptive to new ideas and others' viewpoints
Provides feedback and positive reinforcement
Affords opportunities for student questions
Corrects students without belittling them
Invites students to share their knowledge and experience
VI. Clinical competence
Knows when students are bored or confused
Objectively defines and synthesizes patient problems
Has students apply concepts to demonstrate understanding
Demonstrates skill at data gathering, use of consultations and inter
Presents a sympathetic attitude towards students
preting laboratory data
Has a genuine interest in students
Manages clinical emergencies
Is friendly towards students
Works effectively with health-care team members
Relates to students as individuals
VII. Modelling professional characteristics
Recognizes and greets students out of class
Is self-critical
Is accessible to students out of class
Takes responsibility
Is valued for advice not directly related to the course
Recognizes own limitations
Respects students as persons
Shows respect and consideration for others
Questions students in a non-threatening manner
Does not appear arrogant
Establishes a good rapport with students
Seems to possess self-confidence
Demonstrates respect for students
Demonstrates sensitivity to others
I.
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affecting a faculty member’s career need
more discriminating measures than those
for improving instruction. Defining the
purpose of the evaluation system is there
fore a key consideration upon which sub
sequent decisions depend.
Simply evaluating teaching has little or
no effect on improving instruction.
However, studies3 have shown that
evaluations conducted early in the course,
when the instructor has time to make
changes, are more potent than late evalu
ations; student evaluations are more
effective when conducted in conjunction
with a teacher self-evaluation and in order
for feedback to be effective, faculty mem
bers must have some knowledge of stan
dards, otherwise they will not know
whether the ratings received are good, bad
or indifferent.
Focus o f Evaluation
The focus — what is to be evaluated
— may be on the following three areas:
• Input: for example, what the instruc
tor says and does, instructional material.
• Process: what the students do inter
nally with the teaching input.
• Output: the kinds and levels of learn
ing that the students obtain.
Input is the most common focus of
evaluation. It concentrates closely on the
involvement of the instructor in the teach
ing process. The instructor’s direct con
tribution can be assessed based upon his
or her teaching skills, knowledge and abil
ity to motivate students.
Sources o f Evaluation
Sources of evaluation are many but
may be grouped under the following: per
ceptions, process and product.
Perceptions. —These comprise student
STUDENTS PLEASE COMPLETE AMDRETURN TO THE SUBCERY UNDKNCRADUATE OFFICC.
THE UNIVERSITY OF MANITOBA
DEPARTMENT OF SURCERY
INSTRUCTIONAL EVALUATION SHEET

ratings, teacher self-ratings, peer ratings
and administrative ratings. Student rat
ings are the most popular sources for
evaluation since students are the only
direct daily observers of teaching and
therefore may constitute a valuable source
of information. They will be considered
in more detail later.
Process.—The second source of evalu
ation is observations made on the process
of teaching. In this regard, evaluations
may be made about the teacher’s exper
tise in the subject matter, his or her teach
ing skills, charisma, empathy and
judgement.
Product.—Product outcome is the stu
dent’s performance. However, if teachers
are to be evaluated solely on student
achievement, no teachers may survive.
Because of the difficulty in determining
what part of learning is attributable to
instructor actions, measurements of
product outcome are rarely used for
evaluation.
Student Ratings of Instruction

Methods: the Evaluation Instrument
According to Rippey,3 student ratings
are potentially reliable, valid and useful.
They are, of course, also unavoidable.
They work best for improving instruction
when they are given in conjunction with
teacher self-evaluation both during and
at the end of the course.
Advantages
The advantages of student ratings are
as follows:
• Generally, the data are easy and
inexpensive to collect.
• They are potentially reliable and
valid.
• They are often the only source of
evaluation based on direct ongoing con
tact with the instructor.
• When assistance with teaching skills
accompanies student ratings, improve
ment in instruction does result.

INSTITUTION ___________________________________
I I MED I

Q ] LECTURE

QU PATIENT PRESENTATION

FIG. 1—Evaluation form.

cal problem that demands faculty com
mitment and involvement in the rating
process.
• Data from the student rating instru
ments may discourage some teachers. In
this regard, it is important to keep in mind
the purpose of evaluation.
• The rating instruments are often of
poor standard. Unfortunately this often
is the case. Therefore, the rating system
must be carefully designed.
• Student ratings are merely a popular
ity contest. Research results suggest that
this statem ent is incorrect. Seldin6
reported six studies confirming that the
teachers who received the highest student
ratings were more than entertainers. They
were quality instructors.
Doyle summarized the literature on stu
dent ratings and came to the conclusion
that “ provided that the data are gathered
carefully, reported appropriately and
interpreted judiciously, student evalua
tions appear able to make useful contri
butions to course improvement” .

Criticism
Some of the criticisms of student rat
ings are:
• They are useless if given at the end
of the course when there is no time for
im provem ent. Feedback, therefore,
should be provided so that the proper
time is allowed for necessary improve
ments.
• Some faculty consider students
immature and hence unable to judge cer
tain aspects of teaching performance.
However, the quality of information that
can be collected from professionally con
structed rating instruments suggests that
this criticism may be invalid.
• Faculty may resist a system of stu
dent ratings of instruction. This is less a
criticism of the system than it is a tacti

The criteria for evaluating the surgical
undergraduate teacher’s performance
may fall under seven major headings
(Table III). A t the U niversity o f
Manitoba, 21 items were selected from
this list by surgical faculty and students
in preparing an instructional evaluation
sheet (Fig. 1). Students were asked to
assess the surgical instruction by these
criteria. Presently, surgical teachers at the
University of Manitoba are evaluated by
their students, using this evaluation form.
Implementation o f Student Ratings
It is suggested that the following
general principles should be considered in
implementing a student rating system of
teaching:
• Establish the purpose of the evalua
tion system. This is perhaps the most
important single step in developing the
system. Because so many strategic deci
sions are based on the purpose of the
evaluation, it is obvious that the purpose
must be established early and defined
clearly.
• Obtain faculty commitment to the
evaluation procedure.
• Develop a suitable instrument for
evaluation. In this respect, criteria for
evaluation need to be developed (Table
III). It is recommended that experts in
evaluation and measurement be consulted
to develop a suitable instrument.
• Anticipate resistance. Resistance to
any major change is to be expected. The
degree of resistance can be anticipated if
a faculty survey of attitudes towards var
ious methods of improving instruction,
including the use of student ratings, is
conducted. Candid and truthful informa-
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tion about the proposed evaluation pro
gram should be widely disseminated.
Question and answer sessions should be
encouraged. The evaluation program
should be regarded as experimental and
open to revision, and is best introduced
slowly. Throughout the entire evaluation
procedure, the privacy of the individual
instructor should be guaranteed.
• Apply the data. Data gathered from
the evaluation process should be related
to the original purpose of the evaluation.
If that purpose is to improve instruction,
the data should indicate what improve
ments seem necessary. This information
can then be used to indicate the direction
that changes must take. The data may
lead to reward for outstanding instruc
tion, a list of steps that an instructor can

take to improve ratings and teaching, a
list of available instruction resources or
a program of faculty development activi
ties directed at improving instruction. The
end result of the evaluation should be to
improve instruction.
• Reassess the evaluation program.
Opportunities for feedback are impor
tant. Constructive criticisms can be used
to improve the system and keep it rele
vant to the needs of all involved.
Conclusions

Concern about the quality of instruc
tion in medical schools has increased the
emphasis on the importance of evaluat
ing medical undergraduate teaching. Most
methods of evaluation are directed at the

performance of individual instructors
with the evaluative data frequently being
supplied by students. When carefully
planned and consistently implemented,
student ratings of instruction can make
a valuable contribution to the improve
ment of surgical undergraduate teaching.
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3. Development of the Undergraduate Teacher
Three components are necessary for
effective undergraduate teaching in a
department of surgery: (a) departmental
organization and membership priority
focused on teaching; (b) a clear under
standing and appropriate utilization of all
teaching methods, for example, lectures,
large seminars or demonstrations, small
seminars and bedside teaching; (c) the
acquisition and maintenance of teaching
and evaluation skills by all department
members. The author discusses the
advantages and disadvantages of the
four principal teaching methods and the
means of acquiring teaching and evalua
tion skills that includes the use of
professional educators.
Trois composantes sont necessaires a
I'efficacite de I'enseignement de premier
cycle dans un service de chirurgie: a)
une organisation de service et des membres orientes en priorite vers I'enseigne-

From the Department o f Surgery, Univer
sity o f Manitoba, Winnipeg, Man.

ment; bl une connaissance nette et une
utilisation appropriee de toutes les
methodes d'enseignement telles que
cours magistraux, grands seminaires ou
demonstrations, petits seminaires et
enseignement au lit du malade; c)
I'acquisition et le maintien par tous les
membres du service d'une competence
en enseignement et en methodes d eva
luation. L'auteur commente les avantages et desavantages des quatre principa
l s methodes d'enseignement et les
moyens d'acquerir des competences en
enseignement et en methodes devalua
tion, y compris I emploi d'educateurs
professionnels.

Development of the undergraduate
teacher has three basic requirements:
departm ental requirements, without
which the appropriate milieu for good
teaching will not occur; an understand
ing of the teaching methods involved in
the interaction between surgeons and stu
dents; the training of surgeons as
teachers.
Departmental Requirements
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First, all members of the department,
particularly the department head, must
consciously and outwardly acknowledge
undergraduate teaching as a vital compo
nent of their activities. With such recog
nition, it is incumbent on the department
to maintain yearly records that include all
the assigned teaching activities of each
member. Methods to evaluate the qual
ity of teaching must be developed. Teach
ing activity, both quality and quantity,

must be an essential component when
considering academic advancement.
All new surgical staff must be aware of
and accept their role as teachers of under
graduate students. Each should obtain
instruction on teaching methods within
the first year of joining the department.
All must be prepared to undergo evalua
tion of their teaching activities and to
have their skills upgraded at intervals.
Established staff surgeons must have
their teaching role evaluated, and as a
■result should: (a) continue if they are per
forming as expected by the department;
(b) be “ streamlined” ; that is, they should
be given undergraduate assignments that
are appropriate to their skills and
interests; (c) undergo upgrading of their
teaching skills or (d) be dropped from the
undergraduate teaching roster.
Surgeons who are in full-time academic
positions should develop and constantly
update a teaching curriculum vitae just as
they and others have developed a curric
ulum vitae that lists their scientific activi
ties. This will serve to remind them of
their responsibilities in undergraduate
teaching and also will be an objective
record of their pedagogic activities,
knowledge and skills.
Teaching Methods

There are four methods of teaching
with which most surgeons are involved:
lectures, large seminars or demonstrations
(25 or more students), small seminars (10
or fewer students) and bedside teaching.
All surgeons must be aware of current
methods of student evaluation, since the
method and style of evaluation influences
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the extent and content of what students
learn.
All four of these teaching methods have
similar requirements, if they are to be
effective. There must be conscious
preplanning, and this includes a list of the
aims and objectives, an outline to high
light the content of the teaching session
(brief notes may be appropriate), a care
ful selection of a few pertinent examples
(perhaps using appropriate audiovisual
techniques) and a time calculation to
allow for a resume of material presented.
The best style of presentation (a subject
in itself) should be chosen. Finally, no
teaching session should end without some
form of student and teacher evaluation.
The Lecture
When skilfully planned and performed,
this can be the best method of teaching.
However, when not planned seriously and
correctly, it can be an absolute disaster.
The lecture is very economical of surgeon
manpower. It allows the teacher to direct
both emphasis and content and it allows
presentation of unforgettable examples.
The disadvantages of the lecture method
are that the attention span of students sel
dom exceeds 15 to 20 minutes; many lec
tures suffer from too much detail; the
style of presentation is critical (some lec
turers are born with good style, many
develop effective style with care and hard
work, but a few may never develop the
skills of personal presentation that lead
to a good learning experience); and finally
the lecture is an experience in passive
learning — usually the students are not
actively involved mentally in solving a
problem or bringing the offered facts
towards some positive conclusion.
Large Seminars or Demonstrations
(25 Students or More)
The advantages of this method are that
the students can be actively involved in
learning, the instructor can direct the
emphasis of discussion and content and
there is opportunity for presentation of
unforgettable examples. However, group
dynamics are difficult (a group of more
than 10 people frequently leaves out many
members as participants); the seminar
must be repeated several times to take in
the whole class; the seminar increases sur
geon manpower requirements which can
lead to inconsistencies in presentation,
and students and teachers must be trained
in the dynamics of seminars.
Small Seminars (10 or Fewer Students)
This method provides an active learn
ing experience for all students. Group
dynamics are simpler and the instructor
has much greater personal contact with
individual students. Also there is oppor

tunity for instant feedback. The disadvan
tages of small seminars are that they must
be repeated many times, so surgeon man
power is greatly increased; complicated
meeting-space arrangements must be
made and usually more than one instruc
tor is involved, leading to even greater
inconsistencies in content and presen
tation.
When students and surgeons are
trained and com fortable with this
method, students usually prefer this
experience.
Bedside Teaching (Five or Fewer
Students)
The major advantage with this type of
teaching is that this is the Socratic method
by which most surgeons have learned
their clinical skills. Therefore, familiar
ity allows the instructor to be at ease.
These small-group sessions have all the
advantages of the small seminars with the
added advantage of a “ hands-on”
experience for the student. The major dis
advantage is the tremendous surgeon time
required to teach large classes. All the
other disadvantages of small seminars
apply with the addition that clinical sur
geons frequently have difficulty remem
bering the level o f student or instruction
that is needed — the emphasis when
teaching junior students how to perform
clinical skills is very different from that
when discussing patient management with
a group of clinical clerks.
Training of Surgeons as Teachers

Few physicians are born with the skills
necessary to give quality teaching to all
levels of medical students. Therefore,
improved undergraduate teaching re
quires that the instructors be educated in
teaching methods and skills. These teach
ing sessions for surgeons can be held out
side or within the university or depart
ment. They can include professional
educators or surgeons who have had
specific training. An essential component
is the evaluation of each surgeon’s teach
ing efforts to stimulate improvement in
areas where teaching skills may not have
been developed.
There are many different forms of
external training. Some universities have
held training courses, seeking attendance
by interested physicians and surgeons
from both inside and outside that partic
ular university. There are national and
international societies, such as the Associ
ation for Surgical Education, whose sole
purpose is to improve teaching and
promulgate better teaching methods. Sur
geons can learn these methods by attend
ing meetings of such societies or courses
or workshops arranged specifically for
that purpose.
Internal training, within the parent

university, may take place within the
faculty of medicine or another faculty. It
may take the form of courses or work
shops held annually. Universities, facul
ties or departments may have professional
educators. These may be physicians or
graduates of education faculties. Such
people can be an invaluable resource in
organizing courses and workshops, giv
ing personal assistance, and for individual
teacher evaluation. Also, they frequently
have skills in methods of audiovisual
presentation that can be valuable to sur
geon teachers. In many circumstances, the
use of videotape to play back an instruc
tor’s teaching efforts or time taken to play
various roles in a seminar situation can
be valuable aids in training surgeons for
their role as teachers. Again, evaluation
of teachers when done objectively and in
the right atmosphere is an important
teaching method.
Not to be forgotten is the acquisition
of knowledge and skills by every teacher
in methods of student evaluation. Evalu
ation by multiple-choice questions, short
answers or oral examinations will only be
adequate if the teacher-evaluator under
stands their nature, scope and limitations.
In essence, the format of methods used
for student evaluation has a very strong
influence on the style by which students
will study and learn; for example, they
will “ cram ” facts and practise “ wise
guessing” for multiple-choice questions
rather than learn principles which will
have to be put into practice to “ manage
a patient” for a short-answer test or oral
examination.
Conclusions

Development of surgeons as effective
undergraduate teachers requires three
components.
• That the department recognizes the
value of good teaching and creates a
milieu in which excellence in teaching is
encouraged.
• That all teachers understand the
methods they will be using to teach stu
dents and take the time to prepare teach
ing assignments appropriately.
• That unless surgeons take the time to
obtain training in the skills necessary for
effective teaching, and co n stan tly
upgrade these skills, the role of depart
ments of surgery in undergraduate edu
cation will never advance.
Lastly, a successful teaching session in
which the instructor has seen a group of
students understand a problem and learn
to apply that understanding in the solu
tion of other problems that they will meet
daily as clinical physicians, is every bit as
rewarding (and perhaps much more
important for the future) as experiencing
a patient’s smooth recovery following
successful surgery.
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Fatal, Overwhelming Sepsis After Splenectomy
in the Community Hospital
Charts of all patients who underwent
splenectomy between 1965 and 1981 at
the Orillia Soldiers' Memorial Hospital
were reviewed. At the end of 1983, the
patient, relatives or family physician
were contacted for follow-up. Eighty
spleens were removed, 36 for medical
reasons, 30 for trauma and 14 because
of iatrogenic injury. Of the patients fol
lowed up, 51 were alive and 13 had
died. Three died in the postoperative
period and seven died of unrelated
causes. Three patients died of over
whelming sepsis, 1, 3 and 7 years after
splenectomy. If the three postoperative
deaths are excluded and it is assumed
none of the 16 untraced patients died of
overwhelming sepsis, the incidence of
death from this cause was 3.9% .
Les dossiers medicaux de tous les
patients qui subirent une splenectomie
au Orillia Soldier's Memorial Hospital
entre 1965 et 1981 ont ete passes en
revue. Puis, a la fin de 1983, on est
entre en relation avec les patients, leurs
proches ou leur medecin de famille pour
fins de controle.
Quatre-vingt rates avaient 6te enlevees, 36 pour des raisons medicales,
30 a cause d'un traumatisme et 14 pour
lesions iatrogenes. De tous les patients
pour qui un controle fut possible,
51 vivaient encore et 13 etaient deci
des. Trois patients ont succombe dans la
periode postoperatoire et sept sont morts
de causes n'ayant aucun rapport avec la
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splenectomie. Trois patients sont morts
d'infection fulgurante, respectivement
1, 3 et 7 ans apres la splenectomie. A
I'exclusion des trois deces postoperatoires, et en supposant qu'aucun des
16 patients qui ne purent etre retraces
ne soit mort d’infection fulgurante, la
frequence des deces attribuables a cette
cause de fut de 3.9% .

In 1678, Nicholaus Matthias, town sur
geon of Colberg, carried out the first
known splenectomy for trauma. He
reported that the patient was well 6 years
later. For centuries, splenectomy was con
sidered an innocuous procedure with
obvious salutary results. The first warn
ing that the spleen may have an impor
tant and irreplaceable function came in
1919 when Morris and Bullock1 reported
that splenectomized rats had a higher
mortality from plague than their normal
counterparts. In 1952, the first case
reports of death from sepsis following
splenectomy in children appeared,2 and
by 1973 this was a recognized phenome
non in children, associated with a mor
tality of 2.5% .3 The first reports of simi
lar phenomena in adults appeared in
19774 and by 1981 it was well recognized
that both groups shared a reported mor
tality of 2.4% .5 By comparison, Miller
and associates6 studied 1000 normal
families for 5 years and found an overall
serious sepsis rate of 0.1% with no
deaths. Robinette and Fraumeni7 com
pared 740 splenectomized veterans to
similar nonsplenectomized counterparts
and found six instances of fatal pneumo
nia in the splenectomized group but none
in the control group.
Evidence is beginning to accumulate
that splenectomy places the patient at
increased risk of death from overwhelm
ing sepsis. The present study was under
taken to document the incidence of such
death in a community hospital, to com
pare this incidence to that reported, to
add this epidemiologic data to the litera
ture and to examine whether only immu
nocompromised patients were at risk or

whether “ normal” patients were also
affected by splenectomy.
Patients and Methods
From the Department of Pathology of
the Orillia Soldiers’ Memorial Hospital,
we retrieved the charts of all patients who
had undergone splenectomy from Jan. 1,
1965 to Dec. 31, 1981. Splenectomy was
considered medical when it was carried
out electively in the absence of injury to
the spleen. Splenectomy for splenic injury
was considered surgical; injury caused by
preoperative trauma was classified as
traumatic, whereas injury to the spleen
caused by inadvertent misadventure dur
ing the course of abdominal surgery was
classified as iatrogenic. Arbitrarily, we
decided to include in the iatrogenic group
those spleens removed as part of a
planned procedure unrelated to the spleen
(splenectomy concomitant with total pan
createctomy or total gastrectomy). An
attempt was made to follow up all
patients to the end of 1983. Telephone,
mail and the insuring agent were used to
trace and contact the patient, the family
or family doctor to ascertain the patient’s
status. The cause of death was reviewed
from a transcript of available records of
those reported as dead.
Findings
During the 17 years under study 80
splenectomies were carried out at the Oril
lia Soldiers’ Memorial H ospital in
patients 17 to 82 years old; 36 splenecto
mies were for medical and 44 for surgi
cal reasons. Of the latter group, 30 were
for traumatic injuries and 14 iatrogenic
(Table I). Follow-up revealed that 51
patients were alive at the end of 1983. Six
teen patients could not be traced. Thir
teen patients had died since their splenec
tomy. Three died in the immediate
postoperative period of complications of
their injury or associated operation; .of
the other 10 who died, 3 died of over
whelming sepsis (Table II). Six of the 13
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deaths occurred in other institutions.
Excluding the three patients who died in
the postoperative period, the minimal
mortality from overwhelming sepsis fol
lowing splenectomy in this review was
3.9%. Death from overwhelming sepsis
occurred once in each of the three
categories, medical, traumatic and iatro
genic, 1, 3 and 7 years after splenectomy.
Pneumococcus was the infecting organ
ism in each case. The following brief
reports outline the clinical findings in
patients in the series who died of sepsis
or whose death was associated with infec
tion. The case numbers refer to those in
Table II.
Case Reports

Death From Overwhelming Sepsis
Case 3. —A 79-year-old man underwent
splenectomy in 1980 as the result of splenic rup
ture from a motor vehicle accident. In 1983 he
was admitted to another hospital with non

specific symptoms. A rapid downhill course
ensued; he died within 48 hours of admission.
No specific diagnosis was made. Autopsy rev
ealed bilateral pneumococcal pneumonia.
Case 9. —A 59-year-old woman underwent
hiatal hernia repair in 1973. Inadvertent splenic
injury led to a concomitant splenectomy. In
1980 she came to the emergency department
complaining of nausea and headache. Apart
from a temperature of 37.9°C, no specific ab
normalities were noted. She was treated symp
tomatically and released. Eight hours later she
was brought back dead. Autopsy showed
extensive bilateral pneumonia and bilateral
adrenal hemorrhage. Blood cultures grew
Streptococcus pneumoniae.
Case 13.—A 23-year-old woman underwent
elective splenectomy in 1980 for idiopathic
thrombocytopenic purpura, unresponsive to
medical management. In 1981 she was admit
ted to another hospital with assumed urinary
tract infection during pregnancy. Because of
poor response to treatment, she was referred
to a tertiary care centre where she was deli
vered. Pneumonia was diagnosed and she died

of septic shock and pneumonia, confirmed by
autopsy.

Infection Contributing to Death
Case 2.—A 21-year-old man underwent
splenectomy, repair of a ruptured stomach and
bilateral ruptured diaphragm because of
trauma. Extensive irrigation and drainage of
the contaminated abdomen and both chest
cavities were carried out. Despite large doses
of broad-spectrum antibiotics, he became sep
tic 24 hours after operation; control of the sep
sis was impossible. He was transferred to a ter
tiary care centre where a subsequent operation
for drainage of the abdominal and thoracic
cavities was carried out. Body wall infection
ensued and debridement was carried out. Nine
days after injury he died in septic shock from
sequelae of uncontrolled sepsis.
Case 7.—A 78-year-old woman underwent
esophagogastrectomy and splenectomy for
proximal gastric carcinoma. Histologic exami
nation showed multicentric cancer with
microscopic cancer at the resection line. Four
months postoperatively, she underwent exci
sion of the remaining stomach and pouch for
mation. She did well for the first 48 hours
postoperatively and then deteriorated rapidly
with acidosis, oliguria and hypotension and
died within 2 hours of the onset of symptoms.
Autopsy revealed suppurative pancreatitis as
well as postoperative atelectasis and minor
pneumonia. No cultures were obtained.
Case 8.—A 21-year-old retarded woman
underwent total gastrectomy and splenectomy
because of volvulus of the stomach with infarc
tion of both stomach and spleen. Subsequently,
a stricture formed at the esophagoduodenal
anastomosis, she failed to thrive and lost
weight. Although dilatations were effective, she
continued to regurgitate and died of aspiration
pneumonia before corrective procedures could
be carried out.
Case 12.—A 68-year-old man underwent
splenectomy for idiopathic thrombocytopenic
purpura. Three years later he was hospitalized
at a tertiary care centre with small-bowel
obstruction due to adhesions. The bowel per
forated and after a difficult postoperative
course he died.

T a b le I I — C lin ic a l D a t a o n P a t ie n t s W h o D ie d A f t e r S p le n e c t o m y
S u r g ic a l in d ic a t io n s

G ro u p
Im m e d ia t e
p o s to p

T ra u m a tic , c a s e n o . -

Ia t r o g e n ic ,

c a u s e /t im e lc a u s e o f d e a t h

c a s e n o . — c a u s e /t im e lc a u s e o f d e a th

1 — M V A . D ie d 5 d p o s t o p o f

4 — T o ta l

a s s o c ia t e d in ju rie s

p a n c re a te c to m y .

M e d ic a l in d ic a t io n s , c a s e n o . -

D ie d

9

d

c a u s e /t im e lc a u s e o f d e a th

p o s to p .

S e q u e la e o f h e m o r rh a g e

2 — M V A . D ie d 9 d p o s t o p o f
s e p s is
S u b s e q u e n t,

5 — LH f o r c a n c e r . D ie d 2 y r p o s t o p o f m e t a s -

u n r e la t e d

ta s e s

d e a th

6 -

LH f o r c a n c e r . D ie d 4 y r p o s t o p , C V A

h e a r t f a ilu r e

a n d s p le n e c to m y . E x c is io n o f re m a in in g s to m a c h .
D ie d 4 m o p o s t o p o f s u p p u r a t iv e p a n c r e a t itis

s e p s is
MVA
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*

3 — M V A . D ie d 3 y r p o s t o p
o f p n e u m o n ia

m o to r v e h ic le a c c id e n t , L H -

9 -

T o t a l g a s t r e c t o m y a n d s p le n e c to m y f o r in f a r c 

H ia t a l

h e rn ia

r e p a ir .

D ie d

7

yr

p n e u m o n ia

le f t h e m ic o le c t o m y , C V A -

c e r e b r o v a s c u la r a c c id e n t, IT P

p o s to p

1 1 — R e tic u lu m c e ll s a r c o m a .
D ie d 9 m o p o s t o p o f s a r c o m a
12 —

t io n o f s t o m a c h a n d s p le e n . D ie d 2 V i y r p o s to p
o f a s p ir a t io n p n e u m o n ia
O v e r w h e lm in g

H e m a c h r o m a t o s is a n d H y p e r

s p le n is m . D ie d 4 y r p o s to p o f

7 — P ro x im a l g a s tr ic c a n c e r. E s o p h a g o g a s tre c to m y

8 -

10 -

of

IT P .

D ie d

3

y r p o s to p o f

b o w e l p e r f o r a t io n a f t e r s m a llb o w e l o b s t r u c t io n d u e to
a d h e s io n s
13 —

IT P .

D ie d

1

y r p o s to p

of

p n e u m o n ia
-

id io p a t h ic t h r o m b o c y t o p e n ic p u rp u ra .
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Discussion
This study confirms that overwhelming
sepsis after splenectomy is a real, lethal
entity in the adult population. The mini
mum mortality is unexpectedly high at
3.9%. Death is one of the leading reasons
for inability to trace patients in such ser
ies; there may be other patients among
our 16 lost to follow-up who have died
of overwhelming sepsis. Although it is
reported that most deaths from this cause
occur within the first 2 years after splenec
tomy, only one of our patients died dur
ing this time. The longest interval was 7
years; death has been reported 25 years
after splenectomy. Thus, it is quite pos
sible that continued follow-up of the sur
vivors may yield more deaths in the
future. At the conclusion of our study,
all patients, families or family doctors
were warned of this hazard so that the
patients could be immunized or receive
antibiotic protection, or both. Since these

protective measures are now becoming
routine, the incidence of overwhelming
sepsis following splenectomy may be
markedly altered in the future.
This study does not clearly exclude the
contribution of an immunocompromised
state to death from overwhelming sepsis
after splenectomy. The immune response
becomes depressed with advancing age.
Patient no. 3 was 83 years old at the time
of death, but patient no. 9 was only 66
years old. Patient no. 13 was 24 years old
and suffered from idiopathic throm 
bocytopenic purpura, a condition not
generally associated with a depressed
immune response. Although she had been
treated with steroids, which suppress the
immune response, the drugs had been
withdrawn more than 1 year before her
death. Thus, we believe that healthy
patients as well as the immunocom
promised are at risk of overwhelming sep
sis after splenectomy.
In view of the unexpectedly high mor

tality from overwhelming sepsis, we
believe that if conditions permit, efforts
to conserve traumatically injured spleens
should be encouraged, even in the smaller
community hospital.
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Management of Pancreatic Trauma
Between 1974 and 1984, 25 patients
with pancreatic trauma were seen at
three Regina hospitals. Eighteen had
blunt injuries and 7 penetrating injuries.
The mean injury severity score was 37
and the mean age 24.5 years.
Management was nonoperative in six
patients. Of the 19 treated surgically, 14
underwent laparotomy and drainage, 2
laparotomy without drainage and 3 pan
creatic resection.
Complications related to pancreatic
injury occurred in 11 patients. One
patient died.
The results of this series suggest that
the majority of patients with pancreatic
injuries can be treated by laparotomy
and drainage with a low mortality, but
the complication rate is high. In select
patients, visualization of the pancreatic

duct may allow the surgeon to perform
definitive surgical management at the ini
tial procedure.

Accepted fo r publication Dec. 27, 1984

Entre 1974 et 1984, 25 victimes de
traumatisme pancreatique ont ete vus
dans trois hopitaux de Regina. Dix-huit
patients avaient subi des contusions
alors que 7 presentaient des plaies. La
cote moyenne de gravite des blessures
etait de 37 et I'age moyen des patients
etait de 24 .5 ans.
Six patients ont recu un traitement
non chirurgical. Des 19 operes, 14 ont
subi une laparotomie avec drainage,
2 une laparotomie sans drainage et 3 une
resection pancreatique.
Des complications des lesions pancreatiques sont survenues chez 11 patients.
Un patient est decede.
Dans ce groupe, les resultats indiquent
que la majorite des victimes de blessures
pancreatiques peuvent etre traitees par
laparotomie avec drainage. La mortalite
est faible mais le taux de complications
est eleve. Chez des patients choisis, la
mise en evidence du canal pancreatique
peut permettre au chirurgien d'effectuer
une reparation definitive des I'intervention initiale.
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This paper retrospectively studies 25 cases
of pancreatic trauma seen at three Regina
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hospitals between 1974 and 1984. The
objective was to review patient manage
ment and to identify areas for improve
ment.
Patients were included if they sustained
blunt or penetrating trauma to the abdo
men. Pancreatic injury must have been
identified by radiologic studies, intraoperatively or at autopsy, or by clinica, - 1
dence of pancreatitis. Patients were also
included if they had complications related
to pancreatic traum a which was unrecog
nized initially.
Patients
The 25 patients (18 men, 7 women) had
a mean age of 24.5 years. Eighteen
suffered blunt traum a and 7 penetrating
trauma. The mean injury severity score
was 37. Twelve patients were in shock at
the time of admission.
Findings
Diagnosis
The diagnosis of pancreatic trauma was
made by laparotomy in 18 patients, a per
sistent elevation of the serum amylase
level and a clinical course o f posttraumatic pancreatitis in 1, by endoscopic
retrograde cholangiopancreatography
(ERCP) in 3 and at autopsy in 1. In two
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cases, other radiologic studies (ultra
sonography, computerized tomography,
angiography) were used.
Distribution
The injuries to the pancreas were dis
tributed as follows: body (seven patients),
head (five), tail (four) and neck (three).
In six patients, more than one region was
involved; they included two patients
whose entire pancreas was traumatized
(Fig. 1). In blunt trauma, the most com
monly injured region of the pancreas was
the body, with the remainder of injuries
being evenly distributed to the other
regions. Penetrating trauma was evenly
distributed to all regions of the pancreas.
Grading

according to the classification of Northrup and Simmons' as follows: grade 1 —
minimal pancreatic injury that requires
simple drainage, grade 2 — significant
pancreatic injury with ductal involvement
and grade 3 — combined pancreatic and
duodenal injuries (Table I).
Associated Injuries
For blunt injuries, 50% of the patients
suffered a significant thoracic injury such
as flail chest or pulmonary contusion
(Table 11); 25% also suffered a diaphrag
matic rupture. Three patients had major
vascular injuries; one patient had a por
tal vein laceration, one patient had com
bined avulsion of the renal artery, renal
vein, superior mesenteric artery and
inferior mesenteric vein, and the third had
partial avulsion of the celiac axis.

Our patients in this survey were graded
Table II—Associated Injuries in 12 Patients
With Blunt Trauma*
Type of injury
Thoracic
Liver laceration
Diaphragmatic rupture
Major vascular injury
Duodenal perforation
Splenic rupture
Head injury
Skeletal trauma
Small-bowel perforation
Colonic perforation
Renal trauma
Mesenteric tear

No.

%

6
5
3
3
2
2
2
2
1
1
1
1

50
40
25
25
16
16
16
16
8
8
8
8

*ln 6 patients with delayed presentation, the
associated injuries were not known.

FIG. 1—Distribution of traumatic injuries
to pancreas.

Table Ill-Associated Injuries in
Seven Patients With Penetrating Trauma
Type of injury
Liver laceration
Stomach perforation
Renal injury (minor)
Duodenal perforation
Major vascular injury
Splenic laceration
Skeletal trauma

Table 1—Classification of
Pancreatic Injuries
Grade
Type of injury

1

2

3

Penetrating
Blunt

4
9

1
8

2
1

No.

%

6
4
3
2
2
1
1

86
57
43
28
28
14
14

For penetrating trauma (Table 111),
associated injuries included stomach and
duodenal perforations, major vessel
injury and splenic laceration. Six patients
had minor liver lacerations.
Management
Initial management was nonoperative
in 6 patients and operative in 19. In 14
patients, laparotomy and drainage of the
lesser sac were carried out, 2 patients had
laparotomy without drainage and in 3 the
pancreas was resected.
Two of the patients initially managed
by laparotomy and drainage had com
bined pancreatic and duodenal injuries.
One patient had an associated duodenal
diversion procedure for duodenal trauma
and the other patient with combined
injury ultimately required a pancreaticojejunostomy for pancreatic fistula.
For the patients who underwent pan
creatic resection, two had distal pan
createctomies for blunt trauma and one
had pancreatoduodenectomy for a
penetrating injury to the duodenum and
pancreas.
Complications
In the nonoperative group there were
six pancreatic complications. Pseudocysts
developed in four patients, one patient
had both a pseudocyst and fistula and
another had post-traumatic pancreatitis.
Investigation of four patients by ERCP
showed pancreatic duct abnormalities
consistent with post-traumatic deformity.
In patients in the operative group who
had laparotomy with drainage, four pan
creatic complications occurred — three
fistulas and one pseudocyst. Investigation
of three of these patients by ERCP
showed pancreatic duct abnormalities
related to previous trauma. There were no
complications in the two patients who
underwent laparotomy without drainage.
In one of the patients who had pancreatic
resection, a pancreatic abscess developed.
There was one death due to associated
injuries.

Table IV-Summary of Other Reported Series of Pancreatic Trauma
Series
Graham and colleagues2
Jones3
Stone and colleagues4
Freeark and colleagues5
Sheldon and colleagues6
Wilson and colleagues7
Heitsch and colleagues8
White and Benfield9
Berni and colleagues10
Cogbill and colleagues11
Present series

360

Review
period

No. of
patients

Penetrating
trauma

No. of
deaths

Blunt
trauma

No. of
deaths

Overall
mortality, %

Pancreatic
complications, %

1 9 4 0 -1 9 7 7
1 9 5 0 -1 9 7 7
1 9 5 1 -1 9 8 1
1 9 5 2 -1 9 6 1
1 9 5 2 -1 9 6 8
1 9 5 6 -1 9 6 5
1 9 6 3 -1 9 7 4
1 9 6 5 -1 9 7 1
1 9 7 1 -1 9 8 1
1 9 7 9 -1 9 8 2
1 9 7 4 -1 9 8 4

44 8
300
283
82
56
84
100
63
54
44
25

348
22 6
22 4
59
33
45
77
36
28
29
7

58
46
29
10
10
12
27
5

100
74
59
23
23
39
23
27
26
15
18

15
13
10
5
6
15
2
1

15.6
20
13.8
17
29
32
29
10
9
18
4

45
10
13

_
0

_
1

30
30
44
48
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None of the other 24 patients had sig
nificant sequelae.
Discussion
The results of this series are compara
ble to those of other reported series with
regard to morbidity and mortality (Table
IV211). A lower proportion of penetrat
ing injuries and a higher proportion of
blunt injuries were seen, which reflects the
lower frequency of violent crimes and a
higher frequency of industrial and motor
vehicle accidents in our area. Twenty-four
percent (6 of 25) of patients were initially
managed nonoperatively and 76% (19 of
25) were managed operatively.
Laparotomy in traumatized patients is
generally undertaken because of unex
plained hypotension, an acute abdomen
or a positive peritoneal lavage. Because
of the inherent difficulties in determining
the presence of pancreatic injury preoperatively (especially a solitary pancreatic
injury12), the diagnosis is frequently
made during surgery, which is indicated
by injury to other organs.3,4,12 This was
the case in 18 of the 25 patients reviewed
in this series.
Multiple-organ injury is frequently
associated with pancreatic injury.2'4,12
The nature and extent of associated inju
ries affects not only the prognosis,2'4,12
but also the choice of surgical procedure
used in treating the pancreatic injury.
The majority of patients with pan
creatic injuries treated surgically in this
series underwent only drainage of the
lesser sac (14 of 19 patients). Several of
these injuries were severe (four grade 2,
two grade 3) and although the pancreatic
complication rate was high, the overall
mortality was low (4%). In view of this
low mortality, for those patients whose
general condition is unstable, adequate
drainage of the lesser sac is an acceptable
alternative in treating a pancreatic injury,
particularly when more difficult and timeconsuming procedures might jeopardize
the patient’s life.
Berni and associates10 noted a reduc
tion in pancreatic complications (fistula,
abscess, pseudocyst, pancreatitis) from
55% to 15% after the routine intraoper
ative use of pancreatography was insti
tuted. No postoperative deaths were
reported during that period. These results
are attributed to definitive surgical
management at the initial laparotomy,
which ductal evaluation allows the sur
geon to perform.
In our series, there were major pan
creatic complications in 48% overall and
in 27% (4 of 14) of patients who under
went laparotomy and drainage of the
lesser sac. In three of the latter cases,
delayed ERCP showed pancreatic duct
disruption (in one case ERCP was not
performed). We believe, therefore, that

in selected cases if the pancreatic injury
is strongly suspected and if the patient is
hemodynamically stable, intraoperative
pancreatography may aid the surgeon in
his choice of surgical procedure and
thereby improve the patient’s outcome.
Occasionally, there are cases in which
a delayed diagnosis of pancreatic injury
is entertained.13,14 The patient may have
suffered a solitary injury to the pancreas
caused, for example, by a bicycle handle
bar. The patient may present with con
tinuing abdominal pain, persistent eleva
tion of the serum amylase level or a
pseudocyst. Evaluation of the pancreatic
duct by ERCP early in the post-traumatic
period may demonstrate ductal disrup
tion, which would be a clear indication
for surgical intervention.
Conclusions
This series has shown that the majority
of patients with pancreatic trauma can be
managed by pancreatic drainage with a
low mortality. However, in accepting
drainage as the initial surgical procedure,
the surgeon must accept a high rate of
pancreatic complications. In select
patients, major ductal disruption can be
identified at the initial operation, allow
ing definitive surgery at that time.
A delay in diagnosis of major pan

creatic injury leads to a high rate of pan
creatic complications.
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SESAP IV Critique
ITEM 12
Barrett’s esophagus should be suspected in patients with strictures of the mid
portion of the esophagus. However, the stricture is seldom in the upper third
of the esophagus or above the level of the arch of the aorta. It occurs at the
junction of squamous and columnar epithelium. Esophagitis is present at the
level of the stricture. A Barrett’s ulcer, which is occasionally seen, occurs just
below the squamocolumnar junction in the columnar-lined segment of the
esophagus. A sliding esophageal hiatus hernia is present and believed to be part
of the etiology. Acid peptic reflux, esophagitis, and a gradual replacement of
the denuded squamous-lined esophagus by rapidly growing gastric mucosa are
noted. The risk of malignancy in Barrett’s esophagus has been reported to range
from 8% to 26%.
,— ,
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between 4 and 9 times more potent than cimetidine. Inhibition of gastric acid secre
tion has been observed following intravenous, intraduodenal and oral admin
istration of ranitidine and it is dose related, a maximum response being achieved at
an oral dose of 150 mg.
Pepsin secretion is also inhibited but secretion of gastric mucus is not affected.
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Etiology of Choledochal Cysts: Two Instructive Cases
The etiology of choledochal cysts is con
troversial. The authors report two cases
which show that type 1 cysts (axial dila
tation of the common bile duct and
common hepatic duct) may be caused by
a biliary web and that some
choledochoceles (type 3 cyst) may actu
ally be duodenal duplications (i.e., having
an outer wall of smooth muscle lined
with gastrointestinal mucosa and being
adherent to the gut).
L'etiologie des kystes du choledoque est
contestee. Les auteurs decrivent deux
cas qui demontrent que les kystes de
type 1 (dilatation axiale du choledoque et
du canal hepatique commun) peuvent
etre causes par un voile biliaire alors que
certains choledochoceles (kystes de type
3) sont possiblement des duplications
duodenales (c. a d. qu'ils ont une paroi
exterieure de muscle lisse tapissee par
une muqueuse gastro-intestinale et qui
est adherente a I'intestin).

ing 3 years. There was no history of jaundice
or change in the colour of urine or stool.
On physical examination, tenderness with
guarding was noted in the right upper quad
rant. There were no other positive physical
findings. Results of routine liver-function tests
were normal. Ultrasonography showed a layer
of “ sludge” in the gallbladder. The common
bile duct was not dilated and no stones were
seen in the gallbladder or the common bile
duct. Oral cholecystography showed a “ non
functioning” gallbladder on 2 successive days.
The p atien t was advised to undergo
cholecystectomy but refused and was dis
charged. She did not return for follow-up.
The patient presented 2'h years later with
sudden onset of epigastric pain which radiated
around both sides to her back. In the interven
ing time, she had noticed dark urine on several
occasions, but she had not been jaundiced.
On physical examination, there was tender
ness in the right upper quadrant with guard
ing and, again, no other abnormal physical
signs. The leukocyte count was 15.2 x 109/L ,
the serum glutamic oxaloacetic transaminase
level was 144 U /L (normal less than 40 U /L )

and the alkaline phosphatase 195 U /L (normal
less than 100 U /L ); the total serum bilirubin
level was 90 /rmol/L, most of which was direct
reacting. The serum amylase level was normal.
A bdom inal u ltra so n o g ra p h y show ed
enlarged hilar bile ducts. The gallbladder did
not contain stones or sludge.
A percutaneous cholangiogram (Figs. 1 and
2) showed that the common hepatic duct was
dilated (diameter 2 cm). The duct appeared to
narrow superiorly towards the bifurcation (Fig.
1) and to be bulbous close to the junction of
the common hepatic and common bile ducts.
The common bile duct appeared norm al and
dye entered the duodenum. The cystic duct was
long and tortuous. No stones were seen in the
gallbladder (Fig. 2). The main right and left
hepatic ducts also appeared normal.
At laparotomy, a small, firm mass was felt
in the porta hepatis. The common hepatic duct
was dilated and bulbous at its lower end where
it joined a common bile duct that looked nor
mal. When the dilated common hepatic duct
was opened, it was found to end in a fine
mucosal web with a central orifice 2 mm in
diameter that communicated with the common

Choledochal cysts are rare, fascinating
lesions o f the biliary tract. There are
different types, which have been classi
fied by several authors.1'4 The origin of
these cysts is controversial. We present
two case reports that may help in under
standing the cause o f types 1 and 3
choledochal cysts.1,4

Case Reports
Case 1
A 70-year-old white woman complained of
epigastric pain lasting for 4 days. The pain radi
ated to the right upper quadrant and back and
was associated with nausea and vomiting. She
had had several similar episodes in the precedFrom the Department o f Surgery, Mount
Sinai Hospital, University o f Toronto,
Toronto, Ont.
Accepted fo r publication Jan. 7, 1985
Reprint requests to: Dr. S.M. Strasberg,
Ste. 1142, M ount Sinai Hospital, 600
University Ave., Toronto, Ont. M5G 1X5

FIG. 1—Case 1. Percutaneous cholangiogram shows that common hepatic duct is dilated
at lower end and tapers sharply at upper end. Hepatic ducts appear normal. Cystic duct is tor
tuous but empties into normal common bile duct. Dye entered duodenum readily.
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bile duct. A sound could not be passed up into
the left side of the liver from the opened com
mon hepatic duct. Choledochoscopy showed
that the left hepatic duct was extremely
stenotic. What had been taken as the left
hepatic duct on the percutaneous transhepatic
cholangiogram was in fact a branch of the right
hepatic duct that passed to the left. The orifice
of the true left hepatic duct was stenosed. The
incision in the common hepatic duct was
extended upwards through the stenosis and
many pigmented stones were evacuated from
the left hepatic duct. An opening was then
made in the left lateral hepatic duct in the
lateral segment of the left hepatic lobe after
its position had been located with a sound
introduced through the common duct. Many
more stones were removed through the second
incision. A T tube was placed in the left lateral
hepatic duct and a Roux-en-Y choledochojejunostomy was performed, anastomosing the
jejunum to the left hepatic duct, the area of
stricture and the common hepatic duct (Fig.
3). The gallbladder was also removed. It con
tained no stones.
The patient’s postoperative course was
uncomplicated. Two years after the operation,
she was asymptomatic and liver-function tests
gave normal results.

Comment
The filmy partition at the junction of the
common hepatic and common bile ducts com
pletely separated the lumina of the two struc
tures except for the small 2-mm opening. This
had led to moderate dilatation of the common
hepatic duct but had not obstructed bile
flow substantially. It is unlikely that this web

would have been discovered if the patient had
not had symptoms from the intrahepatic stric
ture and stones.
This case indicates that type 1 cyst may arise
as a result of a choledochal web or membrane.
In most o f these cases, the web would proba
bly not be demonstrable because by the time
it became symptomatic and surgery was indi
cated, secondary inflammation, ulceration and
even stone formation could have occurred and
obscured the original cause. It is impossible to
be sure of the cause of left hepatic duct stric
ture and stones, but a reasonable possibility is
the presence of a second congenital area of nar
rowing as the initial lesion.

the duodenal wall. The common bile duct and
pancreatic duct were cannulated and the medial
wall of the duodenum was incised over the
mass, revealing a cystic structure 5 cm in
diameter (Fig. 7). This structure was incised
and found also to have a mucosa and contain
many stones (Fig. 8). There was a small com
munication (1.5 mm) to the common bile duct,
which was closed. The duodenal wall overly
ing the cystic structure was excised with mar
supialization of the base to the duodenal wall.
The patient’s postoperative recovery was
smooth and 6 years later she is free of gastroin
testinal symptoms; results of liver-function
tests and upper gastrointestinal series are
normal.

Case 2
A 27-year-old white woman had a history of
intermittent, crampy, abdominal pain and
melena present for 1 week. On physical exami
nation, the right upper quadrant was mildly
tender and a mass was palpable in that area.
The hemoglobin level was 46 g/L. Ultrasono
graphy showed a cystic mass in the right upper
quadrant. At endoscopy, the gastric antrum
appeared to be twisted and the pylorus com
pressed. The duodenum could not be entered.
No mucosal lesions were seen. An upper gas
trointestinal series showed that the duodenum
was dilated with a large mass arising from the
posteromedial wall and a coiled-spring sign
typical of small-bowel intussusception (Fig. 4).
The intussusception later reduced spontane
ously (Fig. 5). Shortly after admission, an
arteriogram was performed (Fig. 6).
At operation, the intussusception was found
to be reduced. The duodenum was enlarged
and a cystic mass could be palpated through

FIG. 4—Case 2. Upper gastrointestinal ser
ies. Gastric antrum and pylorus are at upper
right corner. Duodenum is dilated and shows
coiled-spring sign.

FIG. 2—Case 1. Later film shows gallbladder filling. “ Point of communication” in dia
gram indicates site of small opening between common hepatic and common bile ducts found
at operation, not observation made on film.

FIG. 5—Case 2. Later film after reduction
of intussusception showing intraduodenal mass
arising from medial wall.

FIG. 3—Case 1. Postoperative T-tube cholangiogram. True main left hepatic duct can be
seen. Dye enters bowel through hepaticojejunostomy. For clarity, connection to bowel is not
shown on figure.

FIG. 6—Case 2. Hepatic arteriogram failed
to reveal site of hemorrhage but showed avas
cular area near duodenum.
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Comment
The cyst wall consisted of a well-developed
mucosal layer of duodenal type epithelium, a
lamina propria and muscularis mucosae. It also
contained submucosa and muscularis externa.
The latter was poorly developed but clearly
presented using stains for muscle. The speci
men also contained all layers of the true duode-

FIG. 7—Case 2. At operation, medial wall
of second part of duodenum can be seen
stretched over underlying cystic structure.
Large catheter has been inserted into lumen of
third part to indicate its position. Small
catheter enters ampulla.

num which had been excised where it had been
stretched over the cyst (Fig. 9).
This lesion, commonly referred to as a
choledochocele, presented with intussusception
resulting in blood loss over a 1-week period.
It was an example of a type 3 cyst.

Discussion

Biliary cysts were originally divided
into three groups by Alonso-Lej and as
sociates.1 Type 1, an axial dilatation of

FIG. 8—Case 2. Medial wall of duodenum
and cyst wall have been incised. Cyst was lined
by mucosa w hich grossly appeared identical to
duodenal mucosa. Metal sound enters bile duct
through ampulla and small white catheter is in
pancreatic duct. Stones contained in cyst are
shown.

the common bile duct and common
hepatic duct, is the most common type.
Type 2 is a saccular dilatation off the side
of the common bile duct and is less com
mon. Type 3, the choledochocele, is the
least common of the three original types.
Two additional types are now accepted:
Caroli’s disease is considered to be a type
of choledochal cyst.3 Todani and
colleagues4 described a fifth type which
combines intrahepatic and extrahepatic
cysts.
Our first patient had the common type
1 cyst that accounts for approximately
85% of choledochal cysts.5 Classically,
the cystic dilatation begins at the level of
the cystic duct and ends abruptly in the
lower common bile duct. The proximal
biliary tree may be slightly dilated but
usually the intrahepatic ducts are normal.
The distal common bile duct below the
abrupt termination of the cyst is usually
narrow.6 Type 1 cysts may extend into
the common hepatic duct and, in fact,
primarily involve this duct, as in our case;
the common bile duct may be normal dis
tal to the cyst.5

EPITHELIUM
AND LAMINA
PROPRIA
MUSCULARIS
MUCOSAE

MUSCULARIS
EXTERNA

------

___

MUSCULARIS
EXTERNA

SUBMUCOSA
MUSCULARIS
MUCOSAE
EPITHELIUM
AND LAMINA
PROPRIA •
—
FIG. 9—Case 2. Photomicrograph of duodenal and cyst walls. Note that all layers of intestinal wall are present in cyst wall although
muscularis externa of cyst wall is rudimentary. Trichome stain for smooth muscle was used. It colours smooth muscle red and fibrous tissue
green (left, original magnification X 20; right, original magnification X 35).
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The etiology of type 1 cysts is unknown
but it is reasonable to assume that they
are due to distal obstruction or a weak
ness of one section of the wall of the duct,
or both. Either factor could be congeni
tal or acquired. Although weakness of the
wall has been suggested by at least two
authors,1,2 there is no substantial evi
dence that this is the case. On the other
hand, there is evidence that distal obstruc
tion is important. Ono and colleagues7
found that the zone of distal narrowing
often described in cholangiograms from
patients with type 1 cysts is actually the
pancreatic duct. The common bile duct
appears to join the pancreatic duct several
centimetres proximal to the ampulla.7'9
This anomalous junction was present in
58% of adult type 1 cysts. The case
reported here likewise suggests that type
1 cysts can be caused by obstruction. To
our knowledge, this is the first report of
a web being responsible for this lesion.
A second similarity to Ono’s observations
is that the point of obstruction in our case
was also at the junction of ducts. Ono and
associates described the obstruction as
being at the point where the common bile
duct joins the pancreatic duct. In our
case, it was where the common bile duct
bifurcated into the cystic duct and the
common hepatic duct.
Whether the 42% of type 1 cysts not
due to the anomalous common bile ductpancreatic duct junction, described by
Ono and associates, might be due to
mucosal web in the common bile duct
would be very difficult to ascertain. Most
type 1 cysts are causing symptoms when
they are diagnosed. Inflammation, ulcer
ation and stone formation secondary to
obstruction would likely preclude any ac
curate estimation of the initiating cause,
if it were a web. Our observation was pos
sible only because a second, symptomat
ic lesion was present.
The presence of biliary calculi in con
genital cysts is not unusual.10 Approxi
mately 90% of patients older than 30
years have stones in their cysts. There also
seems to be an association between biliary
cysts and intrahepatic calculi, especially
in the left hepatic duct.9 The treatment
of type 1 cysts has been reviewed exten
sively in the literature and will not be
repeated here. The value of making a
counter-incision in the left hepatic duct,
well out into the biliary tree, for intra
hepatic stones is perhaps worth emphasiz
ing.11 This maneuver is frequently easy
and permits backflushing and endoscopy
of the distal biliary tree, and generally
facilitates removal of all the stones in this
difficult situation.
Our second case report brings the num
ber of choledochoceles reported in the
world literature to 21. Various names
have been given to this cystic dilatation
of the terminal bile duct. Alonso-Lej and
colleagues1 classified it as a type 3
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choledochal cyst, implying that it arises
from the choledochus. Recently, several
authors12' 15 have questioned the origin of
this anomaly because of differences in
epidemiologic findings, clinical presenta
tion and, most importantly, pathological
features when compared with other
biliary cysts. Flanigan5 has pointed out
that the choledochocele usually occurs in
older patients than do other biliary cysts.
Ninety-two percent of all biliary cysts oc
cur in patients younger than 30 years but
the mean age for the choledochocele is 32
years.12'13 The most frequent symptoms
in type 1 cysts are jaundice 64%, abdomi
nal mass 58% and pain 55%. However,
in patients with choledochoceles, abdomi
nal pain is uniformly present and usually
associated with nausea and vomiting;
jaundice has been reported only in 25%
of cases and in only two cases (9%) was
there a palpable mass.12'13 Four patients
had recurrent pancreatitis14 and one
presented with melena.15 In our case,
bleeding was associated with a smallbowel intussusception, whereas in the
other patient who presented with this
symptom, the problem was diffuse inter
stitial hemorrhage in the cyst wall.14
There was no hemorrhage in the cyst wall
in our case. To our knowledge, this is the
first case in which intussusception was
associated with a choledochocele.
The are too few cases of choledo
chocele to be sure of the best method of
diagnosis. Ultrasonography, upper gas
trointestinal series, endoscopy and com
puterized tomography are all used. Arteri
ography is not usually required and was
performed in our case as a very early
investigation because the patient pre
sented with gastrointestinal bleeding and
endoscopy did not reveal the cause of the
hemorrhage. Intravenous cholangiogra
phy has been used to demonstrate the
communication between the cyst and the
biliary tree;13 however, this is an incon
sistent way to make the diagnosis.12
The major reason for reporting this
case is to discuss the origin of this type
o f choledochal cyst. Scholz and
colleagues13 have pointed out that there
appear to be two varieties. In one there
is an axial dilatation along the length of
the common bile duct within the duodenal
wall and in the other a saccular dilatation
off the side of the common bile duct
within the duodenal wall. Wearn and
W iot12 reported on the mucosal histol
ogy of the choledochocele in 20 cases. If
our case is included, then 14 of the 20
were lined by duodenal mucosa, 4 by
biliary mucosa, 2 by a combination and
in 2 cases,15 the mucosa was not
described.
Several theories have been proposed for
the etiology of these lesions. Wheeler16
suggested that the cause is similar to that
of a ureterocele with obstructive balloon
ing of the intramural segment of the com

mon bile duct. Sterling17 demonstrated
four diverticula of the distal common bile
duct in 17 cadavers. This suggests that it
may form as a congenital choledochal
cyst, but involving the intramural segment
of the common bile duct. Scholz and
colleagues13 suggested that it was a pul
sion diverticulum produced by contrac
tion of the common bile duct and ampullary components of the sphincter of Oddi.
Any one of these theories could explain
the choledochoceles lined with biliary
mucosa but do not explain the cause of
cysts lined with duodenal mucosa. Several
authors12' 14'18 have suggested the possi
bility that the choledochocele is a duo
denal duplication that, due to pressure or
some other phenomenon, comes into
communication with the common bile
duct. In order to be classified as a dupli
cation, the cyst should have an outer wall
of smooth muscle lined with gastrointes
tinal mucosa and be intimately adherent
to the gut.19 Wearn and Wiot12 found
duodenal mucosa on both sides separated
by fibrous vascular stroma. However, the
cyst from our patient not only had duo
denal mucosa but readily identifiable sub
mucosa and muscularis externa, that is,
all the layers of the intestinal wall, thus
qualifying it as a duplication cyst.
It seems that two varieties of chole
dochoceles exist. One is a choledochal
cyst described by Alonso-Lej, involving
the intramural portion of the common
bile duct. Its origin is unknown and is
similar to type 1 cysts elsewhere in the
biliary tree, differing only in that the cyst
is located in the intramural portion of the
common bile duct. The other type
originates as a duodenal duplication and
develops a fistula to the intramural seg
ment of the common bile duct.
The treatment of choledochoceles is
surgical although one case20 has been
successfully managed endoscopically. Of
prime importance is that the common bile
duct and pancreatic ducts are identified
early and protected. Excision of the
majority of the cyst wall and overlying
duodenal mucosa with marsupialization
of the base seems to be satisfactory.
Conclusions
These two case reports have extended
our understanding of the genesis of
choledochal cysts. The first case demon
strates that a filmy mucosal web in the
bile duct may act as an obstructing lesion,
initiating proximal dilatation and type 1
cysts. The second case indicates that duo
denal duplications are one possible vari
ety of choledochocele.
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Surgery for Coronary Artery Disease in Patients
With Diabetes Mellitus
The results o f su rg e ry fo r o cclu sive coro
nary artery disease w ere studied in 600
conse cutive , unselected pa tie nts w ho
u n d e rw e n t a o rto co ro n a ry bypass grafting
betw een Jan. 1, 1 9 7 7 and Dec. 3 1 ,
1 9 8 2 . F orty (7% ) o f these pa tie nts had
diabetes m ellitu s, requiring m edication.
Sixteen o f the 4 0 pa tie nts w ere insulindependent, th e rem ainder required oral
h yp o glycem ic agents. The freq u e n cy of
previous m yoca rd ia l in fa rctio n , h yperten
sion and peripheral vascular disease in
th e groups o f non diab e tic and diabetic
pa tie nts w a s 3 8 % and 6 2 .5 % , 12% and
2 2 .5 % , and 1 0 .5 % and 2 5 % respec
tiv e ly . There w a s no sig n ifica n t d iffe r
ence in th e rate o f unstable angina,
triple-vessel disease, em ergency surgery,
le ft ve n tricu la r d y s fu n c tio n , m yocardial
in fa rc tio n p e rio p e ra tively and hospital
m o rb id ity or m o rta lity in th e tw o groups.
On coronary angiography, 8 2 % o f coro
nary arteries in d iabetic pa tie nts were
graded as being sm all or m oderate in
size (less than 2 m m in diam eter); at
operation, 6 2 % o f these arteries were
fo u nd to be 2 m m or m ore in diam eter.
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A t a m ean fo llo w -u p o f 3 .9 years and
3 .7 years in the no n diab e tic and d iabetic
p a tie n ts re sp e ctive ly (range from 1 to 6
years), no sig n ific a n t d ifference w a s
n o ted w ith regard to relief o f sym pto m s
o r su rvival in th e tw o groups. It is co n 
cluded th a t d ia b e tic p a tie nts w ith c o ro 
nary a rte ry disease can be offered
bypass su rg e ry w ith good sh o rt-te rm and
m ed iu m -te rm results.

On a e tu die les resultats ch irurg ica u x de
6 0 0 p a tie n ts co n se cu tifs. non choisis,
s o u ffra n t d 'o c c lu s io n des coronaires, qui
o n t subi un pontage aorto-coronarien
en tre le 1er ja n vie r 1 977 e t le 31
decem bre 1 9 8 2 . Q uarante (7% ) m alades
so u ffra ie n t de diabete sucre necessitant
m ed ica tio n . Seize de ces 4 0 patients
e ta ie n t in su lin o -d e p e n d an ts alors que les
autres pre n a ie n t des h yp o glycem ia n ts
oraux. La freq u e n ce des in fa rctu s du
m yocarde precedents, de I'h yp e rte nsion
e t des m aladies vasculaires peripheriques
pour les p a tie n ts non diabetiques et
dia b e tiqu e s e ta ie n t resp e ctive m e nt de
3 8 % et 6 2 .5 % , 1 2 % et 2 2 .5 % , e t
1 0 .5 % e t 2 5 % . On n ’ a note aucune
d iffe re n ce sig n ific a tiv e e n tre les deux
groupes dans le ta u x d 'a n g in e instable,
de trip le o cclu sio n coronarienne, de
ch irurgie d 'u rg e n ce , d 'in su ffisa n ce ventricu la ire gauche, d 'in fa rc tu s peropera to ire e t de m orb id ite ou m orta lite
ho sp italie re . A i'an giog ra p hie
co ro narienne, 8 2 % des coronaires des
p a tie n ts dia b e tiqu e s o n t e te jugees de

ca lib re p e tit ou m oyen (m oins de 2 m m
de diam & tre) on a d e co u ve rt a I'o p e ra tio n
q ue 6 2 % des artferes a va ie n t un d ia m e tre
de 2 m m ou plus.
A p re s des surveillances m oye n n e s de
3 .9 e t 3 .7 annees p o u r les p a tie n ts non
d ia b e tiq u e s e t diabetiques re sp e ctiv e 
m e n t (avec une dispersion de 1 a 6 ans),
on n 'a n o te aucune d iffe re n ce s ig n ific a 
tiv e e n tre les deux groupes en ce qui a
tr a it au so u la g em e n t des sym p to m e s ou
a la su rvie . On c o n c lu t que le p ontage
a o rto -co ro n a rie n p e u t etre o ffe rt au
p a tie n t d ia b e tiqu e coronarien avec
I'e s p o ir de bons re su lta ts a c o u rt et
m o ye n term e.

The adverse effects of diabetes mellitus
on the coronary circulation and the
higher incidence of cardiovascular events
in diabetic patients have been well docu
m ented.1-8 However, the issue remains
controversial with some studies5,9-11 dis
puting the influence of diabetes and its
duration on the extent of coronary artery
disease.
The short-term results of coronary
artery bypass grafting in diabetic patients
have not supported the skepticism of phy
sicians referring these patients for sur
gery.9,11-13 To examine the value of
myocardial revascularization in diabetic
patients, we have reviewed our experience
with coronary artery bypass surgery in
600 consecutive patients over 6 years.
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Patients and Methods
The study comprised an analysis of
preoperative, surgical and postoperative
data of 600 consecutive patients who
underwent coronary artery bypass graft
ing for ischemic heart disease between
Jan. 1, 1977 and Dec. 31, 1982. These
include all elective and emergency oper
ations for myocardial revascularization
only. All operations were performed by
the same surgical team using a uniform,
standard technique.
Forty (7%) of these patients (32 men,
8 women) had adult-onset diabetes mellitus that required medication. A fasting
blood glucose value of less than 7.8
mmol/L was considered normal. Routine
glucose tolerance tests were not per
formed. Sixteen (40%) of the diabetic pa
tients were insulin-dependent. Patients
who had “ diet-controlled diabetes mellitus” and normal blood glucose levels were
not included in the diabetes group.
In-patient and follow-up information
was obtained by chart review and patient
contact. Risk factors and results were
analysed with the x2 test and Student’s ttest using the Minitab Statistical Package
(Penn State University, Duxbury Press,
North Scituhee, Mass.) on a DEC system
10 computer (Digital Equipment Corp.,
Maynard, Mass.). Results of patient sur
vival are reported by the actuarial
method. A p value of less than 0.05 was
considered significant.
Fig. 1 shows the age and sex distribu
tion of the total group. There was no sig
nificant difference in the age and sex dis
tribution between the diabetic and
nondiabetic patients.
Fig. 2 shows the incidence of risk fac
tors, known to be of value in predicting
survival.14 The incidence of previous
myocardial infarction, judged by resting
electrocardiographic findings, hyperten-

sion (blood pressure greater than 140/90
mm Hg) and peripheral vascular disease
diagnosed from history and physical ex
amination, was significantly higher in the
diabetic patients, p < 0.01, p < 0.05 and
p < 0.01 respectively. There was no ap
preciable difference between the two

groups in the incidence of triple-vessel dis
ease as shown by selective coronary
angiography, the presence of unstable
angina and left ventricular dysfunction
studied by left ventriculography and wallmotion studies (i.e., three or more
hypokinetic or akinetic segments).
»

<

FIG. 2—Risk factors in diabetic (hatched bars) and nondiabetic (dotted bars) patients. Ml
= myocardial infarction, PVD = peripheral vascular disease, LVD = left ventricular dys
function.

-t
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FIG. 3—Number of grafts by sex. White bars = women (n = 95), dotted bars = men
(n = 505).

FIG. 1—Age and sex distribution of 600
patients studied. White bars = women
(n = 95), dotted bars = men (n = 505).
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Table 1-Hospital Mortality and Morbidity in
Nondiabetic and Diabetic Patients
Nondiabetics,
no. (%)
Perioperative myocardial infarction
21 (3.751
Hospital morbidity
42 (7.5)
Hospital mortality
21 (3.75)

Diabetics,
no. (%>
2(5)
2(5)
1 (2.5)
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The number of grafts placed, by sex,
in the total patient population is shown
in Fig. 3. The average numbers of grafts
placed in the nondiabetic (n = 473) and
diabetic (n = 32) men were 3.2 and 2.4
respectively (p < 0.05). No significant
difference was noted in the average num
bers of grafts placed in women, in the
nondiabetic (n = 87) and diabetic
(n = 8) patients (2.6 and 2.8 respec
tively).
The preoperative coronary angiograms
of the 40 diabetic patients were studied
and compared with those of 96 nondia
betic patients matched for age, sex and
risk factors. Coronary artery diameter
was measured in the two groups of
patients near the middle segment of the
artery at a site judged suitable for inser
tion of the bypass graft. The measure
ment was made by comparison with a
calibrated measuring grid on the films or
by comparison with the known luminal
diameter of the selective coronary injec
tion catheter on the same film frame.
Intraoperatively, coronary artery size was
measured by gently introducing calibrated
probes into the coronary arteriotomy.
Hospital mortality refers to death
within 30 days of operation or during the
same hospital admission. Morbidity
relates to delay in convalescence or hospi
tal discharge due to poor pulmonary
function, persistent atrial arrhythmias,
wound infection or perioperative
myocardial infarction.
Results

The incidence of perioperative
myocardial infarction and hospital mor
bidity and mortality in the two groups of
patients is shown in Table I. Wound
infections occurred in 23 (4.1%) nondia
betic patients and in 1 (2.5%) diabetic.
The only hospital death in the diabetes

FIG. 4—Percentage of patients free of angi
nal symptoms at intervals up to 6 years after
operation. Circles = nondiabetics, crosses =
diabetics.

group was a 61-year-old woman with two
previous myocardial infarctions, severe
triple-vessel disease and unstable angina.
She died of left ventricular failure secon
dary to a perioperative myocardial infarc
tion and renal failure.
Figs. 4 and 5 show the follow-up results
with respect to relief of symptoms and
survival over a period of 6 years (mean,
3.9 years in nondiabetic patients and 3.7
years in diabetics). There were no signifi
cant differences in the two groups of
patients.
Only 18% of the coronary arteries in
diabetic patients were found preoperatively to be 2 mm or more in transverse
diameter. The corresponding figure for
nondiabetic patients was 61%. Intraoper
ative measurement showed that 62% of
the coronary arteries in the diabetic
patients and 68% in nondiabetics were 2
mm or more in diameter.
Discussion

Several studies based on patho
logical1517 and angiographic data5’6,18
have compared the extent of coronary
artery disease in diabetic and nondiabetic
patients. They showed that diabetics had
more severe coronary artery disease, as
demonstrated by the prevalence of triple
vessel involvement, and more diseased
and occluded coronary arteries per
patient. Vigorito and associates6 have
demonstrated more severe compromise of
left ventricular segmental wall contraction
and a higher frequency of postinfarction
left ventricular aneurysms in diabetics.
This was not related to the extent of coro
nary artery disease or to the development
of collaterals and it is unlikely related to
distal coronary artery disease, because
Dortimer and associates18 could not
show that distal coronary artery disease
is more common in diabetic patients. A
possible explanation would be the effect
of an inherent myocardial factor.8’9'19
These angiographic studies supplement
the epidemiologic data,1,2,10 suggesting

FIG. 5—Actuarial survival in diabetic
(crosses) and nondiabetic (circles) patients after
coronary artery bypass grafting.

that diabetes mellitus is an independent
risk factor for coronary artery disease. As
a result, physicians have often been skep
tical about the role of coronary artery
bypass grafting in these patients.
However, several surgical series9,11,13
have failed to show a relation between
diabetes mellitus and the extent of coro
nary artery disease. Chychota and
associates13 did show a significantly
greater mean flow rate through vein grafts
in nondiabetic patients, 71 mL/min com
pared with 54 mL/min in diabetics.
Verska and Walker,9 however, did not
find any difference in the mean flow rates
in the two groups, raising doubts about
any difference in the microcirculation of
the myocardium between diabetic and
nondiabetic patients.
The results of coronary artery bypass
grafting in diabetics have been encourag
ing.9'11'13 Diabetes mellitus, either alone
or in combination with other risk factors,
does not seem to affect graft patency ad
versely or to influence the progression of
disease in bypassed arteries.11
In our own series, the number of dia
betic patients who underwent bypass
grafting was low (7%) compared with
that (31%) in the series reported by
Verska and Walker.9 We also found a
higher incidence of previous myocardial
infarction, hypertension and peripheral
vascular disease in our diabetics.
However, the severity of coronary artery
disease as judged by the rate of triple
vessel involvement was similar in the two
groups, as was the occurrence of unsta
ble angina and left ventricular dys
function.
An interesting finding was the dis
crepancy between angiographic assess
ment of vessel diameter and the operative
findings. Even though only 18% of coro
nary arteries in diabetic patients were
graded preoperatively as 2 mm or more
in diameter (compared with 61% in non
diabetics), at operation 62% were found
to be 2 mm or larger in diameter. This
poor correlation between angiographic
and operative findings was not found in
the nondiabetic group. Small calibre
should not be a specific contraindication
to coronary artery bypass in diabetic
patients in view of the likely underestima
tion of coronary artery diameter. The rea
son for this discrepancy in artery size is
unclear. It may, in part, be related to
underfilling due to slow flow rate in addi
tion to proximal disease but there was no
indication at operation of more diffuse
disease in the diabetic patients.
The incidence perioperatively of
myocardial infarction, morbidity, includ
ing wound infection, and mortality was
similar in both our groups, although
some9’13'20 have reported more infective
and other complications in diabetic
patients.
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The beneficial role o f surgery in the
management of coronary artery disease
is w ell established.14,21 In diabetic
patients (including those with juvenileonset diabetes), the results o f coronary
artery bypass have not been any differ
ent, at least in the short term.9,11,13,22 In
our series, with a mean follow-up o f 3.9
years and 3.7 years in nondiabetic and
diabetic patients respectively (range from
1 to 6 years), the results o f coronary
artery bypass, as judged by relief of
symptoms and survival, have been equally
encouraging.
Conclusions
Although some risk factors are more
prominent in diabetic patients, they do
not adversely affect the outcome o f coro
nary artery bypass grafting. The value of
coronary angiography in diagnosing
small-vessel disease is questionable; there
appears to be a greater discrepancy
between angiographic and surgical find
ings in diabetic patients. Patients suffer
ing from diabetes mellitus can therefore
be offered coronary revascularization
with good short-term and medium-term
results.
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SURGICAL EDUCATION AND SELF-ASSESSMENT PROGRAM NO. 5
A Standard Pre-Op Procedure for Thousands of Surgeons.
As a surgeon, you face tests of your
ability every day,., but none are
more important than the tests you
undertake yourself.
Thaf s why the American Col lege of
Surgeons' Surgical Education and
Self-Assessment Program (SESAP) can
claim more than 65,000 enrollments
representing all surgical specialties.

SESAP V - The Most Comprehensive
and Individualized Continuing
Medical Education Program
Available to Surgeons.
SESAP V is the result of three years'
intensive review and research con
ducted by 47 nationally-recognized
surgical authorities. The flexible for
mat provides highly individualized
self-assessment in 17 major surgical
categories,
SESAP V reflects the most contem
porary clinical advances in surgery.
It offers hundreds of probing ques
tions... and a Syllabus with detailed
rationales and references for each
answer.
With an expanded Patient Man
agement Problem (PMP) section, a
confidential computer-scoring op
tion, and individualized assessment
reports, SESAP V is the most practical
and comprehensive self-assessment
program available to surgeons.

A Challenge to Your Analytic Skills.
SESAP V is more than a simple
exercise in seif-study, More than 400
multiple-choice items test your ability
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factual information. And each of the
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Accompanying this interrogative are

nearly 200 illustrations, X-rays, charts,
graphs, and diagnostic prints.

A Chance to Compare Your
Performance with Peers.
SESAP V gives you a chance to
determine confidentially your stand
ing among other participating col
leagues. After you've completed the
program, you'll receive a compara
tive scale [The Norm Tables) based
on the computer-scored perform
ance of SESAP V participants. You
may then rank your personal assess
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An Invaluable Preparation for
Recertification.
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recertification in general surgery. The
content of the multiple-choice sec
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tion examination as developed by
the American Board of Surgery.
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next three years, a resident, or a
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Return to:
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personal standards of surgical excel
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vide better care for their patients.
And virtually all SESAP participants
said the program has played an
important role in their personal CME
agenda.
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By Yourself.
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American College of Surgeons.

Yes, I'd like to learn more about SESAP V.
Please send me, without obligation or cost,
a detailed Prospectus.

55 East Erie Street
Chicago, Illinois 60611
A d d ress

City/Stcrte/Zip

Luc

D e s c h e n e s , m d , f r c s c ;* S i m o n J a c o b , m d , f r c p c ; !
J a c q u e l i n e F a b i a , m d , s c d ;§ A n d r e e C h r i s t e n , m s c *

Beware of Breast Fibroadenomas in Middle-Aged Women
On first examination of 8512 Quebec
area women from 40 to 59 years of age
who participated in the National Study of
Breast Cancer Screening, the prevalence
of fibroadenoma was 8.3 per 1000. In
two women, a carcinoma was disco
vered within their fibroadenoma —
intraductal carcinoma in one and an
infiltrating ductal carcinoma in the other.
Clinical and histopathologic findings are
described and the prognosis and treat
ment discussed. The peak age of women
at the time of diagnosis of a fibroade
noma is in their twenties while for those
with a fibroadenoma containing a carci
noma, it is in the forties. For patients
under 25 years, excision can be post
poned for a few months since spontane
ous regression may occur and the risk of
breast cancer is small at that age. For
older women, treatment should not be
delayed.
A Texamen initial de 8512 femmes de la
region de Quebec agees de 40 a 59 ans
participant d I'Etude canadienne sur le
depistage du cancer du sein, la preva
lence du fibroadenome etait de 8.3 pour
1000. Chez deux participantes, un carcinome a ete decouvert a I’interieur du
fibroadenome. II s'agissait dans le pre
mier cas d'un carcinome intracanalaire et
dans le deuxieme d'un carcinome canalaire infiltrant. Les resultats des examens
cliniques et histologiques sont indiques.
Le pronostic et le traitement de tels cas
consideres comme rares sont discutes.
Le mode de I'age au diagnostic des
patientes avec un fibroadenome est dans
la vingtaine alors qu'il est dans la quarantaine pour celles qui ont un fibro
adenome contenant un carcinome. Pour
les femmes de moins de 25 ans, I'excision peut etre differee de quelques mois.

Chez les plus agees, elle ne doit pas etre
retardee.

In a letter to the Lancet, 1 we reported
two cases of breast carcinoma arising in
a fibroadenoma. In this report we
describe our findings and discuss the
management of such cases in more detail.
Subjects and Sources of Data

The lesions were discovered at the ini
tial examination of 8512 Quebec area par
ticipants in the National Study of Breast
Cancer Screening. The protocol for this
study has been published by Miller and
colleagues.2 Eligible for the study are all
women aged 40 to 59 years who have not
had breast cancer, have not undergone
m ammography in the previous 12
months, are not currently pregnant and
give informed consent to participate.
Data were extracted from the Breast
Screening Centre files and the SaintSacrement Hospital surgery and pathol
ogy reports.
Results

The frequency of fibroadenoma found
at the first screening was 8.3 per 1000
women, 10.8 per 1000 in the 40- to
44-year age group and 6.3 per 1000 for

women aged 50 to 59 years. Two par
ticipants in the latter group were found
to have a carcinoma developing within
their fibroadenoma.
Case Reports

Case 1
This unmarried 51-year-old postmenopausal
woman had no family history of breast cancer.
She was randomly assigned to the group of
patients who underwent mammography and
physical examination annually.
No mass was found on palpation. Mammo
graphy showed a small nodule, suggestive of
a cyst, and a few microcalcifications in the
upper, inner quadrant of the right breast.
The screening centre’s consultant surgeon
recommended an excisional biopsy.
Grossly, the biopsy specimen consisted of a
well-circumscribed, white, rubbery, ovoid nod
ule, 1.6 cm in diameter. Microscopically, sec
tions of the nodule showed polypoid intraduc
tal proliferation of connective stroma,
characteristic of a fibroadenoma. The stroma
was inactive and sclerotic. Some ducts were
obliterated by an epithelial proliferation with
obvious features of malignant tissue. There was
no stromal infiltration (Fig. 1). The diagnosis
was noninfiltrating ductal carcinoma of the
breast confined to a fibroadenoma.
Segmental mastectomy was performed. No
residual neoplastic tissue was found in the mul
tiple sections of the specimen.
At follow-up 49 months after operation, the
patient was well with no evidence of recurrence.
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FIG. 1—(A) Edge of nodule showing features of fibroadenoma. Carcinomatous prolifera
tion obstructs some ducts (hematoxylin-phloxine-saffron, original magnification X 10). (B) Detail
of neoplastic epithelium. Note cribriform pattern and disorganized multilayered epithelium with
projecting spurs (hematoxylin-phloxine-saffron, original magnification x 250).
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Case 2
This 53-year-old woman had given birth to
the first of her five children when she was 19
years old. She was postmenopausal and had
no family history of breast cancer. She was ran
domly allocated to the group of patients who
underwent annual physical examination only.
The patient stated that she had been under
medical supervision for the last 8 years because
of a lump in her left breast. She had been told
repeatedly that this lump was benign and did
not need further investigation. Palpation rev
ealed a well-delineated, freely movable mass,
typical of a fibroadenoma, located just above
the areola of the breast.
The consultant surgeon recommended mam
mography and a fine-needle aspiration biopsy
followed by surgical excision. The patient
accepted only excisional biopsy.
Grossly, the biopsy specimen consisted of a
well-circumscribed, white, rubbery nodule, 1.5
cm in diameter. Microscopically, the periph
ery of the nodule was characteristic of a
fibroadenoma with loose proliferation of con
nective stroma around ducts. The inner part
of the specimen was occupied by a welldelineated malignant epithelial proliferation,
confined to the fibroadenoma. Its centre was
largely necrotic and hemorrhagic with some
remnants of loose stroma infiltrated by the car
cinoma (Fig. 2). These findings led to a diag
nosis of poorly differentiated infiltrating duc
tal carcinoma of the breast confined to a
fibroadenoma.
Segmental mastectomy was performed with
dissection of axillary nodes. A microscopic
intraductal carcinoma, involving only one duct,
was discovered close to the biopsy site. All eight
nodes examined histologically were free of
cancer. The patient received radiotherapy
postoperatively: a total dose of 4000 rad to the
supraclavicular region and 5000 rad to the
remaining breast, axilla and the internal mam
mary lymph nodes over 5 weeks at 25 sessions.
At follow-up 26 months after operation, the
patient is well with no sign of recurrence.

Discussion
Carcinoma developing in a fibroade

noma is thought to be rare.3 Harrington
and Miller,4 in 1940, reported 15 such
cases from the Mayo Clinic, providing
details on only 3. The largest series, that
of McDivitt and associates,5 included 26
patients. With a few exceptions,6'8 other
reports are based on only one or two
women.9'21
Sixty-four cases of carcinoma in a
fibroadenoma, including our 2, have been
appropriately documented.22 Among
these cases, the frequency of lobular
neoplasia (62%) is clearly higher than that
of ductal carcinoma (38%). Among duc
tal carcinomas, 44% were noninvasive
com pared with 72% for lo b u lar
lesions.22
Prognosis
The prognosis of this condition is
usually favourable,5'7,8 because the fibro
adenoma is readily discovered on palpa
tion, leading to early detection o f the
cancer within.7'8 Owing to the small
numbers, the prognosis of malignant
lesions developing in a fibroadenoma has
never been compared to that of similar
lesions in nonfibromatous breast tissue.
There is little reason to believe that it is
any different.8 However, one cannot
exclude the possibility that the invasive
potential of a cancer might be thwarted
when it grows in a fibroadenoma.

mutilation. In 1967, McDivitt and
colleagues5 reported that, out of six
patients with noninfiltrating ductal car
cinoma developing in a fibroadenoma,
three underwent a radical mastectomy
and three a wide local excision. Recently,
one of us (L.D.) asked five Canadian sur
geons about their choice of treatment in
such cases. He received five different
answers: modified radical mastectomy,
simple mastectomy with or without axil
lary node sampling and local excision with
or without postoperative radiotherapy. At
its September 1984 meeting, the clinical
trials committee of the National Surgical
Adjuvant Breast Project (NSABP) indi
cated it was contemplating a randomized
clinical trial of treatment for noninvasive
ductal breast cancer. Meanwhile, sur
geons will have to base their choice of
treatm ent on their knowledge and
experience, on the particulars of each case
and on discussions with each patient.
Our second patient underwent segmen
tal mastectomy with axillary dissection
followed by radiotherapy. In their ran
domized clinical trial, Veronesi and
associates25 compared such a treatment
to Halsted’s mastectomy in patients with
small cancers of the breast and no palpa
ble axillary lymph nodes. Disease-free and
overall survival were the same in the two
groups.
Management o f Breast Fibroadenoma

Treatment o f Ductal Carcinoma in a
Fibroadenoma
We elected to treat our first patient by
segmental mastectomy, but there is still
no consensus as to the best treatment of
intraductal carcinoma, whether it is
within a fibroadenoma or not.8,23’24 Sur
geons face a dilemma because of two
opposing considerations: the high prob
ability of multifocality o f the cancer
versus the need to avoid unnecessary

The peak age at diagnosis in women
with breast fibroadenoma is the third
decade.3 For patients with a carcinoma
arising in a fibroadenoma, it is the fifth
decade (mean age 43.4 years, ranging
from 15 to 69 years).5'8’22'26 Management
of a fibroadenoma depends on age. At all
ages, we routinely perform a fine-needle
aspiration biopsy for palpable breast
lesions.27 For women under 25 years of
age with a cytologically confirmed
fibroadenoma, excision can be delayed
for a few months since spontaneous
regression may occur and risk of breast
cancer is small at that age. For older
women, immediate excision is manda
tory. The procedure can be done under
local anesthesia on an outpatient basis.
Microscopic examination of the specimen
will confirm the diagnosis of fibroade
noma and detect malignant change.19
Physicians should be aware that carci
noma can indeed develop within a
fibroadenoma.
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FIG. 2—(A) Panoramic view o f edge of fibroadenoma. Carcinoma is visible in left lower
corner. Note pushing margin (hematoxylin-phloxine-saffron, original magnification x 10). (B)
Detail of carcinomatous proliferation (hematoxylin-phloxine-saffron, original magnification x
160). (C) Central part of tumour. Neoplastic duct infiltrating residual stroma (hematoxylinphloxine-saffron, original magnification X 250).
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Once again, this renowned conference on Hoffmann® External Fixation will be held in North America
and will bring together the world's foremost authorities on the subject of external fixation. As in the
past, various scientific, technical and controversial topics will be presented.
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• The Role of Unilateral External Fixation
• Assessment of When and How to Dynamize
External Fixators
• Advanced Uses for External Fixation in
Microvascular Repair and Orthopaedic Recon
structions
• Bioskills workshops will be available to all
course registrants
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Conference on Hoffmann® External Fixation
will be combined with the University of
Toronto's Orthopedic Trauma Course.
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Dr. James F. Kellam
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2075 Bayview Avenue
Toronto, Ontario
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Esophageal Web Associated With Zenker’s Diverticulum:
a Possible Cause of Continuing Dysphagia
After Diverticulectomy
A 67-year-old man with upper
esophageal dysphagia thought to be
caused by a large Zenker's diverticulum
was found to have an esophageal web at
the time of diverticulectomy and
cricopharyngeal myotomy. The web was
divided by sharp dissection. Untreated,
this thin web would almost certainly
have resulted in dysphagia postoperatively. The authors therefore recommend
routine open diverticulectomy for the
management of Zenker's diverticulum, to
allow inspection of the esophageal lumen
for concomitant disease and palpation of
the cricopharyngeal muscle at the time
of myotomy.
Un voile oesophagien a ete decouvert au
moment d'une diverticulectomie avec
myotomie cricopharyngee chez un
homme de 67 ans souffrant d'une
dysphagie oesophagienne que Ton
croyait due a un gros diverticule de
Zenker. Le voile fut divise par dissection
vive. Non traite, ce mince voile aurait
presque a coup sur entraine une
dysphagie postoperatoire. Les auteurs
recommandent done la diverticulectomie
ouverte systematique comme traitement
du diverticule de Zenker, afin de permettre une inspection de la lumifere oesopha
gienne visant a identifier toute maladie
concomitante et a palper le muscle cricopharynge au moment de la myotomie.

other causes of upper esophageal and
pharyngeal dysphagia exist, such as
esophageal webs, neuromuscular dis
orders, the presence of foreign bodies,
extrinsic pressure and tumours. We
describe a patient with Zenker’s divertic
ulum and a coexisting upper esophageal
web. If the Zenker’s diverticulum in this
patient had been treated in the usual
fashion by diverticulectomy without
opening the diverticulum and visualizing
the esophageal lumen, dysphagia would
undoubtedly have occurred postoperatively.
Case Report
A 67-year-old man complained of dyspha
gia for solids, with food sticking in his cervi-

Dysphagia in patients with pharyngo
esophageal (Zenker’s) diverticulum is
generally caused by preferential passage
of food into the diverticulum, compress
ing the cervical esophagus. However,
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FIG. 1—Upper esophagus and gastro
esophageal junction on barium swallow. Large
Zenker’s diverticulum (large arrow) and slid
ing hiatus hernia (small arrow) are seen.
G astroesophageal reflux was noted at
fluoroscopy.

cal esophagus. This symptom, present for 6
months, had been increasing in severity.
Associated symptoms included regurgitation of
undigested food, particularly at night, accom
panied by coughing and choking spells. He also
complained of water brash and heartburn,
which were not relieved by elevating the head
of the bed, antacids or cimetidine (300 mg four
times a day). Bending and straining exacer
bated the heartburn.
Physical examination did not reveal any
abnormality. The hemoglobin value was 150
g/L, hematocrit 50%, leukocyte count 8.7 x
lOVL and serum electrolyte levels were nor
mal. The chest film was also normal. Roent
genography after barium swallow showed a
large Zenker’s diverticulum, measuring 2 x 2.5
cm, as well as a sliding hiatus hernia with gas
troesophageal reflux (Fig. 1). The esophageal
scintiscan showed marked dysmotility, espe
cially in the upper third of the esophagus, and
reflux occurred during the study.
Since medical measures failed to improve the
patient’s reflux and the diverticulum caused
worsening dysphagia, a combined operative
procedure was planned to correct both condi
tions.
Preoperatively, an attempt to pass a nasogas
tric tube failed. A diverticulectomy and
cricopharyngeal myotomy were performed
through an oblique incision along the anterior
border of the left sternocleidomastoid muscle.
The omohyoid muscle was transected and the
thyroid gland and trachea were mobilized
medially and superiorly. The carotid sheath
and sternocleidomastoid were retracted later
ally. The recurrent laryngeal nerve was identi
fied throughout the procedure. A large
esophageal diverticulum was noted, arising just
proximal to the cricopharyngeal muscle. The
diverticulum was dissected from surrounding
tissue down to its neck, and its apex was
opened. An unsuspected, thin mucosal web was
seen, extending 1.5 cm from the right
posterolateral wall to the left posterolateral
wall of the esophagus. The web projected
anteriorly 0.5 cm into the lumen of the esopha
gus at the level of the cricopharyngeal muscle
(Fig. 2) and obstructed the distal esophageal
lumen. It was therefore divided and the edges
were oversewn with 3-0 chromic catgut suture.
A finger was placed through the apex of the
diverticulum into the distal esophagus and the
myotomy performed. The diverticulum was
excised, closing the esophagus with chromic
catgut in the mucosal layer and silk in the muscularis. The neck wound was drained and
closed. An abdominal approach to the
esophageal hiatus allowed the posterior fixa-
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tion and sphincter calibration (Hill) procedure
to be performed.
Postoperative recovery was smooth and the
patient remains well without dysphagia or
reflux symptoms 12 months later.

Discussion

Zenker’s diverticula and esophageal
webs are uncommon conditions; both can
cause pharyngeal and upper esophageal
dysphagia. Two percent of patients who
complain of dysphagia have a Zenker’s
diverticulum which is well demonstrated
by a standard barium swallow,1 and
12% have esophageal webs.2 However,
the true incidence of webs is unknown
because standard roentgenographic tech
niques are not sensitive enough to pick up
this condition.3 Cineradiographic tech
niques improve the detection of this
lesion.4
Barium swallow in our patient showed
a Zenker’s diverticulum that was the pre
sumed cause of dysphagia. The delayed
passage of barium in the diverticulum and
distortion of the anatomy obscured the
web. Cineradiography was not per
formed.
Endoscopic visualization of esophageal
webs with therapeutic dilation is the treat
ment o f choice for this condition.
However, endoscopic evaluation of
esophageal diverticula can be hazardous,
especially if the diverticulum is large
and the diverticular orifice lies in the
same plane as the esophagus. Even an
experienced endoscopist may confuse the
lumen of the diverticulum with that of the
esophagus and attempts to pass the endo
scope distally may result in perforation.

FIG. 2—Operative findings. Zenker’s diver
ticulum has been opened at its apex. Mucosal
web is identified on right posterolateral wall
of esophagus distal to mouth of diverticulum.
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Both webs and diverticula are asso
ciated with numerous other conditions.
Esophageal webs have been associated
with iron deficiency anemia (PlummerVinson syndrome), cancer, glossitis,
thyroid disease, ulcerative colitis, rheuma
toid arthritis, pernicious anemia, epider
molysis bullosa and pemphigoid. Zen
ker’s diverticula occur frequently in
patients with hiatus hernia and reflux, as
in our patient, and less commonly in
patients with achalasia, cancer of the
esophagus and polyps in the cervical
esophagus. There are, however, no
reports of an upper esophageal web coex
isting with a Zenker’s diverticulum.
Esophageal webs consist of squamous
epithelium, are usually thin, smooth and
arise on the anterior wall of the cervical
esophagus at or just below the crico
pharyngeal muscle, and they may be mul
tiple.5 The web in this patient arose in a
similar location except that it was on the
posterolateral wall. Grossly, it was exactly
like those identified and frequently
treated endoscopically.
Both diverticula and esophageal webs
may cause dysphagia. It is unclear in our
patient with multiple esophageal abnor- •*
malities whether the diverticulum or the
web caused the progressive dysphagia, but
both probably contributed. Zenker’s
diverticulectomy is usually performed
without opening the diverticulum and
visualizing the esophageal lumen. This
may be done with a stapling technique6
or by more traditional suture methods.7
Either way, this would certainly have
resulted in early postoperative dysphagia
in our patient.
We have adopted the technique of rou
tinely opening the apex of the diverticu
lum and inspecting the esophageal lumen.
This allows the surgeon digitally to pal
pate the cricopharyngeal muscle before
and after myotomy. The myotomy is per
formed with the operator’s finger placed
in the lumen of the esophagus through the
cricopharyngeal muscle; this allows excel
lent control of the extent and depth of the
myotomy. With this approach and antibi
otic prophylaxis, we have not had a sin
gle case of esophageal fistula or stenosis,
or any wound infection requiring incision
and drainage.
A mercury-filled bougie passed through
the cricopharyngeal muscle to act as a
stent at the time of myotomy has been
used by some surgeons. In this patient it
would have been difficult to pass the bou
gie without opening the esophagus since
the web deflected the nasogastric tube
into the diverticulum. Even with the
diverticulum open and under direct
vision, the nasogastric tube deflected
laterally at the level of the web. Attempts
at blind passage of the bougie preoperatively might have resulted in inadvertent
perforation of the diverticulum. Intra

operative placement would have been
technically possible by manually guiding
the bougie. However, in our opinion the
diverticulum should be opened routinely,
thereby allowing both inspection of the
esophageal lumen and palpation of the
cricopharyngeal muscle.
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The simple question, “ Why does arterioscle
rosis cause narrowing of the arterial lumen
(atherosclerosis obliterans) in many patients
while in others dilatation of the arterial wall
(aneurysm) occurs?” , does not have a ready
answer. The first two chapters of this book
attempt to shed light on this question by sum
marizing current knowledge of the pathophysiol
ogy and biomechanics of aneurysm formation.
Since the bibliography cites references up to
1980, the more recent developments in genetics
and in collagen structure are not covered.
Nevertheless, these superb reviews should help
busy vascular surgeons to keep abreast of the
extensive information accumulating on this
subject. The discussion ranges from nutrition
of the arterial wall to the role of the
hydrodynamic frequency phenomenon on the
evolution of aneurysms.
Discussions on the relatively rare occurrence
of aneurysms in the carotid and subclavian
arteries are practical, and include illustrative
case reports. To list poststenotic dilatation due
to thoracic outlet compression under “ false
aneurysm” is misleading since it contradicts the
definition of pseudoaneurysms made earlier in
the book. The consensus is that aneurysms and
symptomatic poststenotic dilatations in this
region should be repaired, but whether asymp
tomatic poststenotic dilatation should also be
resected has not been answered. For the lat
ter, the authors suggest that resection of the
rib to relieve compression, without further vas
cular procedures, would be adequate.
The surgical treatments of aortic arch and
thoracoabdominal aortic aneurysms continue
to present a major technical challenge. Craw
ford bases his discussion in this chapter on his
wide experience and excellent results. The sur
gical tour de force depicted so well in the illus
trations and the text indicates the goals that
can be achieved with modern surgery.
Aneurysms in the renal and visceral arteries are
relatively small and are frequently asympto
matic until complications such as rupture or
thrombosis occur. Preservation of the tissue
nourished by the involved artery, such as the
kidney, liver and intestine, is o f particular
importance during reparative procedures.
Whether the newer diagnostic techniques such
as computerized axial tomography and ultra
sonography will identify more of these lesions
at an earlier stage and therefore allow treat
ment before they rupture, as postulated by the
author, remains to be seen.
The chapter on abdominal aortic aneurysms,
which is the most common aneurysm repaired
surgically, is useful to both novice and sea
soned vascular surgeons. The discussions
on avoiding distal thromboembolism, dealing
with horseshoe kidney during aortic aneurysm
resection and preventing spinal cord and other
neurologic complications are “ must” readings

for vascular surgeons in this society that is
increasingly litigation conscious.
Finally, sepsis associated with aneurysms, a
dreaded complication with high morbidity and
mortality, is presented with an in-depth review
o f experimental and clinical data. The ration
ale for using antibiotics prophylactically and
therapeutically, as well as the various options
available to the surgeon dealing with this com
plication, are described. Although the styles
and depths of coverage vary somewhat in this
multiauthored book, it seems to have success
fully met the authors’ objective of producing
a “ most useful resource for the sophisticated
practicing physician” . The basic pathophysiol
ogy and the useful tidbits in surgical techniques
should also make this book valuable to resi
dents training in vascular surgery.
R ay C -J. C h i u , m d , p h d , fr csc
Senior Surgeon,
Division of Cardiovascular
and Thoracic Surgery,
The Montreal General Flospital,
Montreal, PQ
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ATLAS OF BRONCHITIS. Konrad Morgenroth and Michael T. Newhouse. (Translated
by H .P . Schleiss.) 106 pp. PVG Pharmazeutische Verlagsgesellsehaft, Munchen;
Butterworth Scientific, Boston, 1983.
S49.95 (US). ISBN 0-407-00279-0.

This book comprises mostly illustrations of the
histologic features of bronchitis as seen through
the fiberoptic bronchoscope. These are sup
plemented by superb drawings and electron
photomicrographs. Although it provides a
good overall review of the pathologic features
o f bronchitis, this book should not be consi
dered as an atlas of bronchoscopy. No data are
presented to correlate these features with func
tional respiratory testing or with radiologic
images. In the preface, the authors point out
that fiberoptic bronchoscopy has allowed the
clinician to assess the morphology of the bron
chial mucosa more readily and to relate this
to the clinical and physiological state o f the
patient. We are not aware of any data correlat
ing the exact physiopathology of bronchitis and
bronchoscopy; the inflammatory reaction
found in bronchitis frequently begins as a
peripheral process not visible through the
fiberoptic bronchoscope, but nevertheless alters
respiratory function. We also believe that it is
difficult to evaluate the response to medication,
such as bronchodilators, by fiberoptic bron
choscopy. Finally, even if bronchitis is com
monly seen during evaluation of lung diseases
in general, one should not conclude from this
book that bronchitis is necessarily an indica
tion for fiberoptic bronchoscopy.
This book may be helpful to those interested
in the different types of bronchitis if it is read
in its entirety, but the reader will find gaps in
coverage if the text is used as a reference. Mor

phologic aspects of bronchitis are well
presented, but in our opinion the functional
aspect of this disease are more important clin
ically than the bronchoscopic findings.
P ie r r e P a g e , m d , f r c s c , fa c c
J e a n - J a c q u es G a u t h ie r , m d , f r c p c
Cardiovascular and Thoracic Surgery
and Pulmonary Medicine,
Hopital du Sacre-Coeur,
5400, boul. Gouin ouest,
Montreal, PQ
H4J 1C5
HANDBOOK OF CANCER DIAGNOSIS
AND STAGING. A Clinical Allas. Seth A.
Gorg and Susan Rosenthal. 271 pp. Illust.
John Wiley & Sons, Inc., Somerset,
NJ, 1984. $29.95 (US). ISBN 0-47187073-0.

A unique text this brings together in a concise,
yet sufficiently detailed, fashion the tools that
are available to evaluate a patient with cancer,
so that the clinician can provide the most effec
tive treatment. In the past 10 to 12 years there
has been tremendous progress in the field of
imaging, most of which is radiologic in nature
but also includes nonradiologic procedures
such as ultrasonography and nuclear magnetic
resonance imaging.
The text is divided into five major sections.
The first deals with imaging modalities for
diagnosis and staging of cancer, including each
o f the more sophisticated radiologic proce
dures: angiography, barium gastrointestinal
studies, computerized tomography, endoscopic
retrograde cholangiopancreatography, lym
phography, myelography, nuclear imaging of
bone, brain and liver, nuclear magnetic
resonance scanning, ultrasonography, tom o
graphy, urography and percutaneous biopsy.
There is a brief description on how the exami
nation is performed, the indications for the
procedure, what form of patient preparation
is required, the risks o f the procedure and
approximate cost assessment in relative terms.
The second chapter consists of a brief dis
cussion of the methods used in evaluating cer
tain specific sites and includes mediastinal and
retroperitoneal lymph nodes, hepatic masses,
liver nodules, obstructive jaundice and pelvic
masses.
In the third chapter is a more detailed dis
cussion of cancer in various organs of the body
to include, in each case, description o f the
TNM tumour staging. This section is excel
lently done and illustrates the value of the var
ious imaging procedures in properly staging the
cancer. The authors stress the importance of
the TNM classification, which achieves a
degree of uniformity and clarity. Failure to
evaluate fully the extent of disease can lead to
serious, even tragic errors in management.
The problem of patients with cancer of
unknown origin is briefly considered while the
final chapter deals with the diagnostic evalua-
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tion of oncologic emergencies, including such
conditions as the superior vena cava syndrome,
increased intracranial pressure, spinal cord
compression, cardiac tamponade and bilateral
ureteral obstruction.
This is a well-conceived, well-written hand
book on the subject of cancer diagnosis and
staging. The various diagnostic modalities are
well presented and in many cases beautifully
illustrated. There are flow diagrams for evalu
ating patients with suspected cancer in various
organs and regions in the body with excellent
images to demonstrate the pathologic features
and their extent. The only criticism that can
be levelled at this book is that the descriptive
text and particularly that dealing with tech
niques is, for the most part, too brief. For this
reason the usefulness of this handbook is res
tricted to medical students and junior interns,
and to primary care physicians and surgeons
who have been unable to keep pace with the
virtual explosion of recent diagnostic and imag
ing procedures now available to evaluate the
patient with cancer.
E d w a r d J . T a b a h , m d , fr csc
Department of Surgery,
Royal Victoria Hospital,
687 Pine Ave. W,
Montreal, PQ
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M A N U A L OF PREO PERATIVE A N D
POSTOPERATIVE CARE. 3rd ed. Com
mittee on Pre and Postoperative Care.
American College of Surgeons. Editorial
Subcommittee, Stanley J. Dudrick, Chair
man, Arthur E. Baue, Ben Eiseman, Lloyd
D. MacLean, Marc E. Rowe and George
F. Sheldon. 822 pp. Illust. YV.B. Saunders
Company Canada Limited, Toronto, 1983.
$45. ISBN 9-7216-1164-8.

In its third edition, this manual, which is spon
sored by the American College of Surgeons,
has been largely rewritten. There are many new
contributors as well as 11 new chapters. It is
separated into four parts on the basics, the
pediatric surgical patient, the organ systems
and special patient problems. The chapters in
all parts are short and precisely written, allow
ing the reader to update quickly his knowledge
of both the basic and practical aspects o f preand postoperative care. The section on organ
systems contains excellent updates on the con
struction and management of alimentary tract
stomas, conditions that are helped by splenec
tomy, the preparation of patients who must
undergo thyroidectomy for Grave’s disease and
the management of those who undergo
adrenalectomy for various adrenal gland
lesions. The topic of surgical nutrition has been
expanded into two chapters — enteral and
parenteral nutrition; they cover in good detail
the rapid expansion of the nutritional field dur
ing the past several years.
Although relatively short, this book covers
a surprising number of surgical topics. It is
clearly intended for practising surgeons and
senior residents, as a high level of background
knowledge and experience is required for most
chapters. While some might find the detail too
scanty, the book will serve most surgeons as
an excellent update for pre- and postoperative
care and as a reference for special situations.
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J o h n H . D u f f , m d , fr csc
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N6A 5A5
OPERATIVE SURGERY. H. Dudley, W.
Posies and D. Carter. 647 pp. Illust. Butterworths, London, Toronto, 1983 (price
not stated). ISBN 0-407-00656-7.

Whenever a book is into its fourth edition,
there is always the danger that only a few cos
metic changes have been made. However, such
criticism cannot be levelled at this book. In
fact, the material covered has been expanded
to include almost the complete gamut of oper
ations performed in the increasingly sophisti
cated specialty o f colonic and rectal surgery.
Many leading authorities have contributed to
this edition.
This is not a textbook of theory; instead, it
was prepared as a “ how to do it” reference.
Since there are many controversial aspects, the
editors often commissioned more than one
author to detail how a certain operation should
be done or to describe more than one opera
tion to correct a given abnormality.
Divided into several sections, the first part
of the book deals with basic technique. The
chapter on colonoscopy is very concise and
helpful, and is the most beneficial for the least
reading to a would-be endoscopist. The chap
ters on anastomoses provide a fine mixture of
theoretical and practical considerations essen
tial to the construction of a sound anastomo
sis. The various options of anastomotic con
struction are well described and illustrated,
including special techniques to be used when
different diameters of bowel lumen are
encountered.
The next section is devoted entirely to stoma
construction. It points out that attention to
minute detail is mandatory in the construction
of a well-functioning stoma. Recommendations
for fitting and care of the appliance are given
— a valuable aid to the surgeon working
without the help of an enterostomal therapist.
The section on inflammatory bowel disease
includes a particularly strong segment that
describes successful resection for diverticular
disease. The newest operation, restorative proc
tocolectomy with an ileal reservoir, as recom
mended by the late Sir Alan Parks, is outlined,
but consideration might also have been given
to the alternative technique o f the J-pouch.
A new and valuable section is devoted to
emergency problems. Methods of handling a
disrupted anastomosis and principles and tech
niques used to manage trauma to the large
bowel are summarized. Bleeding from the
spleen during mobilization of the splenic flex
ure is not uncommon. A detailed method for
this procedure is described and will prove use
ful to the surgeon. Management of large-bowel
obstruction is explained.
In the section on cancer, alternatives to
hand-sewn anastomoses are shown. Greater
detail of stapled anastomotic techniques would
have been useful, especially their pitfalls and
complications. Peranal operative techniques
are especially helpful as many surgeons are not
familiar with these specialized methods. I took
exception to the statement that most surgeons
would undertake an abdominoperineal excision
for a squamous cell carcinoma of the anal

canal; more appropriate, less radical treatment
should be recommended. Specialized proce
dures such as transsphincteric resection of
neoplasms and pull-through procedures are
described in more detail than is necessary. Since
the introduction of the circular stapler the
role of these techniques has diminished and
in any event they have been popular in the
hands of a few.
Throughout the book, sprinkled editorial
comments are used to inform the reader of an
alternative method of treatment or as a means
of polite disagreement with the author. The one
repeated approach which astounded me was the
strong recommendation for the left parame
dian incision.
The broad range of standard operative
procedures for the correction of common
anorectal problems is included. There are
several topics that should have been covered,
such as the Delorme repair for rectal prociden
tia, approaching retrorectal tumours in adults
and managing patients with anal stenosis.
Nevertheless, this book is well assembled, easy
to read, extremely well illustrated and will be
valuable to anyone performing colorectal sur
gery. Even the experienced surgeon will find
tips that will prove useful.
P h il ip H . G o r d o n , m d , f a c s , frcsc
Division of General Surgery,
The Sir Mortimer B. DavisJewish General Hospital,
Montreal, PQ
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STAPLING IN SURGERY. Felicien M.
Steichen and Mark M. Ravitch. 418 pp.
Illust. Year Book Medical Publishers, Inc.,
Chicago, 1984. $81.25 (US). ISBN 0-81517108-0.

Mechanical stapling devices have been around
for a long time. It is only in the past decade,
however, as the instruments became easy to
use, reliable, and ultimately disposable, that
surgeons have enthusiastically embraced them.
Stapling has now become so widespread that
some surgical teachers are concerned that
trainees may not get adequate exposure to con
ventional suturing techniques. In contrast to
the plethora of texts on surgical handicraft,
there is a real lack of a modern, reliable and
objective manual on stapling. Surgeons have
taught themselves, using journal articles and
the manufacturers’ brochures. Steichen and
Ravitch, pioneers of American stapling and
surgeons of great experience and distinction,
have collaborated to produce the first modern
text devoted to stapling. Unfortunately, this
long-awaited text is disappointing.
The first part of the book is a historical
review comprising more than 100 pages. It is
comprehensive, extensively referenced and will
interest the student of surgical history. The sec
tion is profusely illustrated, but unfortunately
many of the old drawings have lost clarity with
reproduction. The remainder of the book
describes the experience with and use of sta
plers in the different anatomic areas in which
the general surgeon operates. There are chap
ters on urologic and gynecologic procedures
and on operations for morbid obesity. Surpris
ingly, the use of staplers in vascular surgery
has been excluded. The introduction of this
section, perhaps the most interesting part of
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all, is a review of the authors’ experience with
over 1000 cases up to 1976. This portion of the
book is also profusely illustrated and here the
drawings are generally clear and helpful. The
authors are obviously determined to be ency
clopedic. The references are exhaustive but
exhausting for the reader. By not excluding a
single published report on stapling, the book
provides a remarkably up-to-date bibliography;
but this also makes it difficult to read and
ensures its early obsolescence. The wealth of
detail is more than most surgeons need or wish.
Moreover, the interminable cataloguing of
authors’ names, dates and numbers of proce
dures is tedious.
This is not a book with which to settle down
for a comfortable evening read. Nor, regret
tably, is it a step-by-step instruction manual.
The stapling neophyte is still better served by
the manufacturers’ hand-outs.
The authors do not indicate for whom the
book is intended. For its historical value the
book certainly deserves a place in the hospital
library but few surgeons will wish to acquire
it for themselves.
M a x M . C o h e n , m d , frcsc
Member,
Editorial Board.
Professor of Surgery,
University of Toronto,
Ste. 440,
600 University Ave.,
Toronto, Ont.
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THE SURGERY OF TUMORS OF BONE
AND CARTILAGE. 2nd ed. Ralph C.
Marcove. 218 pp. Illust. Grune & Stratton,
Inc., Orlando, Fla., 1984. $49.50 (U.S.)
ISBN 0-8089-1656-4.

This book is a monograph rather than textbook
because it covers only those topics that are of
particular interest to the author. It must, there
fore, be read with this in mind.
In the preface, the reader becomes aware
almost immediately that the style is going to
be anecdotal and based on one surgeon’s
experience.
The author organizes the book into evalua
tion of the patient, therapeutic procedures he
uses and specific tumours with which he has
had extensive experience. The organization can
be criticized in that the specific chapters on
bone tumours do not follow the same format.
For each tumour, different aspects are empha
sized according to the author’s interest. For
example, in a chapter on therapeutic proce
dures, \ ' h pages are devoted to a detailed
description of en-bloc resection of the medial
region of the clavicle because the author has
done this procedure on three occasions. There
is also a tremendous emphasis throughout on
the use of cryosurgery. While this is the
author’s particular area of expertise, its over
emphasis is a bit tedious when reference to
alternatives is so brief.
Marcove also makes anecdotal statements
about other forms of surgical therapy in order
to dismiss them as being ineffective, but he
does not back these statements up with data
or references. For example, in the chapter on
giant-cell tumours he states that “ the results
of en bloc excision are poor” but does not sub

stantiate this sweeping statement. In fact, the
chapter on giant-cell tumours concerns his
results with cryosurgery. This type of dismis
sal of other forms of surgical therapy without
factual support is quite upsetting to the reader
who deals with bone tumours.
The black-and-white reproductions o f histo
logic findings are not really of value; they
should either be in colour or omitted com
pletely. The reproduction of roentgenograms
is variable. Some diagrams of surgical proce
dures are too small to interpret and the label
ling is too small to read. The author goes into
some details about his own surgical procedures
but does not provide quite enough detail for
the reader to use these portions of the text as
an operative manual.
The chapter on therapeutic procedures again
emphasizes cryosurgery, the Tikhoff-Linberg
procedure and en-bloc excision of tumours
around the knee with prosthetic replacement.
These are, of course, procedures that Marcove
has written about extensively in the literature.
Although he refers to his articles throughout
the text, he makes very few references to arti
cles on the same subject by other authors.
Moreover, data given in the text are taken from
his own articles, some of which are not up to
date, and he does not seem to have made any
attempt to update the data for this particular
book. Marcove has, however, many interest
ing ideas and because of this, some of the chap
ters are particularly interesting, such as those
on aneurysmal bone cyst, giant-cell tum our,
chondrosarcoma, Ewing’s sarcoma and osteo
genic sarcoma.
The value of this monograph is only to the
orthopedic surgeon who is interested in how
Marcove treats specific bone tumours. It is not
to be used as a reference text and will be of
little value to medical students or even trainees
in orthopedics, who need a much broader
picture.
A lla n E . G r o ss , m d , frcsc
Professor of Surgery,
University of Toronto,
Chief, Orthopedic Service,
Combined Toronto General Hospital/
Mount Sinai Hospital,
Ste. 437,
600 University Ave.,
Toronto, Ont.
M5G 1X5

T R A N SIE N T ISCH EM IC A T T A C K S.
Science and Practice of Surgery, V ol. 3.
Edited by Peter J. Morris and Charles
Warlow. 412 pp. Illust. Marcel Dekker,
New York, 1982. Price not stated. ISBN
0-8247-1447-4.

Morris and Warlow have brought together an
international collection of recognized authori
ties on occlusive cerebrovascular disease in an
attempt to assemble in one text the current state
of knowledge on transient ischemic attacks. In
this attempt they generally have succeeded. The
majority of the chapters are well written and
comprehensive, limited by the year of publi
cation, with few references past 1980, and mul
tiple authors, resulting in variable quality.
Harrison’s chapter on the pathophysiology
of transient focal neurologic events is excellent.
He considers there to be two factors, a cerebral
lesion and a vascular lesion; he discusses each

one and its clinical implications. In two very
good, complementary chapters, Thomas and
Mitchell discuss the hyperviscosity syndromes
and the difficulties of consistently finding a
platelet abnormality in patients with transient
ischemic attacks. The chapter on the cardiac
causes of neurologic dysfunction is good and
includes an excellent discussion of the risks and
benefits of anticoagulation with Coumadin in
the treatment of cardiac sources of emboli.
Wilson presents the clinical features and
differential diagnoses of transient ischemic
attacks, making a valid point that computer
ized tomography should precede angiography
to rule out other causes of transient cerebral
dysfunction. The excellent chapter on neu
roradiology is followed by a comprehensive one
on noninvasive imaging techniques.
The management of patients with transient
ischemic attacks secondary to atherosclerotic
thromboembolism is controversial with only
rare agreement between any two authors.
Warlow, in the chapter on medical manage
ment, stresses the control of risk factors, espe
cially hypertension, and evaluates the use of
anticoagulants and antiplatelet agents. A good
chapter on the techniques of carotid endar
terectomy by Thompson and Tackington fol
low s. M o rris briefly sum m arizes the
pathophysiology of vertebrobasilar ischemia
then concisely describes the various surgical
approaches used to improve blood flow to the
posterior circulation. Barnett provides an excel
lent chapter on extracranial to intracranial
arterial bypass surgery, describing the indica
tions for its use and outlining the collabora
tive extracranial and intracranial bypass trial.
This book emphasizes the lack of experimen
tal models for and hard clinical data on tran
sient ischemic attacks. Many widely held
assumptions and caveats are based on anecdo
tal reports and small, uncontrolled series of
patients. O f the many opinions expressed in the
various chapters, some are peculiarly British
and not universally agreed upon. The use of
general anesthesia for angiography and
intraoperative shunting during carotid endar
terectomy is not of proven benefit. A few chap
ters do not attain the standard set by the
remainder of the book, such as those on the
epidemiology and pathology of cerebral
atherosclerosis, kinking of the carotid arter
ies and surgery on the asymptomatic lesion.
The most striking aspect of this text is the
importance o f a transient ischemic attack to
the patient and the subsequent increased risk
of cerebral or myocardial infarction. The
reduction of this risk has excited considerable
interest and this text is the result of that
interest. Some questions have been answered,
but many more remain unanswered. The edi
tors have appreciated this uncertainty, hoping
that these unknowns will be the stimulus for
ongoing, future research.
This book is a valuable addition to the liter
ature and will also be of value to any student,
clinician or scientist interested in occlusive
cerebrovascular disease.

S.J. P e e r l e s s ,

m d , frcsc

Professor and Chairman,
Division of Neurosurgery,
Department of Clinical Neurological Sciences,
University o f Western Ontario,
London, Ont.
N6A 5A5
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The Aberdeen Hospital is seeking an individual w ith
leadership capabilities to establish a Department o f Or
thopedic Services.
The Aberdeen is a fully accredited regional hospi
tal located in New Glasgow, Nova Scotia near the
Northumberland Strait. The hospital has recently com
pleted phase I of renovation and reconstruction which
includes a new Physiotherapy Department. It is an
ticipated that phase II w ill commence in the near fu 
ture, which w ill consist of upgrading and expansion
o f existing patient care areas and departments.
Applicants are invited to apply for this challenging
opportunity and are asked to send resume to :

The Administrator
Aberdeen Hospital
New Glasgow, NS B2H 3S6
S85-024
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Bactrim

CLINICAL BURN FELLOWSHIP - A 6-month or
12-month clinical burn fellowship is available at
the regional adult Burn Centre at the Wellesley
Hospital, beginning January 1, 1986. The unit is
a new, 10-bed, ultramodern burn centre. Position
to ta lly funded. Research grants and laboratory
space available. For more information contact :
Dr. Walter J. Peters, Suite 224, Turner Wing,
Wellesley Hospital, 160 Wellesley St. E., Toron
to, ON M4Y 1J3.
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SURGEON: ON — Listowell, serving a referral
population of 18 00 0 people in the north end of
Perth County of Ontario, will require a general
surgeon in 1986 to replace retiring surgeon who has
been in the community for 15 years. The town has a
population of 5000 people and is the centre of com
merce for a prosperous dairy and cattle area. The
hospital is well equipped and operates 87 beds.
There are nine family physicians in Listowel. Ex-

KIDNEY FOUNDATION
RESEARCH FELLOWSHIPS
ALBERTA, CANADA 1 9 8 6 -8 7
A pplications invited fo r Postdoc
to ra l M e d ic a l F e llo w s h ip s in
Nephrology or Urology to run con
currently from Ju ly 1, 1 986 at the
University o f Alberta, Edmonton and
the University of Calgary (Faculty of
Medicine).
Interdisciplinary training in basic
research and/or clinical investigation
available. Programs provide oppor
tu n ity fo r full enrollm ent in School
o f Graduate Studies.
Salary concordant w ith q ualifica
tions and prior training to maximum
$35 0 0 0 per annum.
Fellowship is fo r 1 year, but 2nd
year application anticipated.
For application form s c o n ta c t :
Kidney Foundation o f Canada, A l
berta Branch, 2 0 8 , 8 5 4 0 — 109
S treet, Edm onton, Alberta T6G
1E6.
APPLICA TIONS POSTMARKED
AFTER SEPTEMBER 16, 1985 WILL
N O T BE ACCEPTED.
-S 8 5 -2 2

344

Glycerin Suppositories
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GENERAL SURGEON — Required by the M anito
ba Clinic, a large multispecialty group in Winnipeg,
Manitoba. Applicants must have obtained, or be
eligible and w illing to sit the specialty examina
tions of the Royal College of Physicians and
Sugeons of Canada. Preference will be given to
applicants w ho have successfully completed ad
ditional training in a subspecialty. For further in
form ation and details w rite to the : Chairman,
Manitoba Clinic, 790 Sherbrook St., Winnipeg,
MB, Canada R3A 1M3
S85-23

cellent golf and curling facilities. One hour's drive to
Lake Huron and the University of Western Ontario,
and 1-1/2 hours' to Georgian Bay and BlueMountain skiing. Time to establish practice is flexi
ble. New office facilities under construction. Con
tact: Dr. F. Ellingham, A d m in istra to r, The
Listow el M em orial Hospital, 255 Elizabeth St.
E., Listow el, ON N4W 2P5.
-S 85-25

308, 30 9, 310

NEUROSURGEON
The Moncton Hospital, a teaching 540-bed regional hospital,
is looking for an additional neurosurgeon to join tw o active staff
neurosurgeons.
The hospital, currently undergoing a $50 million redevelopment
project, serves as the Neurological and Trauma Centre to a popu
lation base of over 500 000 people.
Candidates should be eligible for licensure in the Province of New
Brunswick, and be certified w ith the Royal College of Physicians
and Surgeons of Canada.
Applications may be submitted in confidence to :
Dr. Ginette Gagne-Koch
Medical Director
The Moncton Hospital
135 MacBeath Avenue
Moncton, NB
E 1C 6Z 8

-S 8 5 -2 1
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